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The parasite secretome has been shown to play a key role in both pathogenicity and 
the regulation of host defence, allowing pathogens, such as helminths, to establish a 
chronic infection within the host. The recently discovered presence of extracellular 
vesicles within parasite-derived excretory-secretory products introduces a new 
mechanism of potential cross-species communication. Extracellular vesicles (EVs), 
such as exosomes, facilitate cellular communication through the transfer of small 
RNAs, lipids and proteins between cells and organisms across all three kingdoms of 
life. In addition to their roles in normal physiology, EVs also transport molecules 
from pathogens to hosts, presenting parasite antigens and transferring infectious 
agents.  
Here, I examine secreted vesicles from the murine gastrointestinal nematode 
Heligmosomoides polygyrus, and their potential role in the host-helminth 
interactions. Transmission electron microscopy reveals vesicle-like structures of 50-
100 nM in the ultracentrifuged secretory product, and potential evidence of multi-
vesicular bodies in the worm intestine. This, coupled with information from the 
exoproteome, helped support the hypothesis that exosomes originate from the 
parasite intestinal tract.  
I have completed a series of studies looking at the fundamental properties of 
exosome-cell interactions, providing comparative studies between mammalian and 
H. polygyrus-derived exosomes. I have determined some of the key factors 
influencing exosome uptake, including time of incubation, cell type and exosome 
origin.  Through microarray analysis of H. polygyrus exosome-treated small 
intestinal epithelial cells, we see significant gene expression changes, including those 
involved in the regulation of signalling and the immune response, such as DUSP1 
(dual-specificity phosphatase) and IL1RL1 (the receptor for IL-33). The modest 
reduction of inflammatory cytokine responses by exosomes in small intestinal cell 
lines was amplified in immune cells, such as macrophages. Exosomes can 
significantly reduce expression of classical activation markers, as well as 
inflammatory cytokine production in the macrophage cell line RAW 264.7, and this 
is further supported by similar responses in bone marrow-derived macrophages. 
! vi!
Owing to their suppressive nature, I demonstrate that immunization of mice 
with an exosome/alum conjugate generates significant protection from a subsequent 
H. polygyrus larval challenge, as seen through a reduction in egg counts and worm 
burden. 
I have investigated the role of the IL33 receptor (IL-33R); a key molecule 
associated with parasitic resistance that is suppressed by exosomes in type-2 
associated immune responses. Uptake of H. polygyrus-derived exosomes by 
alternatively activated macrophages caused the suppression of type 2 
cytokine/protein release and the reduction of key genes associated with this 
phenotype. In addition, there was also significant repression of both transcript and 
surface T1/ST2, a subunit of the IL-33R). Using a model of lung inflammation, in 
vivo studies demonstrate that, in both prophylactic and co-administration 
experiments, exosomes modulate the innate cellular response. This is represented by 
changes in the number of innate lymphoid cells (ILCs), bronchoalveolar lavage 
eosinophils and type-2 cytokine output. In this system, the expression of T1/ST2 on 
type 2 ILCs was also significantly reduced. 
I have extended the investigation on exosome-IL-33R responses by using 
T1/ST2 knockout mice. Despite generating strong antibody responses, vaccination 
against exosomes could not protect T1/ST2 knockout mice against a subsequent 
infection.  
This work suggests that exosomes secreted by nematodes could mediate the 
transfer and uptake of parasite products into host cells, establishing cross-species 
















Almost a quarter of the world's population suffer from soil-transmitted helminth 
infection, with the majority prevailing in impoverished regions such as eastern Asia, 
sub-Saharan Africa and the Americas.  The increasing incidence of anti-helminthic 
drug resistance in livestock poses a huge socio-economic problem, in addition to the 
potential human threat via infection. Therefore, it is essential that we harness a 
greater understanding of the interactions that occur between parasites and their hosts, 
as this can lead to the development of more effective treatments for helminthic 
disease. Correspondingly, helminth parasites generally establish long-term 
infections, reflecting their ability to drive a new physiological and immunological 
status within their host. Identification of the immunosuppressive molecules that 
helminths use to evade host defence could potentially provide a new approach for the 
treatment of inflammatory and allergic-based conditions such as colitis and asthma.  
                Unfortunately, human helminthiases are difficult to study in a laboratory 
setting, and research can be further hindered due to poor financial investment and 
public awareness. Therefore, animal models of helminth infection are used due to 
similarities in the pathogenesis and lifecycle stages, which can then be extrapolated 
for human study.   
                It has been shown that parasites’ secretory products, including glycans, 
extracellular vesicles and metabolites, can play a key role in both pathogenicity and 
host immunoregulation. Exosomes are small cell-derived vesicles (50-100nm), which 
facilitate communication through the transfer of cellular components (such as 
antigens and small nucleic acids), and are released from the majority of cells.  
                We have demonstrated that secreted vesicles from the murine 
gastrointestinal nematode Heligmosomoides polygyrus (a model of human 
hookworm infection) exhibit a range of immunosuppressive and regulatory 
properties on murine cell lines and in vivo. However, fundamental questions still 
remain about host-parasite communication.  
Comparative studies between mammalian and H. polygyrus-derived 
exosomes highlight some of the key factors responsible for exosome uptake. This 
allowed us to then focus on blocking parasite-derived exosome entry into 
mammalian cells in vitro, inhibiting any parasite-mediated effects on the host cell. 
! viii!
Additionally, I showed that immunization of mice using an exosome/alum conjugate 
contributes to significant protection from a subsequent H. polygyrus infection. This 
vaccination generates sterile immunity against larval challenge, seen through the 
initiation of antibody responses against exosomes, resulting in a reduction of 
parasitic egg counts and worm burden. 
           Conversely, we looked to exploit the immunomodulatory features of H. 
polygyrus exosomes. Using a model of lung inflammation, we found that nasal 
administration of exosomes suppressed the innate cellular immune response in the 
lung tissue (one which would normally drive the symptoms of asthma). This 
demonstrated the ability of parasite-derived exosomes to suppress an inflammatory-
mediated disease, and highlights a potential starting point to test therapeutic 
strategies using exosomes, especially for airway allergy.  
          This project provides a greater understanding of the properties of helminthic 
exosomes and host-parasite communication, and offers new strategies on how we can 
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Chapter 1: Introduction 
 
1.1! Neglected tropical disease 
1.1.1!Introduction – epidemiology and current statistics 
More than one billion people worldwide are affected by parasitic disease, including 
malaria [1] and neglected tropical diseases (NTDs) such as leishmaniasis, Chagas 
disease and helminthiases [2] with the majority prevailing in developing regions such 
as eastern Asia, sub-Saharan Africa and the Americas. One way to assess overall 
disease impact is to score the disability-adjusted life year (DALY). This method is 
used by the World Health Organisation (WHO) to evaluate the number of years of 
‘healthy’ life lost due to premature mortality combined with years lost to disabilities 
induced by a particular disease. Data from the Global Burden of Disease Study in 
2013 states that malaria and NTDs account for approximately ~5% (more than 26 
million DALYs) of the total number of years lost due to ill-health, disability or early 
death worldwide [3].  
 
Susceptibility to disease correlates highly with the geographical location and 
economic status of an individual. Currently, just under half of the world’s population 
live in low-to-middle-income countries. Approximately 65 -80% of people requiring 
treatment for NTDs live within these regions (generally from lower-to-middle income 
countries [2]). Social determinants in impoverished areas; including poor education, 
diet, financial instability, agriculture, struggling healthcare systems and a lack of 
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government intervention are major factors for the persistence of NTDs today [4].   
Furthermore, the lack of sanitation (both in terms of availability and education), is a 
major player for NTD transmission and longevity, especially in soil-transmitted 
helminth infections [5]. The consequences of some NTDs, such as long-term illness, 
decreased productivity and absenteeism from work, contribute to an endless cycle of 
poverty, leading to larger socioeconomic consequences worldwide.  
 
The London Declaration for eradication or control of ten NTDs (lymphatic 
filariasis, onchocerciasis, soil-transmitted helminths, schistosomiasis, trachoma, 
leprosy, human African trypanosomiasis, Chagas disease, visceral leishmaniasis and 
dracunculiasis) in 2012, called for the participation of large pharmaceutical 
companies, governments of affected impoverished nations and charitable 
organizations or foundations and private financial donors in order to achieve this goal  
[6]. This was generated with the aim of providing easy accession to drugs and 
chemotherapeutics, as well as support for other preventative methods such as 
distribution of mosquito netting and the installation of clean water systems. Indeed, 
around 70% of R&D invested in infectious disease in 2014 has been focused on ‘the 
big three’; malaria, HIV/AIDS or tuberculosis (TB), and less than 20% spent on the 
other major NTDs identified by WHO [7]. Furthermore, investment on 
research/therapeutics of major helminth diseases (lymphatic filariasis, hookworm 
infection, trichuriasis, schistosomiasis, and ascariasis) was only ~17% of the funds 
distributed in 2011, despite being responsible for 87% of DALYs and behind three-
quarters of all mortalities caused by NTDs [8].   
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1.1.2!Health status and co-morbidities 
Most DALY statistics associated with NTDs could be attributed to the chronic nature 
of some of these diseases. These can lead to lifelong disabilities such as mental and 
physical retardation, malnutrition, anaemia and lymphoedema [9], contributing to 
productivity loss in the global workforce. Most NTDs, including soil-transmitted 
helminthiasis, are not often thought of as fatal diseases when compared to mortality 
rates of HIV/AIDs or TB patients. However, they actually do contribute to the 
significant burden of “co-morbidities” with either the top three infectious diseases, as 
well as many other health conditions [10]. This is especially concerning, when the 
major group affected by helminthiasis are children of school-age [11]. The main 
species of helminths that infect people are the roundworm (Ascaris lumbricoides), the 
whipworm (Trichuris trichiura) and the hookworms (Necator americanus and 
Ancylostoma duodenale). The geographical overlap is not the only factor that 
contributes to co-infections. For example, the ability of helminths to establish an 
‘immunosuppressed’ or type-2 environment within the host during chronic infection 
[12], can help support the establishment and transmission of other infections, such as 
HIV, malaria and tuberculosis [10]. There are also data suggesting that helminthic 
infection can limit vaccine efficacy, such as associations with enteric-stage 
Schistosoma japonicum infection and the hepatitis B vaccine [13]. However, there are 
some conflicting reports of this phenomenon in vaccination against other viruses [14]. 
This may be due to the potency or construct of the vaccine, which may have to be 
altered following the consideration of a helminth co-infection and its potential 
consequences [15]. Correspondingly, most of the immunomodulatory effects induced 
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by helminth infection can be reversed following drug-mediated parasite clearance 
[16-18]. 
 
1.1.3!Current therapeutics and limitations 
One of the current priorities for WHO looks at tackling the 17 major NTDs by 2020 
[19]. WHO estimates that just 0.1% of domestic expenditure on health projected to be 
spent in low to middle income countries for the next ~15 years would be sufficient to 
fund their contribution to universal NTD treatment [2]. Achieving internationally 
agreed targets of NTD control and elimination [6] will result in significant 
improvements in health and reductions in morbidity, with a projected >80% of the 
global reduction in low to lower-middle income countries (the worst-affected by 
NTDs). This would also reduce the prevailing between-country health inequalities 
normally associated with poverty. Targets include vector transmission control 
(mosquito nets, topical treatments, etc.) and ensuring availability of both preventative 
chemotherapeutics and anti-parasite drugs. Drug donations to United States Agency 
for International Development, have exceeded $11 billion in value, and are to be 
distributed in mass treatment campaigns within a number of developing countries 
[20].  
 
Whilst there has been significant progress in drug-donation programs, there 
are a number of limiting factors that could prevent total success, considering the large 
number of people (more than 1 billion) targeted in more than 100 countries 
worldwide. However, the prospect of drug resistance is alarming, with an increasing 
incidence both in livestock (with the potential threat of zoonotic transmission [21]), 
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and in humans [22], as well as having strong economic and social implications [23]. 
Furthermore, most of the targets for elimination focus on inhibition of transmission 
and infection cycles, with little recognition given to treatment of NTD-induced 
morbidity. A comprehensive programme to treat NTDs must also include 
management of morbidity. For example, reducing the prevalence of disease-
associated stigma, generating support for mental health care, funding surgical 
alleviations and providing livelihood initiatives for those unable to work due to 
morbidity [24]. A longer-term solution, especially for NTDs such as soil-transmitted 
helminth (STH) infections, would be to promote the large-scale improvement in 
sanitation, access to clean drinking water and to educate on the merits of good 
hygiene practice [5]. 
 
1.2! The immune response to helminth infection 
As previously stated, almost one third of the global population is infected with 
helminths, whereby chronic infection has strong implications for co-morbidity, 
permanent disabilities, and the global economy [19]. Unfortunately, human 
helminthiases are difficult to study in a laboratory setting, and research can be further 
hindered due to low study numbers, the variability of subjects, the development of 
potential co-morbidities and poor financial investment. Therefore, veterinary models 
of helminth infection, such as those found in rodents, livestock and canines are used 
[25], due to some similarities in the pathogenesis and lifecycle stages, helping to 
elucidate the host immune response to helminths. One such model is the 
gastrointestinal nematode, Heligmosomoides polygyrus, a natural parasite of wood 
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mice. Although the immune response to H. polygyrus is still being characterized, the 
parasite induces a mixed Th2/T regulatory environment, maintaining longevity and 
establishing a chronic infection within the host [311]. As a murine parasite, H. 
polygyrus offers a tractable model to study chronic helminth infection in a laboratory 
setting (given the length of time it can reside in the murine host), and resides in the 
same Clade (Clade V) as the human hookworms Necator americanus and 
Ancylostoma duodenale. Although rodent models of hookworm infection, such as H. 
polygyrus and Nippostrongylus brasiliensis, offer an alternative model of study to 
human-infective species, they fail to fully recapitulate the characteristic responses to 
human hookworm infection, such as hyporesponsiveness to low level infection, and 
most importantly, anaemia (caused by blood feeding by the parasite) [434]. Despite 
this, we can extrapolate some of the information taken from animal studies, such as 
the detailed characterisation of the type-2 immune response to helminth infection, and 
use this as a framework for future studies in humans. An overall summary from what 
is known of the immune response to helminth infection is shown in Figure 1.1. 
 
1.2.1!Innate Immune Responses 
The primary encounter between parasite and host will often occur at a barrier surface 
(such as skin or intestinal epithelium), which can mediate pathogen recognition via 
pattern recognition receptors (PRRs) or release various ‘alarmins’ [26]. Whilst the 
role of toll-like receptors (TLR) in type-1 pathogen pattern recognition is now well 
understood [27], there is no defined system recognition of Th2-inducing organisms 
such as helminths or fungi. Despite this, there is some literature describing the 
presence of TLR ligands from helminths, including the lyso-phosphatidylserine 
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glycolipid from Schistosoma mansoni [28] and double-stranded RNA in SEA (soluble 
extract from S. mansoni eggs), which is shown to activate TLR3 [29]. There are also 
other receptor systems, such as the C-type lectin receptors (CLRs), which recognise 
nematode glycans to facilitate host immunity [30].  
 
Some alarmins are released to promote mucosal barrier repair, such as 
protease-resistant Trefoil factor family peptide-2, which initiates IL-33-driven 
hookworm expulsion and tissue repair [31].  The release of alarmin cytokines, 
including IL-25, IL-33 and Thymic Stromal Lymphopoietin (TSLP), is closely 
associated with helminth-mediated tissue damage [32-34]. These cytokines promote a 
pro-allergic and anti-helminth immune response by promoting the maturation of 
monocytes, function of innate cells and type-2 immune responses. More recently, tuft 
cells (an intestinal epithelial crypt population) were shown to be a major source of IL-
25 during helminth infection, promoting a strong ILC2 response and goblet cell 
hyperplasia [35]. Additionally, these cells expand during both IL-4Rα activation or 
Nippostrongylus brasiliensis infection [36]. These cells have chemosensory 
properties, potentially used in the detection of parasite-derived molecules, with both 
studies demonstrating that tuft cells are central to IL-25-driven intestinal immunity 
against helminths. Consequently, blocking the IL-25, IL-33 or TSLP response (or a 
combination thereof) can sustain a chronic helminth infection [37, 38]. Importantly, 
these cytokines are crucial for the activation of type-2 innate lymphoid cells (ILC2) 
[39]. ILC2s are a prominent early source of type-2 cytokines, such as IL-5 and IL-13 
[40], and promote both innate eosinophil responses [41] and adaptive Th2 responses 
[42]. A recent paper also demonstrates that ILC2s may be a source of IL-4, required 
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for Th2 differentiation during Heligmosomoides polygyrus infection in vivo [43]. 
Interestingly, IL-9 was shown to be critical for ILC2-mediated cytokine responses 
and barrier repair during the lung stages of N. brasiliensis infection [44].  
 
Other innate effector cells also play a role in helminth-mediated immunity. 
Basophils are an early source of IL-4 during helminth infection [45] that release 
vasoactive substances like histamine upon degranulation, and are also important for 
mediating IgE-dependent secondary immunity to helminth infection [46]. A strong 
indicator of both helminth infection and type-2 allergic responses is often observed by 
the induction of eosinophilia [47, 48]. Driven by both IL-5 and eotaxin, eosinophils 
are suggested to be another early source of IL-4 during nematode infection [49]. 
Furthermore, eosinphillic granule proteins were shown to mediate protection against a 
primary infection with the filarial parasite Brugia malayi, regulating IgE antibody 
responses and lung inflammation [50]. In addition to direct parasite killing, 
eosinophils also limit tissue larval stage survival and migration in secondary 
infections in other nematodes [48]. 
 
There is also literature demonstrating the importance of the type-2 immune 
driven mucus response, also known as the ‘weep’ response. The mucus layer provides 
a physical barrier, and is maintained by specialised epithelial cells known as goblet 
cells. Goblet cells are shown to provide luminal antigens to antigen presenting cells 
(APCs) [51], as well as releasing effector molecules to drive the anti-parasite 
response, such as mucins and resistin-like molecules (RELM) [52, 53]. Innate sources 
of IL-4 and IL-13 promote the secretion of mucin-5ac and RELM-β from goblet cells, 
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and were shown to be essential for N. brasiliensis expulsion [54]. Notably, either 
mucin-2 or mucin-5ac deficiency led to limited worm expulsion in different 
gastrointestinal nematode infections [55, 56], demonstrating the importance of 
mucosal responses in parasitic immunity. Furthermore, goblet cell-derived RELM-β 
is also implicated in immunity to H. polygyrus, by reducing both adult worm fitness 
and fecundity [52]. 
 
 In addition to the mucus response, there is evidence that pulmonary epithelial 
cells can release surfactant-protein-D following the lung stages of N. brasiliensis 
infection. This is shown to enhance both the ILC2 and alveolar macrophage 
responses, driving immunity and subsequent killing of the parasite [57].  
 
1.2.2!M2 macrophages 
There has long been an appreciation for the role of macrophages in helminth 
infection, often providing a link between innate and acquired immune responses [58]. 
These cells, which can be initially driven under the influence of IL-4 and IL-13, 
polarise to an anti-parasite or wound-healing phenotype, where they become known 
as alternative activated macrophages (AAM), where they are also classified as M2 
macrophages [59]. The sources of IL-4 and IL-13 can derive from innate cells, such 
as ILC2s [60], basophils [45], and possibly eosinophils [49], with adaptive T cell-
derived IL-4/IL-13 required for a sustained AAM response that promotes wound 
healing [61]. Furthermore, AAM polarisation can be significantly enhanced by IL-33 
(with AAMs expressing the cognate receptor, IL-33R or T1/ST2) during airway 
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allergy and inflammation [62]. Knockout studies have also demonstrated the 
importance of global [63], and macrophage-specific, IL-4 receptor-alpha (IL-4Rα)  
[64] in facilitating responses to gastrointestinal nematodes, as well as expression of 
downstream TFs, such as Signal Transducer and Activator of Transcription-6 (STAT-
6) [63]. IL-4-driven macrophage recruitment and subsequent effector mechanisms, 
such as intestinal smooth muscle contractility, are required to mediate parasite 
expulsion [65]. IL-4Rα signalling in AAMs was shown to be important for activation 
of these cells, helping to ameliorate acute inflammatory responses during S. mansoni 
infection [66]. IL-4Rα signalling is also important for wound healing during helminth 
infection e.g. caused by N. brasiliensis larvae migrating through the lung. This was 
shown to drive AAM-mediated release of molecules such as insulin-growth factor-1 
(IGF-1), which is known to facilitate tissue repair [67]. In addition, AAM expression 
of programmed death ligand 2 (PD-L2) is dependent on the IL-4/STAT6 pathway. 
This inhibitory ligand binds to a cognate T cell receptor PD-1 (programmed-death 1), 
regulating Th2 cell proliferation and function during N. brasiliensis infection in the 
lung [68]. Furthermore, there is data demonstrating the capacity of AAMs to undergo 
site-specific proliferation, driven by IL-4, during infection with the filarial nematode 
Litomosoides sigmodontis [69]. This overcomes the potentially counter-active 
inflammatory response that could be induced by blood monocyte recruitment. Taken 
together, these data show varied roles for IL-4Rα in AAMs during type-2 immune 
responses, required at different stages of infection, from clearance to repair.   
 
However, it should be mentioned that recent evidence suggests that an IL-4Rα 
independent pathway could also drive AAM polarisation; such is seen in Trichinella 
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spiralis infection [70]. Additionally, there is data suggesting that IL-4Rα-/- 
macrophages can display some hallmarks of alternative activation, and can still 
immobilize the larval stage of H. polygyrus when supported by specific antibodies 
generated against the parasite [71]. Furthermore, M2 polarization is becoming 
increasingly more complex, with the identification of an epigenetic regulator Jmjd3 
and its target, the TF IRF4, shown to induce M2 polarization to both N. brasiliensis 
infection and following the administration of chitins (sugars found in fungi and 
parasites) in vivo [72]. Finally, the role of cellular metabolism and it's influence on 
macrophages polarisation has been described. It has been shown that aerobic 
glycolysis is required for the rapid generation of an M1-centric innate anti-bacterial 
response, driving the production of reactive-oxygen species and nitric oxide whilst 
blocking other methods of metabolism, such as oxidative phosphorylation. 
Consequently, it is oxidative metabolism that drives the differentiation of 
macrophages to a M2 state, and this can also be enhanced by IL-4 stimulation, 
subsequently leading to mitochondiral biogenesis and respiration [73].  
!
Macrophages, like epithelial cells, have a suite of PRRs on their surface. 
Despite the wealth of literature surrounding M1 macrophage PRRs, there is limited 
data available for M2 macrophages, with the focus largely directed to helminth-
derived PAMPs on DC innate receptors [33]. Some studies now show that parasite 
secreted molecules which activate the MAPK pathway via PRRs can induce IL-10 
production in macrophages [74]. IL-10 is an anti-inflammatory cytokine strongly 
associated with AAMs, and suppression of T cell-mediated pathology during 
infection [75]. The critical balance of TLR signalling is evident from studies with S. 
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mansoni, where elevated levels of CD14 (an inflammatory TLR4 accessory protein), 
correlated with reduced STAT6 activation and corresponding M2 responses, 
potentially to limit any type-2 mediated pathology [76]. 
 
AAMs secrete a number of factors involved in the type-2 immune response to 
helminths. The macrophage-derived protease inhibitor, serpinB2, has been shown to 
promote both Th2 and mucosal immunity, as well as inducing positive feedback for 
macrophage polarization and infiltration [77]. Conversely, parasite-derived serpins 
have been associated with dampening the alarmin cascade or degrading components 
of the cellular immune response [78]. There is also interesting data on the 
macrophage migration inhibitory factor (MIF), a pleiotropic mediator, which is 
normally considered to promote macrophage-driven inflammation [79]. Recently, it 
was shown that MIF deficient mice had stronger Th2-driven anti-parasite responses, 
mediating greater expulsion during N. brasiliensis infection [80]. The paper also 
showed that MIF deficiency resulted in reduced numbers of IL-6-producing CD4+ T 
cells, suggesting a further role of IL-6 deficiency in promoting Th2-mediated 
expulsion of H. polygyrus [81]. Interestingly, MIF deficient mice are more 
susceptible to Taenia crassiceps [82], but this may be due to the mixed Th1/Th2 
response induced by this parasite, where early Th1 responses are required for 
protection against the larval stages [83].  
 
Chitinases such as YM1 [chitinase-3-like-3 (Chi3l3)] and AMCase (acidic 
mammalian chitinase) are strongly upregulated in AAM during both allergic 
responses and nematode infection, and are produced to break down chitins from 
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parasites or other allergens [84, 85]. The function of Ym1 is still relatively unknown, 
although it has been shown to initiate IL-17A-driven neutrophilia in the lung 
following infection by N. brasiliensis. However, whilst the host Ym1/IL-17A 
response limits parasite survival in the small intestine, it results in an increased 
likelihood to develop acute lung pathology [86]. The association of AMCase with 
allergic airway responses are well defined, where it serves as a biomarker in human 
asthma [87]. AMCase is also upregulated during nematode infection [84] although 
their role, until recently, was less understood. AMCase-deficient mice failed to clear 
infection by N. brasiliensis, with reductions in Ym1 and IL-13 expression in the lung 
and intestine respectively [88]. Furthermore, these mice, although capable of 
expelling a primary H. polygyrus infection, failed to clear a secondary infection, and 
this was associated with reductions in IL-13, Ym1 and RELMβ and a decrease in 
mucus production. Another key protein associated with AAM is the resistin-like 
molecule, RELMα  [85], with expression correlating to both nematode infection and 
IL-4Rα signalling. Previous studies have highlighted a counter regulatory role of 
RELMα (from both macrophages [89] and eosinophils [90]) in parasite infection. 
During S. mansoni infection, both pulmonary inflammation and parasite expulsion 
were enhanced in Retnla-/- mice, demonstrating the potential role of RELMα in 
balancing type-2 immunity. Lastly, the enzyme arginase-1 is another important 
marker for AAM. Arginase competes with the classically activated macrophage 
molecule, inducible nitric oxide synthase (iNOS), for a shared arginine substrate, 
shifting the immune response to prevent inflammation. Arginase-1 has also been 
proposed to modulate intestinal inflammation during a S. mansoni infection by 
promoting T regulatory cell responses [91]. In the context of H. polygyrus, higher 
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transcript levels of arg1 were found in more resistant strains of mice during infection 
[92]. Recent evidence suggests that arginase can facilitate trapping of H. polygyrus 
larvae by antibodies [71], demonstrating a direct inhibitory function of this protein, in 
addition to balancing type-1/type-2 inflammation. 
 
These studies collectively suggest that macrophage-secreted molecules 
contribute to type-2 immunity in a context-dependent manner, and this should be 
noted during future studies into allergies, atopies and parasitic infections. AAMs play 
a crucial role during helminth infection; enabling parasite expulsion through IL-4Rα-
driven ‘weep and sweep’ responses [59], as well as promoting both innate and Th2 
cell responses. AAMs also contribute to host protection, both through the release of 
molecules that enable tissue repair, as well as facilitating immune regulation through 
the release of immunomodulatory cytokines and proteins. 
 
1.2.3!Dendritic cells 
DCs are professional APCs that can polarize a Th2 response against helminth 
infection [93], and like macrophages, can often represent a link between innate and 
adaptive immunity. DCs, in a similar fashion to macrophages and ILC2s, can initiate 
the response to parasites by sensing epithelial alarmins including IL-25, TSLP and 
IL-33 [32, 33]. DCs can also recognize a host of PAMPs, such as double-stranded 
RNAs in SEA via TLR3 [29] and calreticulin from the larval stages of H. polygyrus 
via the scavenger receptor [94]. Additionally, the role of CLRs in in parasite product 
recognition/uptake by dendritic cells is becoming more established [95]. Specifically, 
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there is data demonstrating that the SEA antigen, omega-1 [96], and glycans derived 
from Fasciola hepatica ES [97], can bind to mannose-type receptors, leading to their 
internalisation. Interestingly, the uptake of these glycans may favour the parasite 
rather than the host, by inducing type-2 polarisation of DCs to limit TLR-driven 
immunity and inflammatory responses. In addition to innate recognition, dendritic 
cells also play a crucial role in priming adaptive immunity. Specific depletion of 
CD11c+ dendritic cells resulted in diminished Th2 effector responses during chronic 
infection in two helminth mouse models; S. mansoni and H. polygyrus [98, 99]. 
Particular transcription factors (TFs) have been highlighted when identifying 
dendritic cells that promote this type of immunity. For example, IRF4 (interferon-
regulatory family member-4) expressing dendritic cells were important for driving 
Th2 polarization and immunity to N. brasiliensis [100, 101]. Furthermore, mice 
deficient for the TF BATF3 had enhanced type-2 immune responses in helminth 
infection, with accelerated clearance of H. polygyrus infection [102]. Although their 
function during helminth infection is still to be fully characterized [103], these data 
give insight into the important role that DCs play in inducing and promoting Th2 
immune cell responses. 
 
1.2.4!Acquired immune responses 
Acquired immunity to helminths involves a concerted effort of different immune 
cells. Following their activation by cells in the innate immune compartment, CD4+ 
Th2 cells play a central function in the adaptive immune response to helminths. 
During a helminth infection, naïve T cells interact with ILC2s or APCs to recognize 
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antigen and receive co-stimulation [42, 101]. These cells subsequently receive 
polarizing IL-4 signals from innate cell sources [45, 49, 60], to differentiate into Th2 
cells. Generally, CD4+ T cell responses are considered to rely on parasite-derived 
antigens to initiate protective adaptive responses [104]. However, there is some data 
suggesting they can take on a more ‘innate’ role following helminth infection [105]. 
This study demonstrated that a secondary challenge, with either a different helminth 
or an airway allergen, resulted in Th2 effector responses independent of the T cell 
receptor. Activated Th2 cells release a host of cytokines that have been previously 
shown to facilitate type-2 immunity, including IL-4, IL-5, IL-9, IL-10 and IL-13 
[106]. T cell-derived IL-4 and IL-13 have been shown to mediate B cell maturation 
and IgE/IgG1 class-switching [107]. This response is of particular relevance to 
vaccination studies during a model H. polygyrus infection, whereby protection against 
larval challenge is mediated by IgG1 antibodies [108]. T cell-derived IL-4/IL-13 is 
also shown promote AAM generation and innate immune cell recruitment during 
nematode infection [54, 109].  
 
T cells can also release the immunosuppressive cytokine, IL-10, in response to 
repeated skin challenge with S. mansoni cercariae, regulating local inflammation and 
T cell proliferation [110]. Moreover, helminths have been shown to drive the 
activation of T regulatory cells (T regs) [111]. Specifically, H. polygyrus larvae have 
been shown to drive local T reg expansion in peyer’s patches and MLN [112]. These 
cells limit Th2-mediated immunity and pathology [113], and are shown to correlate 
with chronicity of parasite infection [111, 114]. Interestingly, dampening the effector 
immune response will benefit both host and parasite, controlling excessive 
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inflammation in the host (caused by barrier damage or granuloma formation), but at a 
cost of suppressing active immunity or killing of the parasite. Incidentally, the 
immunosuppressive response induced during some STH infections can render the 
host more susceptible to co-infection [10], or limit the efficacy of particular vaccines 
[13].  
Despite a prominent regulatory environment, the induction of Th2 memory 
responses was shown to be critical for parasite expulsion during secondary infection 
[115]. There is also data suggesting that T follicular helper cells act as an alternative 
source of IL-4 [116], driving the secondary humoral response within lymphoid 
follicles during nematode infection [117].  
 
B cells can also support Th2-mediated immunity during helminth infection 
[107]. During H. polygyrus infection, B cells promote T cell expansion, maintenance 
of antibody responses (discussed below) and worm expulsion [107, 118]. B cells have 
also been shown to support antigen-dependent CD4+ T cell immunity to N. 
brasiliensis infection [119]. A large body of literature supports the capacity of 
antibody responses to mediate anti-helminth immunity, with elevated levels of IgE or 
IgG associated with protection in animals [120] and humans [25, 121]. Indeed, it has 
been shown that polyclonal IgG1 responses, but not IgE or IgA, were essential for 
parasite expulsion during H. polygyrus infection [108]. Functionally, IgE was shown 
to inhibit migration of N. brasiliensis larvae by binding to basophils via the Fc!-
receptor [122]. IgE was also shown to promote mast cell recruitment to eliminate T. 
spiralis larvae [123]. The capacity for helminths or helminth-derived antigens to drive 
strong antibody responses offers an interesting perspective for the development of 
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future anti-parasite treatments. However, given the variability of protection mediated 
by B cells during different infections [118], consideration must be given to other 
effector cells working in tandem with the humoral response to establish anti-helminth 
immunity.  
 
1.3! Modulation of the host immune system by 
parasites 
The co-evolution of helminth parasites with their hosts has occurred over millions of 
years [124]. This has required these pathogens to develop a host of molecular 
adaptations to manipulate, suppress or activate different host cells in order to 
maximise parasite survival in their chosen niche [125]. Helminths suppress host 
detection systems that would otherwise initiate a ‘danger’ response, and then 
effectively tolerise the immune system to parasite antigens (Figure 1.2). 
Consequently, helminth-induced immunoregulation can dampen responses to 
bystander antigens in allergy or autoimmunity [126]. The on-going modulation of the 
host immune response requires a constant dialogue between the parasite and host, 
something that can be reversed using anti-helminthic treatments [16-18]. Ivermectin 
has been shown to inhibit the secretion of immunosuppressive proteins by B. malayi 
[127], whereas other anti-helminthics have also been shown to suppress the parasite-
induced T reg response [128]. These therapeutic interventions can thereby improve 
responses to co-infections like TB and malaria [129, 130], as well as promoting better 
vaccine efficacy in helminth-endemic regions [131]. However, as repeated anti-
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helminthic treatment can lead to drug resistance [22] it is essential that future 
interventions (such as vaccines) are developed to enable longer-term immunity.  
 
1.3.1!The hygiene hypothesis 
The ability of helminths to suppress the host immune system has been widely 
associated with the ‘hygiene hypothesis’ (HH) [132]. This was first recognized back 
in 1968, whereby ‘immunological disturbances’ generated by multiple parasite 
infections could lead to the low level prevalence of autoimmunity in tropical Africa 
[133]. The official proposal of the HH occurred in 1989, following observations that 
increased microbial exposure in early life could protect children from developing 
immune hypersensitivities later in life [134]. In the case of helminth infection, the HH 
refers to the inverse correlation between rates of helminthic burden with the incidence 
of autoimmune or hypersensitivity disorders, such as Inflammatory Bowel Disease 
(IBD), allergy, multiple sclerosis and rheumatoid arthritis [132]. Additionally, there is 
added complexity of the influence of helminth infection on the establishment of the 
intestinal microbiota, which has subsequent consequences on development of the 
immune system [135]. A recent study found that helminth infection controlled 
colonization of particular bacterial species associated with protecting or promoting 
IBD [136]. This is supported by an earlier study, which demonstrated use of helminth 
infection as a therapeutic against Idiopathic Chronic Diarrhoea by restoring 
populations of protective intestinal flora [137]. The relationship between helminths 
and local microbiota is immensely complex, having effects on host immunity and 
nutritional status, parasite viability and bacterial colonization. This emerging field of 
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research will require further study to determine whether this represents a viable 
alternative for anti-helminthic treatment. 
 
These data have led to the use of helminths, their ova (egg cells) or excretory-
secretory products (ES) in the treatment against atopic and autoimmune diseases 
[138, 139]. Allergic disease has been more difficult to control using helminth-based 
therapies [140], as overall, studies show that helminth infection could not control 
asthma in humans. This is surprising given the potency of some helminth-ES products 
in suppressing airway allergy in mice [141, 142], which suggest that these 
interventions may improve inflammation-induced pathology. However, human trials 
may not consider outside factors like time of trial (considering the seasonality of 
some atopies), or may be due to limitations in dosage of the parasites or their ova. It 
may also be due to inadequate study design, as recent restructure of a hookworm-
based trial for coeliac disease improved clinical outcomes [143]. The 
immunosuppression that is caused by helminth infection is both incredibly complex 
and context dependent. As such, isolating helminth products with similar 
immunomodulatory properties, such as those found in ES, represent a more focused 
option for treatment. 
 
1.3.2!Evasion strategies 
Immune evasion is imperative for parasites to maintain a chronic infection within 
their host. Some intracellular parasites, such as Leishmania, escape complement-
mediated lysis and immune cell recognition through alterations of surface antigens 
[144]. In parallel, some parasitic nematodes can undergo rapid turnover of their 
! ! Chapter!1!
! ! ! ! ! Chapte!
! 21!
cuticle, resulting in shedding of surface antigens preventing an antigen-specific 
immune response [145]. Indeed, the large diversity of surface antigens in parasites 
could hinder the development of an effective vaccine. Larval life stages of helminths, 
such as T. spiralis and Echinococcus spp., occupy physical niches, such as nurse cells 
and hyatid cysts, to evade immune attack [146]. Interestingly, immune evasion may 
be stage-specific, requiring adult-stage ES to induce modulation to host responses 
[147].  
 
1.3.3!Parasite excretory-secretory products 
Parasites are able to modulate the host immune response to a remarkable degree 
[148, 149]. Parasite excretory/secretory (ES) products may play a significant role in 
immunomodulation, as, for example S. mansoni secretes an omega-1 glycoprotein 
demonstrated in a number of studies to promote Th2-skewing of dendritic cells and T 
cells during infection [96, 150]. Indeed , a lot of literature points to the 
immunomodulatory effect of ES on both macrophages and DCs through PRRs [149]. 
The interactions between innate receptors and parasite products offer a potential 
target for future intervention, potentially to limit uptake of parasite products or 
inhibit skewing of host immunity. H. polygyrus secretes a functional transforming 
growth factor-" (TGF-") homologue to initiate immune regulation [151]. Indeed, 
extensive data attest to the ability of singular parasite molecules to reduce immune 
activation [149]. The ES-62 molecule, secreted by Acanthocheilonema viteae, is 
shown to have potent anti-inflammatory properties on mast cells [152] and affects 
downstream signalling of TLR4 in macrophages, promoting bias towards a M2 
phenotype [153]. Another example is the immunomodulatory lipoprotein, Antigen B, 
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secreted by Echinococcus granulosus, which facilitates Th2 polarisation and limits 
migration of neutrophils to the site of infection [154]. Helminth cystatins are also 
known to have a range of immunomodulatory functions, limiting both antigen 
presentation and DC differentiation [155] to induction of IL-10 release [74]. 
Protozoan parasites similarly secrete a range of immunomodulatory molecules. For 
example Trypanosoma cruzi mucins have been associated with suppression of active 
T cell immune responses by inducing arrest in the cell cycle [156]. Secreted parasite 
proteins have also been proposed to be involved in metabolic adaptation to the host 
environment [157] and tissue invasion where proteases are shown to play a major 
role [158]. Owing to their importance, we have to consider how a large variety of 
different parasite-derived molecules are packaged and delivered successfully to the 
host, evading host immune clearance to carry out their specific functions.  
 
1.4! Extracellular vesicles 
1.4.1!Origin and discovery 
In mammalian systems, extracellular vesicles (EVs) represent a previously under-
appreciated mechanism that allows successful transfer of genetic material, proteins 
and lipids between cells and tissues. These complex vesicles, which include 
exosomes, ectosomes and microparticles, communicate by carrying a range of 
specific molecules and targeting motifs to reach and interact with their cell of interest 
[159]. Microvesicles can be difficult to distinguish from exosomes, but are generally 
up to 1 µm in diamteter and bud from the plasma membrane, incorporating certain 
lipids, surface proteins and other molecules prior to fission [160]. Exosomes are 
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classified as endocytic vesicles of around 50-100 nm size, which are released from 
most cell types [159]. In recent years, the literature surrounding EV function has 
exploded as their ubiquity in many biological and disease contexts has become 
realized [161]. Historically, these were first identified in reticulocytes as a 
mechanism to release transferrin receptors during maturation [162, 163]. However, 
early on it was generally considered that exosomes function as disposal units of 
cellular waste, transporting obsolete proteins to the lysosomal compartment for 
degradation [159]. Almost two decades later, exosomes then became of interest to 
immunologists as EVs released by B cells and DCs contain major histocompatibility 
complexes and can present antigens [164, 165]. However, following the report that 
functional messenger RNA (mRNAs) and microRNAs (miRNAs) are transferred 
between mast cells via exosomes [166], there was further momentum in studying 
EVs as a mechanism of cell-cell communication. 
 
1.4.2!Biogenesis and cargo selection 
Exosome biogenesis is initiated by inward budding of multi-vesicular endosomes or 
multi-vesicular bodies (MVBs) (Figure 1.3), forming intra-luminal vesicles (ILVs). 
Upon fusion of the MVB with the plasma membrane and their subsequent release, 
these vesicles are then known as exosomes [167]). The molecular sorting of the 
cytosolic contents of the parent cell, and subsequent release, is regulated by 
intercellular Rab GTPases [168], which enable encapsulation of proteins, lipids and 
RNAs into ILVs. The specificity of cargo loading has been demonstrated for 
miRNAs, signalling molecules, tetraspanins, lipids, and others [167]. Consequently, 
exosomes express markers of their parent cells, and their presence in bodily fluids 
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make them useful biomarkers revealing the condition of host cells and tissue injury 
[169] including the diagnosis of some cancers [170]. The presence of many key 
proteins, as well as RNA species, in secreted vesicles highlights both the complexity 
and diversity of cargo within exosomes, with a correspondingly wide range of 
potential interactions within recipient cells [171]. Exosomes are also specifically 
enriched in other molecules associated with their biogenesis by the endosomal sorting 
complexes required for transport (ESCRT) pathway, such as Alix, which is used to 
initiate vesicle formation [172], or  tetraspanins such as CD9 or CD63, which support 
vesicle formation and targeting to recipient cells [173]. The ESCRT pathway, 
composed of approximately 30 proteins that group into 4 complexes, are recruited 
into the multi-vesicular endosome upon recognition of ubiquitinated proteins [174], 
inducing invagination of membrane into vesicle ‘buds’, and drive vesicle scission 
(reviewed in [175]). The release of EVs into the extracellular environments, mediated 
by MVB fusion to the host cell plasma membrane, is poorly understood, although has 
been associated with fusogenic machinery such as SNAREs (soluble N-
ethylmaleimide-sensitive fusion protein-attachment protein receptor) [176], in 
addition to Rab-GTPases [168].  
Exosomes are retained within late endosomes (MVBs) until they are released 
into the extracellular environment. Cargo selection, MVB maturation and subsequent 
plasma membrane fusion is an active process, requiring a host of cell factors that are 
still relatively unknown. Once these limitations are overcome, we can develop new 
methods to manipulate exosome biogenesis and release, important for the generation 
of new exosome or EV-based therapeutics and interventions. Adding to this 
complexity, is establishing the route whereby exosomes are internalised by host 
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cells. It is routinely suggested that exosomes, and other EVs, are internalised by 
cellular endocytosis. Of note, a recent study demonstrated the method by which 
exosomes are said to "surf" on filopodial extensions from the cell prior to 
internalisation, a method which the authors show is dependent on actin 
polymerisation [177]. However, other work has shown that EVs may also enter by 
direct fusion [178], macropinocytosis or indeed phagocytosis (all reviewed in [179]). 
This is discussed in more detail in Chapter 4.  
 
1.4.3!Functions and therapeutic potential 
Extracellular vesicles have been shown to play a variety of functions in immune cell 
activation and suppression [180] and are also proposed to play a role in disease 
development and tissue homeostasis [181]. An ever-expanding literature has also 
demonstrated various roles of EVs in cancer, since tumours also secrete these 
vesicles with oncogenes [170], including those seen in gastrointestinal stromal 
tumour cell lines [182]. Exosomes and other EVs are now part of larger clinical 
initiatives to test their properties in drug delivery, for example, transporting small 
RNAs and chemotherapeutic agents [183]. As previously mentioned, they have also 
been hailed for their potential as diagnostic biomarkers [169], and function as 
modulators in disease, for example, by cell regeneration [184]. Whilst the majority of 
this work has focused on oncology [185], these vesicles also have exciting 
implications across a range of infectious diseases. The development of a directed 
anti-pathogen response by host exosomes has also been explored. Several studies 
have shown that host exosomes collected from parasite antigen-primed dendritic 
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cells induce protection from different protozoan infections, including Toxoplasma 
gondii [186] and Leishmania major [187].!
 
1.5! Parasite-derived extracellular vesicles 
The functional importance of EVs during parasitic infection is becoming greatly 
appreciated [188], distinguishing their roles in immunomodulation, and transfer of 
material between parasites or with their host (see Table 1). In this broader setting, 
exosomes and other microvesicles may not only serve as a functional mechanism 
used by parasites to evade host responses, but equally host exosomes may be part of 
an effective anti-parasite strategy (Figure 1.4). 
 
1.5.1!Intracellular protozoan parasites - host manipulation by 
EVs 
Several protozoan parasites have been shown to release exosomes and/or 
microvesicles including Leishmania species [189] and Trypanosoma cruzi [190-192], 
the parasites which cause human leishmaniasis and Chagas disease respectively. 
Seminal reports showed that promastigote and amastigote forms of Leishmania 
donovani and Leishmania major can release exosomes that are detected in host cells 
and selectively induce IL-8 secretion from macrophages [193, 194]. The subsequent 
chemokinetic recruitment of neutrophils has been proposed as a ‘Trojan horse’ 
effect, whereby Leishmania can invade these cells and gain access to macrophages 
upon phagocytosis of the infected neutrophils [193, 195]. Leishmania exosomes have 
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also been shown to induce the release of the immunosuppressive cytokine IL-10, and 
inhibit the inflammatory cytokine tumour necrosis factor (TNF) in human monocyte-
derived dendritic cells in response to interferon # (IFN#). Pre-treatment of mice with 
exosomes derived from L. major and L. donovani resulted in exacerbated infection 
and pathogenesis in vivo, associated with enhanced IL-10 production and a skewed 
Th2 response preventing parasite expulsion, as a type-1 response is normally 
required for clearance [193]. Specific components of Leishmania exosome cargo 
have also been identified and shown to be involved in immunomodulation, including 
elongation factor 1 alpha (EF-1$) and the membrane-bound metalloprotease GP63 
[196].  These have both been associated with a suppression in signalling events 
during a pro-inflammatory IFN# response by monocytes (and potentially, subsequent 
Th1 polarisation) [194, 197].  GP63 is also associated with a number of downstream 
modulatory effects during Leishmania infection, including the modulation of 
inflammation by activating macrophage protein tyrosine phosphatase (PTP) 
signalling. This metalloprotease has also been shown to impact protein sorting into 
the exosomes and to inhibit miRNA processing in host cells by targeting the 
endoribonuclease DICER [196] [198, 199].  
 
At least two types of EVs have been identified from the infective (metacyclic 
trypomastigotes) and non-infective (epimastiogotes) forms of T. cruzi parasites: both 
forms release microvesicles from the plasma membrane as well as exosomes 
presumed to derive from the endocytic pathway [190]. Following initial 
identification of these EVs [200], they were shown to contain a cohort of proteins 
associated with immune modulation and virulence and include the homolog to the 
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multifunctional metalloprotease GP63 [190] described above. Notably, following 
inoculation of parasite microvesicles and subsequent infection with T. cruzi, mice 
develop heightened cardiac parasitism and increased inflammatory infiltrates 
associated with higher levels of IL-4 and IL-10 [192]. These cytokines induce the 
polarization of a Th2 response, as well as lower levels of iNOS in the tissue, 
suggesting that these microvesicles may serve to promote parasite dissemination and 
enhance survival.  Acid phosphatases involved in adherence and infection of 
different trypanosome strains have also been shown to be present in the 
microvesicles [201].  
 
1.5.2!Intracellular protozoan parasites - host manipulation to 
release EVs 
In addition to the direct secretion of exosomes and microvesicles by these 
parasites, both Leishmania spp. and T. cruzi induce the release of exosomes from the 
cells that they infect. A study of L. mexicana-treated macrophages in vitro showed 
that exosomes released from infected cells are capable of inducing phosphorylation of 
signalling proteins and significantly upregulating immune-related genes, including 
adenosine receptor 2a (Adora2a) on macrophages [197]. Interestingly, Adora2a 
receptor activation on these cells by Escherichia coli, another pathogen which 
normally drives type 1 immune responses, has been associated with increased IL-10 
and down-modulated TNF [202]. Conversely, a recent study suggests that exosomes 
from L. amazonensis-infected macrophages can prime other naïve macrophages to 
initiate anti-parasitic Th1 responses through the release of inflammatory cytokines IL-
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12, IL-1" and TNF [203].  T. cruzi also induces the release of microvesicles from 
infected host cells, including lymphocytes and monocytes in vitro and erythrocytes in 
vivo. These microvesicles express surface TGF-", which has been shown to facilitate 
eukaryotic cell invasion by the parasite and leads to maturation and continuation of 
the lifecycle [204]. The microvesicles also protect extracellular life cycle stages of T. 
cruzi (including epimastigotes from the vector and trypomatigotes from ruptured 
cells) from complement-mediated attack, thus facilitating parasite invasion of host 
cells [205]. More specifically, monocyte-derived microvesicles develop a complex 
with the complement C3 convertase C4b2a on the parasite surface, limiting the 
interaction with its substrate C3. The inhibition of this crucial step prevents 
complement-mediated lysis, opsonisation and the release of anaphylatoxins, 
subsequently leading to increased parasite survival [204].  In an analogous manner, 
erythrocytes infected with the malaria parasite, Plasmodium falciparum, produce 
microvesicles that enhance dose-dependent secretion of proinflammatory cytokines 
such as IL-1", IL-6, and IL-12 from monocytes following phagocytosis [206]. In the 
context of malaria infection, it has been hypothesized that these cytokines may aid 
endothelial cell activation and erythrocyte sequestration, thereby prolonging 
infection. 
 
1.5.3!Extracellular parasites – communication within their 
environment 
An obvious function of EVs in extracellular pathogens is their ability to 
protect secreted cargo and move this into host cells.  However mechanistic aspects of 
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this are not understood, including whether there is specificity in the uptake by certain 
cell types, whether the parasite cargo is recognized by the host immune system, and 
how communication is carried out between two phylogenetically distant species. 
Among extracellular protozoan parasites, comparative analysis of the secretome of 
Trypanosoma brucei subspecies, the causative agent of African sleeping sickness, 
identified a number of exosome-associated proteins such as enolase, heat-shock 
protein 70, and the clathrin heavy chain. Different members of the metallopeptidase 
family are also found in the secreted microvesicles and may serve as potential drug 
targets or even diagnostic biomarkers during stages of African trypanosomiasis [207]. 
Complimentary studies on the T. brucei secretome also demonstrate the presence of 
50-100 nm vesicles budding from the plasma membrane of the infective parasite 
[208]. The parasitic protozoan Trichomonas vaginalis, which can cause infertility 
through sexual transmission, has been shown to release functional exosomes that can 
play a role in both parasite-to-parasite, as well as parasite-to-host communication 
[209]. Virulence proteins, such as metalloproteases, are present within the exosomes 
that are able to specifically downregulate IL-8 secretion by ectocervical cells 
(potentially limiting neutrophil migration in order to prevent pathogen clearance). 
 
1.5.4!EVs from microorganisms and ectoparasites - more 
players at the extracellular surface 
Other eukaryotes, such as the pathogenic fungus, Paracoccidioides brasiliensis, 
release highly immunogenic EVs that are detectable in the sera of 
paracoccidioidomycosis patients [210]. One such immunogenic epitope is the 
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cellular membrane carbohydrate, galactose-$-1,3-galactose ($-Gal), which is not 
found in human cells. Although $-Gal enriched EVs may generate a robust immune 
response in the host, they are suggested to be beneficial to the pathogen, both by 
binding to host lectins, and potentially stimulating a suppressive type 2 response. 
This is in accordance with previous literature showing that $-Gal enriched T. cruzi 
exosomes are able to stimulate IL-4/IL-10 expression in cardiac tissue and 
splenocytes [192].  Indeed, many types of opportunistic fungi including 
Cryptococcus neoformans, Candida albicans and Histoplasma capsulatum, release 
EVs [211, 212], which have been suggested to contain virulence-associated factors 
including polysaccharides and lipids, reviewed further in [213]. The EVs released by 
C. neoformans, for example, are enriched in virulent capsular components such as 
glucosylceramide and glucuronoxylomannan (GXM) [214]. Interestingly, a recent 
study has shown the importance of phospholipid translocases (flippases) in C. 
neoformans exosome packaging and transport, whereby mutant Apt1 flippase-
knockout fungi have diminished levels of GXM, and are consequently unable to 
successfully colonize the lung and brain of infected mice [215]. Furthermore, the 
yeast Malassezia sympodialis, a component of natural human flora, is able to release 
extracellular vesicles capable of inducing IL-4 and TNF secretion from peripheral 
blood mononuclear cells, enhancing an inflammatory response in patients afflicted 
with atoptic dermatitis [216]. Fungal-released EVs may also induce antimicrobial 
activity by host cells: EVs released by C. neoformans are taken up by macrophages 
in vitro and stimulate TNF, IL-10, TGF-β, and nitric oxide production [217].  
A recent study in the argasid tick, Ornithodoros moubata, suggests that some 
immunomodulatory proteins may be secreted in arthropod saliva and it is tempting to 
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speculate that EVs would also be found in this environment. Proteomics of the tick 
saliva reveal a number of exosome associated proteins e.g. aldolase and enolase, as 
well as anti-inflammatory lipocalins, which serve as scavengers of leukotrienes, and 
adenosine nucleotides at the location of the bite [218].  It is clear that we are only at 
the beginning of many new discoveries concerning extracellular parasites and the 
functionally diverse EVs they might secrete. There are a growing number of reports 
containing proteomic matches to exosome proteins in parasite secretomes, and this 
should cement the idea that these are probably used by most, if not all pathogens at 
some stage in their life cycle. The effect that parasite-derived EVs may exert at this 
interface will be of particular importance in the context of anti-parasite treatment. 
Addtionally, due to the ability of some parasite-derived EVs to suppress an innate 
immune response [219] these may also be useful tools to ameliorate inflammatory-
associated disease [149]. 
 
1.5.5!Extracellular pathogens – helminth-derived EVs 
Helminth worms are ubiquitous pathogens of plants and animals that have co-
evolved with their hosts for hundreds of millions of years, using sophisticated 
mechanisms for manipulating them [149]. It has only recently been demonstrated 
that these complex parasites also secrete exosomes, and potentially other classes of 
EVs, into the environment where they can be internalized by host cells. Marcilla et al 
[220], showed that EVs derived from the trematodes, Fasciola hepatica and 
Echinostoma caproni, are detectable on tegumental surface of the parasites. 
Furthermore, these EVs are internalised by rat intestinal epithelial cells in vitro, and 
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contain homologues of proteins found in mammalian exosomes. Notably, earlier 
work examining the glycocalyx of S. mansoni cercariae demonstrated the potential 
presence of structures similar to multi-vesicular bodies adjacent to the schistosomula 
tegument [221]. Furthermore, a recent study has discussed the presence of exosome-
like vesicles secreted by S. japonicum adults, which were shown to induce 
macrophage polarisation to a M1 phenotype, thereby highlighting the potential 
immunomodulatory properties of schistosoma-derived exosomes and their role 
during infection [222]. 
 
A previous report demonstrated that the model free-living nematode 
Caenorhabditis elegans releases peptide-containing exosomes using a defined apical 
secretion pathway [223] and it is expected that EVs may be used by all nematodes, 
either as a mechanism of cell-to-cell communication within the organism or, when 
exported outside of the organism, as a mode of communication with other species. In 
addition to the above reports, analyses of secretion products from other helminths 
suggest the presence of exosome-associated proteins, including CD63-like 
tetraspanins from the cestode E. granulosus [224]. As previously mentioned, 
tetraspanins are a set of membrane-bound proteins which have been implicated in the 
formation and targeting of exosomes to recipient cells [173]. As these proteins 
appear to be conserved amongst mammalian and pathogenic EVs, their role in EV 
function must be investiagted further. Interestingly, tetraspanins have independently 
been suggested as promising targets for vaccination against another parasite, 
Echinococcus multilocularis, the causative agent of alveolar echinococcosis [173, 
225]. Sotillo et. al. further reported that adult S. mansoni worms release 50-130nm-
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sized exosome vesicles, containing over 80 identifiable proteins, 5 of which are 
tetraspanins and an abundant saposin-like protein [226].  Finally, a recent report 
showed that the liver fluke Opisthorchis viverrini, a trematode prevalent in parts of 
South-East Asia, releases secretory material contained exosomes with spectrum of 
associated proteins, including tetraspanins [227]. Most significantly, O. viverrini 
exosomes were found to stimulate cell proliferation in a human cholangiocyte cell 
line, and also induce the production of the pro-inflammatory cytokine IL-6 in a 
manner that was partly inhibited by an anti-tetraspanin antibody. This suggests 
targeting exosomes via their surface proteins may provide an important anti-parasite 
vaccination strategy.  
 
1.6! EVs in other communication  
1.6.1!Host to parasite communication –defence or support? 
As parasites have evolved to secrete vesicles that are able to effectively interact with 
the host, it is only logical that the host would also use this pathway as a defence 
mechanism. Indeed, during infection with a rodent malaria parasite, Plasmodium 
berghei, plasma cell-derived microvesicles induce CD40 on antigen presenting cells, 
generating a potent inflammatory response through T cell priming and effector 
initiation [228]. Subsequently, macrophage activation may be responsible for 
clearance of the parasite. This is further supported by studies in Plasmodium vivax 
infection in humans, whereby immune cell-derived microvesicles are associated with 
higher acute inflammation in the pursuit of parasite eradication [229]. These 
mechanisms can be exploited in a therapeutic context; for example, murine 
! ! Chapter!1!
! ! ! ! ! Chapte!
! 35!
reticulocytes infected with the non-lethal Plasmodium yoelii X strain can 
significantly attenuate pathogenesis when transferred into mice which are then 
infected with lethal strain, P. yoelii XL [230]. On a separate note, intestinal epithelial 
cells were shown to increase the release of antimicrobial peptide-containing 
exosomes in response to Cryptosporidium infection, which is driven by enhanced 
toll-like receptor 4 signalling following recognition of the protozoan parasite [231]. 
The facultative intracellular bacterium Mycobacterium tuberculosis induces exosome 
release by infected macrophages, which consequently promotes recruitment of 
lymphocytes through heightened inflammatory chemokine secretion (such as 
RANTES and MIP-1$) [232]. In addition, exosomes derived from Mycobacterium 
bovis-infected macrophages are able to promote dendritic cell activation, as well as 
generating an antibacterial T cell response in vivo [233].   
 
Host-derived exosomes also play important functions in antigen presentation. 
Dendritic cells pulsed with T. gondii antigens are able to induce both a systemic and 
local humoral response against the parasite in vivo, thereby serving as an efficient 
vaccine against toxoplasmosis [186, 234]. Similar results are seen in a vaccine trial 
with L. major-challenged DC exosomes, showing that DC-derived exosomes are able 
to mediate protective Th1 immunity against cutaneous leishmaniasis in a cell-
independent manner [187]. Importantly, several studies have emerged using DC-
derived exosomes for protection against common livestock parasites. Chickens 
vaccinated with Eimeria parasite antigen-loaded DC exosomes were able to 
successfully ameliorate symptoms of avian coccidiosis caused by several species, 
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Eimeria tenella, Eimeria maxima and Eimeria acervulina, as well reducing mortality 
rates [235]. 
 
1.6.2!Parasite to parasite communication – crosstalk 
In addition to manipulation of the host immune response, EVs can also mediate 
intercellular communication between parasites. It has been reported that 
microvesicles traffic between P. falciparum-infected erythrocytes enhances the 
commitment of asexual parasites to the sexual stages (gametocytes) to promote 
transmission [206, 236]. Furthermore, it is suggested that EVs (described by Regev et 
al. as “exosome-like” [236]) secreted by erytrocytes following infection with 
transgenic P. falciparum parasites can rescue parasitic growth by transferring DNA 
encoding a drug resistance marker to other P. falciparum in infected cells.  Thus, 
genetic material can be transferred between the infected erythrocytes via 
microvesicles, and this may also contribute to the sexual development mentioned 
above.  This pathway has been shown to be dependent on trafficking mechanisms 
which transport parasite-encoded proteins to the host-erythrocyte membrane through 
membranous structures called Maurer’s clefts which are found in infected 
erythrocytes [236]. 
 
A further example is provided in the case of the extracellular parasite 
Trichomonas vaginalis. Pre-incubation with exosomes released from a more adherent 
strain of the parasite, B7RC2, can induce better adherence of weaker strains, such the 
lab strain G3, in a dose-dependent fashion, which is not seen in the converse scenario 
[209]. These are some of the few examples to date of vesicle involvement in parasite-
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to-parasite communication. This likely represents a bias in the literature, which 
focuses largely on the immunomodulatory properties of parasite secretion products. 
In the microbial context, it is well established that secreted vesicles play a role in 
microbe-microbe communication and genetic exchange, reviewed in [237]. There are 
still many gaps in our understanding of how different eukaryotic parasites 
communicate with one another to regulate aspects of their life cycles, including 
reproduction or commitment to transmission stages. It will be interesting to see if this 
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1.7! Aims of the thesis 
Broadly, this work aimed to characterise extracellular vesicles found in the 
excretory-secretory products released by adult H. polygyrus worms. The field of 
exosome research is still very much in its infancy, requiring standardization in 
vesicle detection, identity, and origin. This has been an ongoing process, given the 
breadth of the field, whereby extracellular vesicles have been shown to be released 
by virtually all mammalian cell types, and are associated with a number of host 
diseases. The release of vesicles by an extracellular parasite adds further novelty to 
this field and in the context of the host-parasite relationship. It was therefore 
important to isolate H. polygyrus-derived exosomes for further study, establishing 
new methods for their detection, and determining their role in cross-species 
communication. The mains questions of this study are;  
 
Where do exosomes originate from in H. polygyrus, and how can they be 
characterised? 
There is limited evidence available about helminth-derived exosomes, and nothing is 
currently known about their biogenesis and origins in nematodes. In this novel 
biological system, it is necessary to understand the localization and mechanisms of 
how exosomes are formed, as this may be key to their function. I plan to address this 
by: 
•! Analysing the proteomic profile of exosomes – determining 
enrichment of surface markers to hypothesise origin and unique 
characteristics compared to total HES. 
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•! Using common methods of extracellular vesicle analysis and 
optimising their use for parasite-derived exosomes e.g. silver stain, 
western blot, flow cytometry and qNANO particle analysis. 
•!  Developing tools, e.g. a H. polygyrus exosome-specific antibody, to 
detect exosomes. 
•! Identifying the vaccine candidates present in exosomes for future 
therapeutic interventions. 
 
What are the fundamental interactions between H. polygyrus exosomes and host 
cells? How does this affect host cell immunity?  
The dynamics of exosome-cell interactions are poorly understood. As exosomes 
contain a suite of bioactive molecules, such as small RNAs, lipids and proteins, we 
must determine how these contents could be delivered into host cells, and whether 
they mediate any effect. This will be especially interesting given that these exosomes 
are isolated from H. polygyrus ES (HES), which is known to have a broad 
immunoregulatory functions in the host. It is therefore prudent to define the potential 
mechanisms of exosome uptake, and how exosomes may function in host cells. This 
was addressed by: 
•! Visualising exosome uptake over the course of time and under different 
stimulatory conditions. 
•! Attempting to interfere with exosome uptake, and establishing how this may 
affect the function of exosomes. 
•! Determining any effects on the host by miRNAs that are enriched in parasite-
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derived exosomes.  
•! Determining the modulatory effects of exosomes on different cells in vitro; 
e.g. epithelial cells and macrophages, during both type 1 and type 2 immune 
responses (as both would occur during a gastrointestinal helminth infection). 
•! Examining exosome uptake in the small intestine using a model organoid 
culture. 
 
Can exosomes be used in a therapeutic capacity during allergic/inflammatory 
responses in vivo?  
Both H. polygyrus, and its excretory/secretory product (HES) can create a down-
modulated immune environment in vivo, suppressing responses to bystander antigens 
during allergic or autoimmune disease. As exosomes derive from HES, their potential 
contribution to these responses must be explored. This was addressed by: 
•! Determining the modulatory effects of exosomes in a model of airway allergy, 
testing their ability to modulate immunity in a prophylactic manner or 
following recall responses.  
•! Analysing the different cell populations and cytokines associated with the 
alarmin/type-2 response in this model following exosome treatment. 
 
Do exosomes contribute to the establishment of a H. polygyrus infection? 
It has been previously demonstrated that vaccination against the ES products of H. 
polygyrus can protect from a subsequent larval challenge, thus demonstrating the 
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importance of HES in establishing infection. It would be useful to elucidate the role 
of exosomes during natural infection, and determine whether they are immunogenic. 
The importance of this can be realised when designing anti-helminthic drugs and 
future vaccinations. This was addressed by: 
•! Employing the alum-adjuvant vaccination model, vaccinating mice with 
exosomes, HES or HES depleted of exosomes before a challenge infection. 
•! Determining the antibody responses elicited by exosomes, and whether this is 
specific to these vesicles or shared amongst other components of HES. 
 
Why does H. polygyrus-derived exosomes suppress the IL-33 receptor in 
mammalian cells? Does this contribute to their functional properties in host cells or 
during infection?  
A secondary unit of work in this thesis focused on the associations between exosomes 
and the IL-33 receptor (commonly referred to as T1/ST2), which was shown to be 
suppressed in a number of the models investigated during my PhD. Given the strong 
association of this receptor with anti-parasitic responses (whereby T1/ST2 knockout 
mice have differing susceptibilities to helminth infection), the suppression of IL-33R 
by exosomes was studied in greater detail. This was addressed by: 
•! Analysing the effects of exosomes on alternative activation of macrophages in 
the absence of IL-33R. 
•! Determining the susceptibility of T1/ST2 knockout mice to H. polygyrus 
infection. 
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•! Determining the effects of exosome vaccination in T1/ST2 knockout mice 
following a larval challenge. 
•! Establishing whether exosomes can still induce antibody responses in T1/ST2 
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Chapter 2: Materials and Methods 
 
2.1 Buffers and Solutions 
 
2.1.1 Protein lysis buffer 
1% Nonidet P-40 (Sigma-Aldrich) 
50 mM Tris-HCl pH 7.4 (Thermo Fisher Scientific) 
150 mM Sodium Chloride (Sigma-Aldrich) 
2 mM EDTA (Sigma-Aldrich) 
1/100 Protease and Phosphatase inhibitors (Sigma-Aldrich) 
 
2.1.2 Western Blot Buffers 
Western Blot 4X Reducing Sample Buffer 
NuPAGE® LDS sample buffer (4X) (Invitrogen)  
8% β-2-mercapthoethanol (Sigma-Aldrich) 
 
Western Blot Running Buffer 
NuPAGE® MOPS SDS Running Buffer 20X for BisTris gels (Invitrogen) 
 
Western Blot Transfer Buffer 
NuPAGE® Transfer Buffer 20X for BisTris gels (Invitrogen) 
10% Methanol (Thermo Fisher Scientific) 
 
Western Blot Wash Buffer 
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1X Phosphate Buffered Saline pH 7.2 (Gibco) 
0.1% Tween-20 (Scientific Laboratories Supplies) 
 
2.1.3 Flow Cytometry (FACS) Buffer 
1X PBS pH 7.2 (Gibco) 
0.5% Bovine Serum Albumin (Thermo Fisher Scientific)  
 
2.1.4 ELISA buffers 
Carbonate buffer 
45 ml of 1M NaHCO3 (Sigma-Aldrich) 
18 ml of NaCO 3 (Sigma-Aldrich) ! made up to 1 L with ddH20, pH 9.6. 
 
Wash Buffer 
1X Phosphate Buffered Saline pH 7.2 (Gibco)  
0.05% Tween-20 (Scientific Laboratories Supplies) 
 
2.1.5 Silver stain reagents  
Fix – 100 ml ethanol and 25 ml acetic acid  ! make up to 250 ml with ddH2O 
Sensitisation - 0.5 g Sodium thiosulphate, 17 g sodium acetate and 75 ml ethanol ! 
make up to 250 ml with ddH2O 
Silver stain - 0.1 g silver nitrate in 40 ml ddH2O  
 
Develop - 2.5 g Sodium carbonate, 100 ml ddH20 and 20 µl formaldehyde 
 
Stop - EDTA-3.65 g Ns2H20 ! make up to 250 ml with ddH2O 
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2.1.6 Organoid Immunofluorescent reagents 
Glycine/PBS rinse buffer 
130 mM NaCl (Sigma-Aldrich) 
7 mM Na2HPO4 (Sigma-Aldrich) 
3.5 mM NaH2PO4 (Sigma-Aldrich) 
100 mM Glycine (Thermo Fisher Scientific)  
 
Immunofluorescence buffer 
130 mM NaCl (Sigma-Aldrich) 
7 mM Na2HPO4 (Sigma-Aldrich) 
3.5 mM NaH2PO4 (Sigma-Aldrich) 
7.7 mM NaN3 (Sigma-Aldrich) 
0.1% Bovine Serum Albumin (Thermo Fisher Scientific)  
0.2% Triton X-100 (Sigma-Aldrich) 
0.05% Tween-20 (Scientific Laboratories Supplies) 
 
2.2 Cell isolation and culture 
 
2.2.1 Culture Media 
Parasite Media  
RPMI 1640 medium (Gibco) 
100 U/ml penicillin/100 µg/ml streptomycin (Lonza) 
2 mM L- glutamine (Lonza) 
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5% sterile D-glucose  (Sigma-Aldrich) 
1 µg/ml of gentamycin  (Sigma-Aldrich) 
 
Complete RPMI (used for RAW 264.7 cell line culture [238]) 
RPMI 1640 medium (Gibco)  
10% FCS (Invitrogen) 
100 U/ml penicillin/100 µg/ml Streptomycin (Lonza) 
2 mM L-glutamine (Lonza) 
 
Complete DMEM 
Dulbecco’s Modified Eagle Medium  (Sigma-Aldrich) 
10% FCS (Invitrogen) 
100 U/ml penicillin/100 µg/ml Streptomycin (Lonza) 
2 mM L-glutamine (Lonza) 
(For bone marrow macrophages – add 20% L929 medium – contains M-CSF) 
(For bone marrow dendritic cells – add 10% GM-CSF) 
(For MODE-K cells [239] – add 1% non-essential amino acids and sodium pyruvate 
(Gibco)) 
 
Complete Media (for lungs) 
Hanks Balanced Salt Solution (HBSS) (Sigma-Aldrich) 
100 U/ml penicillin (Lonza) 
1.8 mM CaCl2  (Sigma-Aldrich) and 1 mM MgCl2  (Sigma-Aldrich) 
(Digestion media – add 4 U/ml Liberase TL (Roche) and 160 U/ml DNase I (Sigma)) 




Advanced DMEM/F12 media (Invitrogen) 
2 mM L-glutamine (Lonza) 
10mM HEPES (Sigma-Aldrich) 
100 U/ml penicillin/100 µg/ml Streptomycin (Lonza) 
1% N2 supplement (Invitrogen) and 2% B27 supplement (Invitrogen) 
50 ng/ml EGF (Invitrogen) 
100ng/ml Noggin (Peprotech) 
500ng/ml R-spondin (R&D systems) 
 
2.2.2 Isolation of bone marrow for macrophage/dendritic cell culture 
Donor mice were sacrificed and the femur and tibia were isolated. Bone marrow cells 
were extracted in PBS, and red blood cells were lysed by incubating cell suspensions 
in red blood cell lysis buffer (Sigma-Aldrich) at room temperature for 5 minutes. For 
macrophage culture bone marrow cells were kept in specific culture conditions (see 
above), and media changed on day 2, 4 and 6. Macrophages were mature on day 7. 
For dendritic cell (DC) culture, bone marrow cells were kept in specific culture 
conditions (see above), and media changed on day 2, 4 and 6 and 8. DCs were 
mature on day 10. For macrophage or dendritic cell polarization, see table 2.1 
 
2.2.3 Cell stimuli/reagents and restimulation 
For antigen-specific restimulation, 2.5 x 10
6 
cells were plated in duplicate in a 24-
well flat bottom plate (Costar) in complete RPMI medium with or without 1 µg/ml 
exosomes, or 2 µg/ml anti-CD3/CD28 (eBiosciences) at 37 ̊C with 5% CO2 for 72 h. 
Supernatants were then collected and frozen at -20 ̊ C prior to analysis. For 
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restimulation prior to intracellular cytokine staining, 1-2 x 10
6 
cells were plated in a 
96-well round bottom plate (Costar) and stimulated with 0.5 µg/ml PMA (Sigma-
Aldrich), 1 µg/ml Ionomycin (Sigma-Aldrich) and 10 µg/ml Brefeldin A (Sigma-
Aldrich) overnight at 37 ̊C with 5% CO2.  
 
Table 2.1 Specific cell culture reagents for in vitro assays 
 
2.3 Mice, parasites and products 
C57BL/6, BALB/c, CF1 (C57BL/6 & CBA background) and IL-33R/ST2-/- (BALB/c 
background) mice were bred in-house and housed in individually ventilated cages 
(IVCs) according to UK Home Office guidelines. 
 
2.3.1 H. polygyrus infections and lifecycle 
Parasite lifecycles were maintained in CF1 mice using 500 H. polygyrus L3 stage 
larvae for infection. Mice were infected with 200 H. polygyrus L3 stage larvae in 200 
µl ddH20 by oral gavage as described in [240] for experimental infections. To 
determine infection status, 3-5 faecal pellets were collected from mice on days 14, 21 
and 28. Pellets were weighed and dissolved in 2 ml ddH20. 2 ml of saturated salt 
solution (400 g NaCl in 1L ddH20) was added and eggs were calculated using a 
Reagent Supplier Concentration used at Function in cell culture assay 
LPS Sigma 100-500 ng/ml Stimulate classical activation 
Recombinant 
IL-4/IL-13 Peprotech 20 ng/ml Stimulate alternative activation 
Recombinant 
IL-33 Peprotech 20 ng/ml 
Activate ST2 alarmin responses & 
enhance alternative activation 
Cytochalasin D SLS 4 µg/ml Inhibit actin polymerisation 
Naïve rat IgG Sigma 1 µg/ml Fc Receptor block 
Polyclonal exosome 
antisera In House 1:2000 Binding to exosomal proteins 
Polyclonal anti-
TSPAN11 Eurogentec 1:2000 Binding to TSPAN11 
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McMaster egg counting chamber. Egg counts are represented as eggs/g faecal 
material. Adult worms were harvested from the small intestine on day 28, and 
recorded as total worms in the intestine. Granuloma counts were conducted 
following isolation of the small intestine. 
 
2.3.2 HES production and exosome isolation 
For collection of HES (H. polygyrus excretory secretory product), adult worms were 
isolated from the small intestine on day 14, and were kept in serum-free media in 
vitro and the secretion product is collected every 3 days for 18 days (as per previous 
publications for HES collection, see [236]). This was amended to 14 days of 
collection, given the reduced exosome protein yield (as measured by Quibit) in the 
latter days of collection. Eggs are removed from the collected product by spinning at 
400#g before filtering through a 0.2 µm filter (Millipore). Purified media is then spun 
at 100,000#g for 2#h in polypropylene tubes at 4#°C in a SW40 rotor (Beckman 
Coulter). Ultracentrifuged material is washed twice in filtered PBS at 100,000#g for 
2#h. In some instances, (and this is also routinely done for total HES [236]), the level 
of LPS contamination in a given exosome batch was quantified using a Chromogenic 
LAL assay (Limulus Amebocyte Lysate, Lonza) according to the manufacturer’s 
instructions. If LPS levels are <1 U LPS per 1 µg exosomal protein, samples were 
used for further experimentation (note; all batches tested were signficantly below this 
limit ~0.15U/µg). The resulting supernatant (and total HES) was concentrated using 
a Vivaspin 6 5000 MWCO tubes (Fisher) at 5,000#g and washed twice with PBS. 
 
2.4 Exosome quality control 
 
2.4.1 Transmission electron microscopy 
For visualization of the vesicles, the purified ultracentrifuged pellet from H. 
polygyrus ES (100#µg/ml protein concentration) was fixed in 2% paraformaldehyde 
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(PFA), deposited on Formvar-carbon-coated EM grids and treated with 
glutaraldehyde before treatment with uranyl oxalate and methyl-cellulose 
In parasite morphology experiments, adult H. polygyrus parasites were 
washed with PBS before fixation in 2.5% glutaraldehyde solution in 0.1 M sodium 
cacodylate buffer overnight. Parasites were rinsed three times with 0.1 M Na 
cacodylate buffer, and post-fixed in 1% osmium tetroxide for 1 h. After rinsing in 0.1 
M Na cacodylate buffer, they were sequentially dehydrated in a graded acetone series. 
Finally, samples were sequentially incubated for 30 min in a araldite:acetone solution 
and filtered in resin and polymerized at 60°C for 24 h. Ultrathin slides (50 nm) were 
stained with 2% uranil acetate prior to viewing. 
 
 
2.4.2 Qubit for protein quantitation and qNano analysis 
Exosome protein concentration was quantified using the Qubit® Protein Assay Kit 
(Thermo Fisher Scientific), using the Qubit® 2.0 Fluorometer, according to the 
manufacturer’s instructions. Samples are diluted in supplied buffer with protein 
reagent, and concentration is measured against BSA standards. Exosomes are 
quantified by qNano (Izon Science). For exosome samples, a polyurethane nanopore 
rated for particles <100 nm (NP100-, Izon Science) and was stretched to 47 mm, as 
measured from adjacent teeth on the qNano unit. 40 µL of sample diluted to an 
appropriate protein concentration in filtered PBS and vortexed prior to acquisition. 
The sample was passed through a nanopore by single-molecule electrophoresis, by 
establishing a voltage (between 0.3V and 0.5V) and suitable pressure (between 6-12 
mbar). Optimally, measurement durations were greater than two minutes. All 
measurements were calibrated with 115 nm (NP100) beads. Data analysis were 
carried out on the Izon Control Suite software v2.2 (Izon Science). 
 
 
2.4.3 Silver stain 
1.! 3 µg exosomes are subjected to SDS-PAGE ! Add 150 ml Fixation buffer to 
gel for 2 h on rocker. 
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2.! Remove Fixation buffer and add 150 ml Sensitisation buffer for 30 min. 
3.! Wash 3x 5 min with ultrapure water on rocker. 
4.! Add 150 ml Silver Stain for 20 min ! Cover as this is light sensitive. 
5.! Wash 2x 1 min with ultrapure water on rocker 
6.! Add 150 ml Developer solution ! Monitor visualization of bands 
7.! Add 150 ml Stop solution when satisfied with band development for 10 min 
 
 
2.5 Enzyme-linked Immunosorbent Assays  
 
2.5.1 Supernatant quantitation ELISAs (table 2.2) 
Supernatants from cell culture assays were measured for cytokine levels by ELISA 
using monoclonal capture and biotinylated detection antibody pairs (see table 2.2), 
according to the manufacturer’s instructions. Plates were developed with 
streptavidin-alkaline phosphatase and p-nitrophenyl phosphate substrate (both 
Sigma-Aldrich). Cytokine concentrations were determined by reference to a standard 
curve of doubling dilutions of a recombinant cytokine standard. Levels of IL-1α, IL-
1β, IL-4, IL-5, IL-10, IL-13, IL-17A and IFNγ were detected in BAL fluid using BD 
cytometric bead array kits (BD Biosciences), and acquired on a BD FACSArray. 
 
2.5.2 Antibody ELISAs (table 2.2) 
In serum antibody ELISAs, whole blood from naïve mice or mice used in 
vaccination experiments, was collected via cardiac puncture. Blood was clotted for 1 
h at room temperature and then spun for 20 min at 12,000 g to remove red blood 
cells. After blocking at 37°C with 10% BSA in carbonate buffer, serum was 
subsequently added in serial dilutions to ELISA plates coated with either 1 µg/ml 
HES, exosomes or HES Sup, goat anti-mouse Ig (Southern Biotech) at 1 µg/ml or 
anti-IgE (clone R35- 72, BD Biosciences) at 1.5 µg/ml, in carbonate buffer. 
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Antibody binding was detected using HRP-conjugated goat anti-mouse IgM, IgG1, 
IgG2a, IgA or IgE (Southern Biotech) and ABTS Peroxidase Substrate (KPL), and 
read at 405 nm.   
 
Table 2.2 Enzyme-linked Immunosorbent Assay reagent list 




Antibody Used at  Source  
IL-6 MP5-20F3 2 µg/ml 25 ng/ml MP532C11 0.5 µg/ml BD Biosciences 
IL-10 JES5-16E3 0.5 µg/ml  10 ng/ml SXC-1 0.5 µg/ml eBioscience 
IL-12p40 C15.6 2 µg/ml 50 ng/ml 554476 0.5 µg/ml BD Biosciences 
IL-13 eBio13A 4 µg/ml 10 ng/ml eBio1316H 0.5 µg/ml eBioscience 
CCL17 DY529 2 µg/ml 2 ng/ml DY529 0.2 µg/ml R&D Duoset 
IFNγ R46A2 0.5 µg/ml 50 ng/ml XMG1.2 2 µg/ml eBioscience 
RELMα 500-P214 0.25 µg/ml 100 ng/ml P214Bt 0.25 µg/ml Peprotech 
TNF TN3-19 2 µg/ml 20 ng/ml 13-7341-85 2 µg/ml eBioscience 
Ym1 DY2446-05 2.88 µg/ml 10 ng/ml DY2446-05 0.14 µg/ml R&D Duoset 
Detection Substrate Extravidin-AP      Source Sigma 
       




Antibody Used at Source  
IgA C10-3 1:300 0.5 µg/ml 1040-05 1:4000 BD/ Southern Biotech 
IgE R35-72 1:300 0.5 µg/ml 1110-05 1:4000 BD / Southern Biotech 
IgG1 Polyclonal - 101004 1:1000 0.5 µg/ml 1070-05  1:6000 
Bio-Rad/ 
Southern Biotech 
IgG2a Polyclonal - 101004 1:1000 0.5 µg/ml 1080-50 1:4000 
Bio-Rad/ 
Southern Biotech 
IgM Polyclonal - 101004 1:1000 0.5 µg/ml 1020-05  1:2000 
Bio-Rad/ 
Southern Biotech 
Detection Substrate  ABTS-Peroxidase   Source KPL  
 
 
2.6 Fluorescence Activated Cell Sorting 
 
2.6.1 Surface staining 
Single‐cell suspensions were made from bone marrow myeloid populations, 
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mesenteric lymph nodes, peritoneal washes or the spleen, and were subsequently 
washed in phosphate‐buffered saline (PBS). To exclude dead cells, cells were stained 
with live/dead Fixable Yellow or Aqua dyes (Invitrogen) at a 1/10000 dilution in 100 
µl PBS for 15 m at 4°C. Subsequently, Fc receptors were blocked 50 µl of FACS 
buffer containing 100 µg/ml of naïve rat IgG (Sigma Aldrich) for 15 min at 4°C. 
Samples were then washed several times in FACS buffer and surface stained in 20 µl 
of FACS buffer containing different cocktails of antibodies (See Table 2.3), or with 
appropriate isotype controls (as recommended by the manufacturer for each 
individual antibody). Samples were acquired on a Becton-Dickinson LSRII flow 
cytometer (BD Biosciences). 
 
2.6.2 Intracellular staining 
To measure intracellular cytokines, cell suspensions were stimulated for 4 h at 37°C 
in the presence of PMA (50 ng/ml), Ionomycin (1 µg/ml), and Brefeldin A (10 
µg/ml) (Sigma). Following any cell surface staining, cells were permeabilised for 30 
min at 4°C in Cytofix/Cytoperm solution (BD), and then washed twice in 200 µl of 
Perm/Wash (BD). Cells were stained for intracellular cytokine expression (For 
antibodies, see Table 2.3), or with appropriate isotype controls in 20 µl perm/wash. 
For intracellular cytokines; Foxp3, IL-5 and IL-13, corresponding isotype controls 
were used (Rat IgG2a-! Control or IgG1-! Control respectively).  For macrophage-
derived RELM" and Ym1, corresponding isotype antibodies were used (Normal 
Goat IgG control (R&D) and Normal Goat IgG-biotin (R&D), respectively). After 
staining, cells were washed twice in 200 µl of FACS buffer before acquisition on the 











Table 2.3 List of antibodies for flow cytometry 
Antibody target Clone  Fluorophore Conc. used   Source 
Lineage markers 
   
  
CD3 17A2 FITC 1/100 BioLegend 
CD4 RM4-5 FITC 1/100 BioLegend 
CD5 53-7.3 FITC 1/100 BioLegend 
CD8α  53-6.7 FITC 1/100 BioLegend 
CD11b M1/70 FITC 1/100 BioLegend 
CD11c N418 FITC 1/100 BioLegend 
CD19 6D5 FITC 1/100 BioLegend 
Gr1 RB6-8C5  FITC 1/100 BioLegend 
CD49b DX5 FITC 1/100 eBioscience 
Foxp3 NRRF-30 PE 1/50 
  ! ! !  !
Innate lymphoid cells 
  
  
Lineage negative  See above        
ICOS 15F9 PerCP-710 1/100 eBioscience 
ST2 DJ8 biotin 1/100 MD bioproducts 
IL-5 TRFK5 PE 1/50 eBioscience 
IL-13 eBio13A eF660 1/50 eBioscience 
  





F4/80 BM8 PeCy7 1/300 BioLegend 
CD11b M1/70 Pacific Blue 1/100 BioLegend 
CD11c N418 APC 1/200 BioLegend 
ST2 DJ8 FITC 1/100 MD bioproducts 
MHC II (I-A/I-E) M5/114.15.2  AlexaFluor 700 1/400 eBioscience 
CD86 (B7-2) GL1 PE 1/300 eBioscience 
Relm-α  226033 (R&D) and rabbit IgG-AF647 labelling reagent kit (Invitrogen)  
Ym1  Biotinylated goat α-mouse Chitinase 3-like 3 (R&D) and Streptavidin-PeCy7 (BioLegend)  
  
   
  
Other lymphocytes/immune cells*  Excluding lineage markers or previous 
CD4 RM4-5 AF700 1/100 BioLegend 
CD3 17A2 FITC 1/100 BioLegend 
CD25 PC61.5  PE 1/100 eBioscience 
SiglecF E50-2440 PE 1/100 BD Biosciences 
B220 RA3-6B2 PCP 1/100 BioLegend 
CD45.2 104 Pacific Blue 1/100 BioLegend 
Streptavidin   APC/PerCP 1/200 BD Biosciences 
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Table 2.4 List of antibodies for exosome flow cytometry and 
western blot 
Specificity Clone Host Dilution (WB) 
Dilution 
(FACS) Source 
Whole H. polygyrus 
exosomes N/A Rat 1:2000 1:100 In House 
Whole H. polygyrus 
exosomes N/A Mouse 1:2000 1:100 In House 
TSPAN 11 - variant 1 SY6093 Rabbit 1:1000 1:100 Eurogentec 
ALIX 3A9 Mouse 1:1000 1:200 Cell Signalling 
DUSP1 C-19 Rabbit 1:1000 N/A Santa Cruz  
ST2 P14719  Goat 1:1000 N/A R&D Systems 
β-Actin 3-A9 Rabbit 1:3000 N/A Cell Signalling 
  
HRP-conjugated antibodies        
Rabbit IgG   Goat 1:3000 N/A Cell Signalling 
Mouse IgG   Goat 1:3000 N/A Cell Signalling 
Rat IgG   Goat 1:3000 N/A DAKO 
 Fluorescent antibodies         
Rabbit IgG-DyLight 800   Goat 1:10,000 N/A Life Technologies 
Mouse IgG-AlexaFluor 680   Goat 1:10,000 N/A Life Technologies 
Rat IgG - AlexaFluor 680   Goat 1:10,000 N/A  Life Technologies 
  
Rabbit IgG-Alexa Fluor 594   Goat N/A 1:3000 Thermo Fisher Scientific 
Mouse IgG-AlexaFluor 488   Goat N/A 1:3000 Thermo Fisher Scientific 
Rat IgG-AlexaFluor 647   Goat N/A 1:3000 Thermo Fisher Scientific 
 
 
2.6.3 Exosome-Latex bead detection 
5 µg of exosomes were conjugated overnight to aldehyde-sulphate latex beads in 
PBS (4 µm, 4.2 g/100 ml, Invitrogen), washed in PBS with 0.5% BSA, and 
incubated with primary antibodies (see Table 2.4 for list) or naïve sera for 30 min. 
After several washes, a secondary antibody conjugated to a fluorophore (Table 2.4), 
is added prior to acquisition on the MacsQUANT (BD Biosciences). 
 
NB: all flow cytometry data was analysed using FlowJo software (TreeStar). 




2.7 Western blot 
 
2.7.1 Protein lysis, quantitation and sample preparation  
BM‐derived macrophages or MODE-k cells (1 × 106) were stimulated as indicated 
and washed with PBS on ice. For whole‐cell lysates, cells were lysed in lysis buffer 
(described in 2.1.1), for 30 min on ice, spun at 12,000 g for 5 min at 4°C. The post-
nuclear supernatants were transferred to 1.5 ml eppendorf tubes and, if not used 
immediately, were stored at -80°C. 
Total protein was determined by the BSA quantification method (Pierce). In 
other experiments testing the affinity of exosome antisera, 5 µg of whole exosomes, 
HES or HES depleted of exosomes (HES Supernatant) were used (protein 
concentration assessed by Qubit quantification – described in 2.4.2).  
5 µl of 4X reducing sample buffer (2.1.2) were added to samples (made up to 
20 µl with ddH20) and mixture was boiled for 5 min at 95°C on a heat block. The 
samples were briefly centrifuged prior to gel loading.  
 
2.7.2 Running and transfer protocol 
For 1-dimensional gels, the protein ladder (PageRuler Pre-stained Protein Ladder, 10 
to 180 kDa, Thermo Fisher Scientific) and samples were loaded and run down a well 
of a 15-well NuPAGE 4-12% BisTris gel (Life Technologies), in 1x MES buffer, at 
200 V for 50 min at room temperature with constant stirring.  
For 2-dimensional gels, exosomes (2 µg) were diluted into a final volume of 
125 µl with rehydration solution (7M urea, 2M thiourea (both BDH), 65 mM DTE 
(Fluka), 4% CHAPS (Sigma-Aldrich), 0.8% resolytes (GE Healthcare), trace 
bromophenol blue (Sigma-Aldrich), and used to rehydrate 7 cm pH 3–10 IPG strips 
(GE Healthcare) for 14 h at 20 °C. Isoelectric focusing was performed (500 V for 30 
min; 1000 V for 30 min; gradient to 8000 V for 5 h; total ∼20 kV h) using an 
IPGphor (Pharmaca Biotech). Strips were reduced and alkylated in 20mg DTE and 
80 mg idoacetamide, before second dimensional electrophoresis using NuPAGE 4–
12% BisTris gels and NuPAGE MES SDS running buffer for 2 h at 150 V. 
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Sample proteins on the gel were transferred to 0.45 µm nitrocellulose 
membranes (BioRad) or PVDF membranes (Millipore), which were first activated by 
soaking in 100% ice-cold methanol for 30 s, using 1x NuPAGE transfer buffer (Life 
Technologies) for 90 min at 120 V in a wet transfer apparatus (BioRad).  
Blots were blocked in 2% BSA–TBS with 0.05% Tween 20 (or 5% milk in 
TBSt) for 2 h at RT, before primary antibody probe overnight at 4 °C (see 2.4 for 
antibodies). In some instances, membranes were incubated for 1 h in secondary Ab, 
(HRP-conjugated, see table 2.4) with 2% BSA-TBSt, in conjunction with Amersham 
ECL prime Western blotting detection reagent (GE Healthcare) to visualize bands 
using X‐ray film (Kodak). Using the Licor-based fluorescence detection system, 
membranes were incubated with fluorophore-conjugated antibodies (table 2.4) in 5% 
milk-TBSt for 45 min and acquired in PBS using the Odyssey Scanner (Li-Cor).  
 
2.8 Molecular biology techniques 
 
2.8.1 Reverse transfection of MODE-k cell line 
To prepare the transfection reaction; Lipofectamine
 
2000 was prepared with opti-
MEM (both Thermo Fisher Scientific) to a final reaction concentration of 0.3% and 
incubated for 5 min at room temperature. To prepare RNA complexes, DUSP1 
siRNA (small interfering RNA), a mix of synthetic H. polygyrus miRNAs (Let-7, 
miR71, miR200 and miR425, Thermo Fisher Scientific) or a non-gene targeting 
control, Select Negative Control No.1 siRNA (NT1) (Ambion), were prepared with 
opti-MEM media to a final reaction concentration of 25nM. Equal volumes of the 
two mixtures were added together and incubated for 20 min at room temperature. 
The mixture was then aliquoted into wells and 1.5 x 104 MODE-k epithelial cells 
were seeded in a 96-well plate in complete DMEM (antibiotic-free). After 24 h, 
samples were assayed for transcriptional changes in il1rl1 and dusp1 by qRT-PCR 
and/or western blot.  
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2.8.2 Isolation and quantitation of RNA  
(1) A small piece of tissue (for Alternaria experiments – trachea and lung) were 
placed in 1ml of TRIzol reagent (Invitrogen). Tissue was first homogenized using a 
steel bead and TissueLyser II machine (both Qiagen) for 2 min at 20Hz. Samples 
were then centrifuged at 10000 g for 5 min at 40C to remove debris and the resulting 
supernatants moved into fresh eppendorf tubes. (2) For cultured cells (commonly at a 
density of 1 x106 /ml in a 24-well plate), plates were washed twice in PBS before 
addition of 0.5ml-1ml TRIzol. To allow for nucleoprotein dissociation, cells were 
incubated for 5 min at room temperature before lysed RNA were aspirated and 
placed into eppendorf tubes.  
 
Chloroform was added (200 µl/1 ml TRIzol) and samples were inverted continuously 
for 1 min. After a further 3 min incubation at room temperature, samples were 
centrifuged at 12,000 g at 4°C for 15 min. The clear aqueous phase (harbouring total 
RNA) was carefully recovered and transferred to a new 1.5 ml eppendorf tube, 
avoiding any aspiration of the white interphase (containing precipitated DNA), and 
the organic phase (containing cellular debris). Isopropanol (500 µl/1 ml TRIzol) and 
0.5 µl of 15 mg/ml glycogen blue for visualization of RNA (Ambion) were added 
and left for 10 min at room temperature before centrifugation at 12,000 g for 20 min 
at 4°C. The resulting supernatant was removed and the RNA pellet was washed twice 
in 75% pre-chilled ethanol and air-dried before being dissolved in 30-50 µl 
RNase/DNase free H2O (Gibco) with 0.1 mM EDTA (Promega) and stored at -20°C. 
The concentration and degree of contamination of the acquired RNA samples was 
assessed on a Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific). 
The level of UV absorption was measured at wavelengths of 230nm, 260nm and 280 
nm. 1.2 µl of purified total RNA sample was used for spectrophotometry, with 1.2 µl 
RNase/DNase free H2O/0.1 mM EDTA used to calibrate background. Optimally, 
RNA samples had a A260:A280 ratio of > 1.7 and a A260:A230 ratio of  > 1.4. 
 
2.8.3 Generation of cDNA and gene detection by quantitative PCR 
A fixed amount of 200 ng of extracted RNA was used for the reverse transcription of 
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cellular RNA to cDNA. Reverse transcription reactions were performed using 
miScript System kit II (Qiagen) containing 1 µl of Reverse Transcriptase Mix, 2 µl of 
5x HiFlex buffer, 1 µl of 10x Nucleics mix and appropriate amounts of RNase-free 
water and RNA in a total volume of 10 µl. Samples were incubated for 60 min at 
37ºC followed by 5 min at 95ºC and were stored at −20°C.  
 
Table 2.5 List of primer sets used in quantitative PCR 
Primer Target mRNA sequence 5'- 3' sequence 
Arg-1 FWD 
Arginase 
GTC TGT GGG GAA AGC CAA T 
Arg-1 REV GCT TCC AAC TGC CAG ACT GT 
Dusp1 FWD Dual specificity 
phosphatase-1 
CTC CTG GTT CAA CGA GGC TAT T 
Dusp1 REV TGC CGG CCT GGC AAT 
FAS v1 FWD 
Death receptor (variant 1) 
AAA CCA GAC TTC TAC TGC GAT TCT 
FAS v1 REV GGG TTC CAT GTT CAC ACG A 
GAPDH FWD 
Housekeeping gene 
CAT GGC CTT CCG TGT TCC TA 
GAPDH REV GCG GCA CGT CAG ATC CA 
IL1R1 v2 FWD IL1 receptor-like 1 
(variant 2) 
CCT CAC GGC TCT GAG CTT AT 
IL1R1 v2 REV CTG AGG TAG GGT CCA GAA GAG A 
IL6 FWD 
IL6 cytokine 
TGC CTT CAT TTA TCC CTT TGA A 
IL6 REV TTA CTA CAT TCA GCC AAA AAG CAC 
iNOS FWD 
Nitric oxide synthase 
CAG CTG GGC TGT ACA AAC CTT 
iNOS REV CAT TGG AAG TGA AGC GTT TCG 
LTβ FWD 
Lymphotoxin-β 
CCT GGT GAC CCT GTT GTT G 
LTβ REV TGC TCC TGA GCC AAT GAT CT 
RELMα FWD 
Resistin-like molecule-α 
TAT GAA CAG ATG GGC CTC CT 
RELMα REV GGC AGT TGC AAG TAT CTC CAC 
TNF FWD 
Tumour necrosis factor-α 
GGA AAT AGC TCC CAG AAA AGC AAG 
TNF REV TAG CAA ATC GGC TGA CGG TGT G 
Ym1 FWD 
Murine chitinase 
CAT GAG CAA GAC TTG CGT GAC 
Ym1 REV GGT CCA AAC TTC CAT CCT CCA 
 
Real-time SYBR-green PCR assays for mRNA detection were performed 
using Light Cycler System in 384-Well Reaction Plates (both Roche). Primers 
(Invitrogen) were designed using the Universal Probe Library Assay Design Center 
Roche software (available at http://www.roche-applied-science.com), see table 2.5 
for primer information. Reactions were performed using SYBR Green System 
(Roche) according to the manufacturer’s instructions. 0.5 µl of cDNA (1:10 dilution) 
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were used per sample in a total reaction volume of 5 µl. The cycle conditions used 
were: 5 min pre-denaturation at 95°C, then 45 cycles of denaturation 10 s at 95°C, 
annealing 10 s at 60°C, 10 s elongation at 72°C. All samples were tested in technical 
duplicates and nuclease-free water was used as a non-template control. 
 
2.8.4 Immunoprecipitation with exosome anti-sera 
HES exosome proteins were immunoprecipitated with polyclonal anti-exosome sera 
using a Pierce Cross-link Immunoprecipitation kit (Thermo Fisher Scientific), 
according to manufacturer’s instructions. Briefly, antibodies were coupled to Protein 
A/G agarose resin and cross-linked using 2.5 mM DSS/DMSO. Exosome antigens 
were immunoprecipitated to the antibody-crosslinked resin overnight. Bound 
proteins were eluted with a provided buffer and neutralized by 1 M Tris, pH 9.5. 
Silver stains were run from several stages of the protocol to assess adequate 
antibody-agarose binding, ensure antibody cross-linking and analyse eluate for 
presence of antigen. Following rigorous optimisation, modifications included;  
•! Used 10 µg of antibodies to 40 µl of Protein A/G agarose resin (changed 
from 1:2 ratio to 1:4) 
•! Used 60-80 µg of exosome protein for immunoprecipitation (~7x less 
than recommended amount due to limited resources) 
 
2.8.5 Microarray and Mass spectrometry!
For detailed methodology/author contributions of mass spectometry analysis 
(compiled by Thierry Le Bihan, University of Edinburgh) and microarray data with 
subsequent target prediction (analysed by Cei Abreu-Goodger, Laboratorio Nacional 
de Genómica para la Biodiversidad) as shown in Tables 3.2.1A, 3.2.1B and 4.2.4A 
respectively, see [216].  
 
In brief, for analysis of broad gene changes in murine cells that could be induced by 
exosomes, MODE-k cells were seeded for 24 h at a density of 20 x 104 per well (in a 
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24-well plate). The following day the cells were incubated with 5 µg of exosomes for 
20 h, before harvest of RNA for extraction prior to preparation for microarray 
analysis and parasite miRNA target prediction for the 3' UTRs of murine dusp1 an 
il1rl1. The data generated allowed further investigations (shown in Chapter 4). 
 
The mass spectometry analysis of whole exosome pellet, as in [216], was carried out 
using 5 µg of exosome protein. For the mass spectometry analysis of exosome 
proteins isolated by cross-link immunoprecipitation, approximately 50 µg of 
exosome protein was used, and analysed similarly to the whole-exosome protein 
analysis as above. Briefly, MS/MS data were searched against the in-house H. 
polygyrus transcriptome database using the Mascot program (Matrix Science Ltd). 
For any given protein, a minimum of 2 unique peptide matches were required. 
Peptide matches with expect values < 0.05 at a Mowse significance threshold of p < 
0.05 were considered significant.  
 
!
2.9 Exosome uptake assays 
 
2.9.1 Sample preparation and PKH67 
Exosomes purified from H. polygyrus adult culture or MODE-K cells, were labelled 
with PKH67 (Sigma-Aldrich) for 5#min at room temperature, according to the 
manufacturer’s instructions. Approximately 2 µg of dye was used per 5 µg of 
measured exosome protein. The staining reaction was stopped by adding an equal 
amount of 1% purified bovine serum albumin (BSA). Subsequently, exosomes were 
washed in PBS by ultracentrifugation (1#h at 100,000#g). A control probe solution 
was prepared with the PKH67 label in PBS in the absence of exosomes. Cells 
(BMDMs, MODE-k and RAW 264.7 cells) were given approximately 1-5 µg 
exosomes per 2 x105 cells and left in culture for varying time points at 37°C.  Cells 
were then washed twice in PBS before staining with antibodies for determining cells 
by flow cytometry or confocal analysis. Control samples were treated similarly 
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before the addition of 50 µl 0.25% trypsin/EDTA (Gibco) for 5 min in order to 
remove exosomes which may have remained on the cell surface prior to analysis. 
 
2.9.2 Assessment of exosome uptake by flow cytometry and confocal 
microscopy 
For acquisition by flow cytometry, labelled exosomes were incubated with cells for 
varying time points (as indicated per figure legend), and single‐cell suspensions were 
made from cell populations for subsequent washes in FACS buffer. Live/dead 
Fixable Aqua dye (Invitrogen) was used to exclude dead cells. BMDMs, BMDCs 
(using markers indicated in table 2.3), and live singlet populations of MODE-k and 
RAW 264.7 cells were assessed as % of PKH67+ cells or by the expression intensity 
of PKH67 following acquisition on the BD FACS Canto II flow cytometer (BD 
Biosciences). Approximately 50-100,000 events were collected from each data set 
and analysed using FlowJo software (Tree Star)  
For confocal analyses, 3 x 104 BMDMs were allowed to attach on to the 
coverslips overnight and the following day shifted to complete DMEM medium 
supplemented with 1% L-glutamine.  Cells were incubated with labelled exosomes or 
controls, as described above, before subsequent staining in 1:300 F4/80-AF647 
(Table 2.6) in PBS (to determine macrophage identity). Cells were then fixed with 
4% PFA (with residual PFA quenched with 50#mM glycine). The coverslips were 
washed 4x in PBS, and nuclei were stained with 4',6-diamidino-2-phenylindole-
supplemented ProLong Fade Gold (Invitrogen) mounting media. Samples were 
examined on the Leica SP5 II (Leica Microsystems, ×63 objective) using the LAS 
AP software (Leica). Image analysis was performed using ImageJ software (NIH). In 
some experiments, cells were treated with culture stimuli in addition to exosomes (as 
indicated in appropriate figure legends), including LPS, IL-4/IL-13, polyclonal 
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Table 2.6 List of antibodies for confocal microscopy 
Specificity Fluorophore Clone Host Dilution Source 
Primary antibodies 
F4/80 (macrophages) AlexaFluor-647 T45-2342 Rat 1:300 BD Biosciences 
E-cadherin (epithelium) N/A DECMA-1 Rat 1:2000 Genetex 
MUC2C3 (goblet cells) N/A N/A Rabbit 1:500 G. Hannson [241] 
Lyzozyme C 
(paneth cells) N/A C-19 Goat 1:100 Santa Cruz 
 Secondary antibodies 
Anti-Rat IgG AlexaFluor-594 N/A Goat 1:500 Life Technologies 
Anti-Goat IgG AlexaFluor-647 N/A Rabbit 1:500 Life Technologies 
Anti-Rabbit IgG AlexaFluor-488 N/A Goat 1:500 Life Technologies 
 
2.10 Organoid studies 
 
2.10.1 Small Intestinal Crypt Organoid Culture 
The most proximal 10 cm of small intestine was isolated and flushed with ice cold 
PBS.  Intestine was cut longitudinally in order to expose the lumen and scraped 
gently with a glass cover slip to remove upper mucosa.  The intestine was cut into 1-
2 mm pieces and washed 3-4x with ice cold PBS.  Tissue was then incubated with 2 
mM EDTA in PBS for 30 min with agitation at 4°C.  After aspirating the EDTA, 10 
ml of ice cold PBS was added and crypts were extracted with vigorous 
pipetting.  The supernatant containing crypts was removed and set aside.  This 
process was repeated 4x, with each fraction checked under the microscope for crypt 
enrichment.  The fractions with highest crypt enrichment were combined through a 
70 µM cell strainer and washed with advanced DMEM/F12 media 
(Invitrogen).  Crypts were then centrifuged at low speeds (around 150 g) to remove 
single cells.  The tissue was then spun at higher speeds (300 g) and the pellet re-
suspended with ~500 µl Matrigel matrix (Corning). Approximately 20 µl 
crypt/Matrigel mix are added to each well (based on a 24-well plate). Organoids 
were incubated at 37°C, 5% CO2 and culture media (see 2.2.1) was renewed every 2-
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3 days. Where indicated, cultures were pre-stimulated for 24 h with recombinant 
murine IL-4/IL-13 (20#ng/ml) prior to exosome uptake/microinjection assays. 
 
2.10.2 in vitro exosome microinjection and co-localisation assays 
1mm OD glass capillaries (World Precision Instruments) were pulled into two 
needles using a micropipette puller (Sutter), according to manufacturer’s 
instructions. Needles were backloaded with 20 µl of injection material (equating to ~ 
2 µg labelled exosomes) using a microloader pipette tip. The needle was inserted into 
the microinjector and tightly sealed. The needle end point is sheared off (~ <0.1 mm) 
using forceps to allow approximately 1 nanolitre of material to be expelled per 
injection. Needle tip is moved over organoid of interest at a 30-40° angle and 
adjusted using the micromanipulator for fine control to lower the needle into the 
lumen of the organoid (darker in colour). Using a pressure of ~20 kPa, the sample is 
microinjected 3-4 times to ensure maximal insertion into the organoid lumen. 
  As previous uptake experiments (See 2.9), PBS is prepared with the PKH67 
dye in the same way as exosomes to eliminate any carry-over from labelling. 
Exosomes isolated from the enterocyte cell line, MCICL2 are used as a comparative 
mammalian vesicle control. 
   
  Organoids were subsequently washed 2x in PBS before 20 min fixation in 4% 
PFA at room temperature. Samples were then permeabilised in 0.5% Triton X-100 in 
PBS before 3x rinses in glycine/PBS rinse buffer and blocked for 1 h in 
immunofluorescence buffer (for both, see 2.1.6) at room temperature. Wells were 
incubated overnight with primary antibodies (see Table 2.6). The next day, wells 
were washed 3x in immunofluorescence buffer (20 min each), before incubation with 
fluorescent conjugated secondary antibody (see Table 2.6) for 50 min. Wells are then 
washed 1x in immunofluorescence buffer, and 3x in PBS prior to nuclear staining 
with 4', 6-diamidino-2-phenylindole-supplemented ProLong Fade Gold (Invitrogen) 
mounting media. Samples were examined on the Nikon N-STORM & A1+ confocal 
laser scanning microscope (Nikon, ×60 or x100 objective) using the Nikon Nis-
Elements (Version 4) software (Nikon). Image analysis was performed using ImageJ 
software (NIH). 
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2.11 Exosome vaccination studies 
To generate anti-exosome sera, female rats were immunized intraperitoneally with 
75 µg exosomes or 75 µg exosomes pre-treated with 0.1% Triton X, in 9% alum 
adjuvant (Sigma-Aldrich) i.p., then boosted with 15 µg of exosomes on days 28 and 
35, before serum collection via cardiac puncture on day 42. For subsequent analyses 
(by western blot or otherwise) Naïve rat sera was used as an isotype control. 
In immunization studies, female C57BL/6, BALB/c or ST2–/– (6-10 weeks 
old) mice were immunized with 10 µg of exosomes, HES, or HES depleted of 
exosomes in 9% alum adjuvant (Sigma Aldrich) i.p., then boosted on days 28 and 35 
with 2 µg of HES product-alum i.p. prior to serum collection via cardiac puncture on 
day 42. To ascertain exosome effects in ST2–/– mice, mesenteric lymph nodes were 
isolated for T cell restimulation (see 2.6.2) and RPMI washes of the peritoneal cavity 
were taken to look at levels of variable cytokines. In some experiments, mice were 
challenged with 200 H. polygyrus L3 larvae on day 42, and faecal egg counts 
determined at days 14, 21 and 28 post-infection, and adult worms counted at day 28. 
 
 
2.12 Exosomes in an Airway Allergy Model 
 
For all experiments presented in these studies, the sample size was large enough to 
measure the effect size. In all experiments;  
(1)! All intranasal challenges were carried out under brief isofluorane sedation. 
(2)! Bronchoalveolar lavage (BAL) was assessed for presence of RELMα and 
Ym1 by standard ELISA (see 2.5.1), as well as IL-1α, IL-1β, IL-4, IL-5, IL-
10, IL-13, IL-17A and IFNγ using BD cytometric bead array Flex-set kits  
(3)! Cell suspensions (1 x 10 6) from BAL and lung homogenate (previously 
treated with digestion media) were taken for analysis of different innate cells; 
CD4+ T cells, eosinophils, neutrophils, innate lymphoid cells (ILC), 
macrophages, epithelial cells and dendritic cells (see table 2.3). 
(4)! Cell suspensions (2 x 10 6) from lung homogenate were stimulated, as 
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described in 2.6.2 and [141, 242], for subsequent analysis of intracellular IL-
5 and IL-13 in ILCs. 
(5)! In some experiments, lung tissue was harvested in 1ml RNA-later (Thermo 
Fisher Scientific) for subsequent RNA extraction. 
 
2.12.1 Challenge-recall using ovalbumin 
Mice were administered intranasally on day 0 with 20 µg ovalbumin (OVA), 50 µg 
Alternaria alternatus antigen and/or 10 µg HES or exosomes in 50 µl PBS On days 
14, 15 and 16; mice are given an intranasal recall challenge with 20 µg OVA in 50 µl 
PBS. On day 17 mice were sacrificed for tissue harvest.  
 
2.12.2 Short-term allergic airway modulation 
Mice were co-administered intranasally with 10 µg of exosomes, HES or HES 
depleted of exosomes (or PBS as a control) with 50 µg of Alternaria alternatus 
antigen (Greer). Mice were sacrificed 48 h later for tissue harvest. Mice were 
administered intranasally with 10 µg of exosomes, HES or HES depleted of 
exosomes in 50 µl of PBS or PBS alone for 24 h prior to a second intranasal 
challenge with 50 µg of Alternaria alternatus antigen (Greer) and a further 5 µg of 




2.13 Statistical analysis 
All statistical analyses were performed using Prism 6 (Graphpad Software Inc.). 
Unless otherwise indicated in figure legends, data analysis was done as follows;  
For comparisons of two groups, a parametric student’s t-test, unpaired, and two-
tailed was used. When three or more groups were analysed, in-group variance was 
assessed by Brown Forsythe test and data were log-transformed and analysed by one-
way ANOVA, with a Tukey’s multiple comparisons post-test. ****P<0.0001, 
***P<0.001, **P<0.01, *P<0.05, N.S. not significant P>0.05.  








The murine gastrointestinal nematode, H. polygyrus, has long been used as a model 
to study immunity to helminth infection and has revealed interesting mechanisms of 
host immunosuppression [243]. It is well known that helminth excretory-secretory 
products (ES) can modulate the host immune response, through either direct cellular 
effects or initiation of regulatory T cells [244, 245]. H. polygyrus ES (HES) has been 
shown to immunomodulate host cells [92], as well as well as driving a regulatory 
pathway, which includes the secretion of a TGF-β homolog [141, 151]. The protein 
composition of HES has been found to be a complex mixture of molecules, with 374 
proteins identified by LC-MS/MS [246]. Following the discovery of exosomes (a 
type of extracellular vesicle) in the ES of trematodes, Fasciola hepatica and 
Echinostoma caproni [220], it led others to postulate the presence of extracellular 
vesicles (EVs) in the secretory material of other parasitic worms. Exosomes are 
nanovesicles around 50-100nm in size that are secreted by virtually all cells to 
facilitate the transfer of selected cargo, mainly lipids, proteins and RNA species, 
between cells [167].  Exosomes develop within a cell by inward budding of multi-
vesicular endosomes, and thus contain components of the parental cell, such as 
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RNAs or proteins, that may be trafficked into the same compartment. The discovery 
of extracellular vesicles from kinetoplastids, fungi and bacteria drove the theory that 
communication via vesicles could operate on a cross-species platform [188]. Data 
from the trematode studies further suggests that ES-derived exosomes are capable of 
reaching the host environment, as they appear to be found intact on the parasites’ 
tegument, and were taken up by host intestinal cells in vitro [220]. The formation of 
exosomes by helminths had originally been established in free-living nematodes, 
with the demonstration that Caenorhabditis elegans use a novel secretion pathway 
from the apical membrane to co-secrete multivesicular bodies, containing exosome-
like vesicles, with peptides that normally promote cuticle development. [223]. 
Exosomes from helminths and protozoa appear to share many specific markers with 
those known to be present in mammalian exosomes, such as Heat-shock protein 70 
(HSP70), endosomal sorting components e.g. ALIX, and surface tetraspanins 
including CD9 and CD63 [167]. 
 
During my PhD, our group published a study documenting the release of 
exosomes in H. polygyrus ES. These exosomes represent approximately 10% of the 
total protein secretion of an adult worm [219].  Proteomic comparison of the secreted 
products represented in the soluble and vesicular fractions separated by 
ultracentrifugation also demonstrated enrichment of a number of key components 
within the exosomes. Interestingly, H. polygyrus exosomes contained a suite of RNA 
species, including miRNAs such as let-7, miR200 and bantam [219], which were 
shown to suppress the mouse phosphatase DUSP1 using a reporter assay. Additional 
data identifying extensive small RNA repertoires, including miRNAs, in helminth-
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derived exosomes are now becoming available, including data from nematodes such 
as B. malayi [247] and trematodes including D. dendriticum [248] and S. mansoni 
[249]. Most importantly, truly definitive evidence for helminth-derived miRNA 
acting on host genes remains to be obtained. However, the circumstantial evidence 
remains enticing; not only are extensive seed sequences shared between helminth 
and host miRNAs, but the miRNA-rich exosomes (of H. polygyrus at least) also 
carries a worm Argonaute protein [219], suggesting that a functional package for 
gene repression is being delivered to the target cells. 
There is evidence that some pathogens use exosomes to subvert a host 
immune response, therefore promoting their survival. For example, the protozoan 
parasite Leishmania donovani, not only induces the production of 
immunomodulatory exosomes from macrophages [197], but also releases its own 
exosomes that have an immunosuppressive effect on myeloid-derived cells [193]. In 
addition, exosomes derived from T. vaginalis were shown to promote recruitment of 
neutrophils, which was suggested to support the spread of infection [209]. Therefore, 
it could be hypothesized that helminths would release exosomes to aid in the 
infection process by modulating host immune responses. 
There is limited evidence available regarding the cellular origin of EVs from 
within helminths [188]. To address this, researchers have relied on molecular 
techniques such as proteomics and transcriptomics to suggest the origin of EVs, based 
on protein enrichment of potential parental cell markers. For example, recent data 
suggests different populations of EVs from F. hepatica may derive from either the 
gastrodermal layer (larger vesicles) or the tegument (exosome-like vesicles), based on 
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enrichment of cell origin markers [250]. In this novel biological system, it is 
necessary to understand the localization of exosomes within the helminth and 
mechanisms of how exosomes are formed, as this may be key to their function. 
Furthermore, identification of the immunogenic proteins on the exosome surface 
could provide future opportunities to interfere with H. polygyrus exosome-host cell 

















3.2.1 Existence of extracellular vesicles in H. polygyrus excretory 
secretory products 
At the start of this thesis project, there was pilot data to suggest that adult H. 
polygyrus produces EVs that can be found in the ES products, and the goal here was 
to characterize the properties of these EVs and their functional effects on host cells. 
Adult H. polygyrus worms produce excretory-secretory products (HES) that are 
harvested in vitro by keeping parasites in culture media [240], and assumed to be 
similar to that released in the intestinal lumen of the murine host. Following HES 
ultracentrifugation, the pellet material was analysed using transmission electron 
microscopy (TEM). Indeed, small, irregularly shaped vesicles of around 50-100nm 
in size can be detected (Figure 3.2.1A), which are similar to those classified in the 
literature as exosomes [159, 220].  Total protein content of isolated exosomes, 
compared to HES depleted of exosomes (Sup), or total HES, highlighted distinct 
differences in the profile of these samples, and enrichment of particular proteins in 
the exosome fraction (Figure 3.2.1B) To address whether exosome secretion is 
gender-specific, male and female adult worms were separated following harvest 
from the murine intestinal tract. Worms were separated by hand under a light 
microscope according to their distinct physical differences, and HES was collected 
separately from flasks of male and female parasites. Upon initial TEM analysis, 
exosomes only appear to be secreted from female H. polygyrus (Figure 3.3.1.C, left 
panel). However, when ultracentrifuged HES fractions (which was shown 
previously to contain exosomes) from both sexes were analysed, there does not seem 
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to be any difference in protein content (Figure 3.2.1C right panel). This suggests that 
exosomes are produced by both sexes, and that inconsistencies may have occurred 
during the processing stages for TEM analysis. Finally, mass spectrometry-based 
proteomic analysis of the exosome pellet was carried out [219], whereby 139 
proteins were expressed at significantly higher levels than those found in HES 
supernatant (p <0.05 associated with the protein change). As part of this project, 
these data were analysed to produce a shortlist of the top 25 most highly expressed 
proteins in exosomes compared to the supernatant fraction (Table 3.2.1A). Of note, 
common exosome markers were found, including RAL-1 (Ras-related GTPase-1), 
heat-shock protein-70, and tetraspanin-11. An adapted shortlist from [219] and 
results from our LC-MS/MS analysis identifies more exosome-associated markers, 
and their determined functions (Table 3.2.1B). The characterization of proteins 
associated with exosomes will help inform on how they may be generated, as well as 
their origins and role by looking for markers of biogenesis, specific cell types and 
other functional components. 
 
3.2.2 Potential origin of H. polygyrus-derived exosomes 
Next, we sought to determine where exosomes may originate from inside the H. 
polygyrus adult worm. Analysis of the proteomic profile showed that some of the 
highly expressed proteins in exosomes are homologous to those found in intestinal 
proteins of other worm species (Figure 3.2.2A) [219]. It seems reasonable to 
suggest, given that exosomes tend to express markers of their parent cell [159], that 
these exosomes may originate from a subset of intestinal cells within the worm. We 
analysed cross-sections of whole adult worm, in order to find any evidence of 
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exosomes, or multi-vesicular bodies located near the intestinal tract (Figure 3.3.2B-
E). During fixation and processing of worms for TEM analysis, it was immensely 
difficult to straighten worms to ensure longitudinal cross-sections. Furthermore, it 
was extremely rare to obtain images of an intact intestinal tract (complete with open 
lumen, etc). Despite this, there appears to be vesicles of the correct shape and size 
localised near the intestine (Figure 3.2.2F-I), which are consistent with multi-
vesicular bodies or late endosomes.  
 
3.2.3 Quantification of H. polygyrus extracellular vesicles  
There is a growing requirement for standardization within the field of EV research, 
both with regards to quantitative and qualitative assessment of EVs [251]. Optical 
methods such as TEM give a rough indicator of size and morphology of the vesicles 
(Figure 3.2.1A). Additionally, quantitation techniques such as Qubit or bicinchoninic 
acid assay (BCA), will only reveal protein concentration of the vesicle sample, and 
this may differ due to the heterogeneity of vesicle populations. It is becoming 
increasingly apparent that virtually all mammalian cell EV populations can have a 
degree of heterogeneity [252], and this is now being shown in parasite-derived ES 
preparations as well [219, 247, 250].! Collectively, these techniques give no 
indications of the relative quantities of vesicles within a particular isolation 
preparation. Thus, techniques such as optical single particle tracking analysis or 
resistive-pulse sensing were developed, commercially known as Nanoparticle 
Tracking Analysis (NTA) [253] and the IZON qNano technique [254] respectively.  
The qNano technique quantifies individual EVs by the transient decrease of an ionic 
current that is generated by the movement of a particle through nanopores in a 
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specially designed membrane (See methods and materials).  This gives a readout of 
both size distribution and average concentration of EVs within a sample. H. 
polygyrus exosome preparations consist of a population of vesicles, which on 
average are around 95-112nm in diameter (Figure 3.2.3A). According to qNano 
analysis, 1µg of the ultracentrifuged HES pellet (measured previously by qubit), 
which we know by TEM to contain EVs, equates to ~1 x 109 vesicles. There is clear 
enrichment of vesicles within this preparation, compared the remaining supernatant 
(Sup) concentrate or total HES (Figure 3.2.3B). With regards to infection, it would 
be of biological relevance to know the average number of vesicles secreted per 
worm. Based on average worm burdens, the average concentration of total HES 
secreted during infection [240], and the proportion of the exosome fraction within 
total HES [219],  this equates to approximately 1 x 107 vesicles secreted per worm 
during a two week culture (Figure 3.2.3C). It is noted however that we do not have a 
clear assessment of the efficiency of vesicle recovered during purification, and 
whether the approximation is necessarily reflective of vesicles secreted during 
infection. 
 
3.2.4 H. polygyrus exosomes elicit strong polyclonal antibody 
responses 
In order to detect H. polygyrus exosomes by western blot or flow cytometry, we 
developed anti-exosome polyclonal sera. Rats were immunized using an alum 
vaccination schedule [255], with intraperitoneal doses of exosomes, or exosomes that 
had been pre-treated with Triton X-100 detergent, which degrades exosomal 
membranes (Figure 3.2.4A). As we do not know how H. polygyrus exosomes interact 
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in another species in vivo, i.e. processing by other cells, direct recognition, etc. it was 
essential to compare the sera raised from both types of exosome preparations i.e. 
with or without an intact lipid membrane. The polyclonal sera obtained from both 
immunization schedules were analysed for reactivity via western blot, and specificity 
was determined by comparison with sera from a naïve rat (Figure 3.2.4B). Despite 
antisera recognition of proteins common to exosomes, total HES or HES supernatant, 
there also appear to be a few bands unique to exosomes (for example, at approx. 38 
and 10 kDa). It would be beneficial to determine the proteins that correspond to these 
exosome-specific proteins. Therefore, a two-dimensional gel electrophoresis was 
performed to determine the identity of exosome proteins, and showed a range of 
protein spots when analysed by silver stain (Figure 3.2.4C top). The polyclonal rat 
serum generated against exosomes recognized several of these spots by western blot 
(Figure 3.2.4C bottom), as well as many others. It should be noted that this 
polyclonal serum was used in a number of future experiments (Chapter 3, 4 and 6). !
Additionally, we received purified polyclonal rabbit sera that had been 
generated against two peptide sequences from the C-terminus of H. polygyrus 
Tetraspanin-11. This was expected to be highly enriched on the exosome surface 
[219], given the presence of tetraspanins on surface of mammalian exosomes, where 
they are suggested to be implicated in a number of exosomal functions, including 
cargo sorting, target cell selection and anchorage [173]. There appear to be several 
exosome-specific bands that the anti-TSPAN11 antisera bind to in comparison to 
HES Sup and total HES, following visualization by western blot (Figure 3.2.4D).  
However, none of these match the expected size of ~30kDa (based on LC-MS/MS in 
[219]). The presence of bands with a higher molecular weight than expected could 
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suggest possible post-translational modification of the protein, protein misfolding or 
non-specific binding to exosome surface proteins. The non-specific nature of this 
polyclonal serum was kept in mind for any future experiments. 
 
3.2.5 Antibody-based capture of exosomes by flow cytometry 
Using a latex bead-based system, we can determine the relative presence of various 
surface proteins on EVs through detection on a standard flow cytometer [256] 
(Figure 3.2.5A). We can use this method to determine the binding capacity of 
polyclonal rat antisera and other antibodies to the proteins on the surface of H. 
polygyrus EVs.  Based on the relative fluorescence intensity and histogram (Figure 
3.2.5B), rat polyclonal serum that was raised against exosomes recognized a higher 
repertoire of proteins on the surface of exosomes, compared to either total HES or 
HES depleted of exosomes. Non-specific binding was assessed with either beads 
alone, or in comparison to naïve sera. The corresponding histograms show the 
proportion of binding from naïve serum (green line) or anti-serum to exosomes (red 
line), and the bead only control (grey). In addition, polyclonal anti-tetraspanin 11 
(anti-TSPAN11), antibodies had higher proportion of binding to exosome surface 
proteins compared to other HES fractions (Figure 3.2.5C), suggesting their potential 
to interact with exosomes in future studies. Finally, we used a monoclonal antibody 
against murine ALIX in this system, which has approximately 42% sequence identity 
to the H. polygyrus ALIX protein. Based on the relative binding fluorescence to H. 
polygyrus exosomes, this suggests the presence of cross-reactive ALIX proteins on 
the nematode exosome surface (Figure 3.2.5D).  
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3.2.6 Cross-link immunoprecipitation of H. polygyrus exosomes 
In order to identify the primary exosomal protein candidates as targets for 
vaccination, we must first isolate exosomal proteins recognized specifically by 
polyclonal rat serum. I carried out cross-link immunoprecipitation of exosomal 
proteins by anti-serum, followed by subsequent LC-MS/MS analysis (Workflow in 
Figure 3.2.6). These data revealed a number of candidate proteins specifically 
targeted by antibodies (Table 3.2.6), along with proposed functions as exosomal 
proteins. Some of these proteins are involved in direct vesicle/exosome functions, 
including zinc metallopeptidase and ubiquitinases, scavenger receptors and vacuolar 
ATPase subunits [198, 223, 257]. Furthermore, proteins such as Galectin-1, Histone 
deacetylase-1 and Heat-shock protein 70 are associated with immune modulation 
[258-260], whereas others such as lysozyme-2 have bacteriolytic activity [246]. The 
list of proteins recognized by antibodies generated in exosome-immunized animals 
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Table 3.2.1A – Top 25 proteins enriched in exosomes 





Species with protein 
similarities 
1 Hypothetical protein CRE_25189 274.61 4 9.5 Hp_I15305_IG07249_L1196 C. remanei 
2 Protein RAL-1, isoform b 139.11 3 10.4 Hp_I14286_IG06230_L1419 C. elegans 
3 No BLASTX similarities 28267638:28268138 forward 138.66 2 36.7 Hp_I28260_IG20204_L501 N/A 
4 Zinc Metallopeptidase 1 104.65 19 19.6 Hp_I12518_IG04462_L2600 A. caninum 
5 Hypothetical protein CRE_03026 77.99 3 15.1 Hp_I14432_IG06376_L1375 C. remanei 
6 Temporarily Assigned Gene name family member (tag-234) 73.25 2 16.8 Hp_I11897_IG04033_L376 C. elegans 
7 hypothetical protein CAEBREN_05149 64.35 5 8.9 Hp_I13513_IG05457_L1688 C. brenneri 
8 O-Acyltransferase-32 61.44 2 7.4 Hp_I12671_IG04615_L2329 A. suum 
9 ACTIN-5 57.11 10 28.5 Hp_I15213_IG07157_L1209 C. brenneri 
10 Myoglobin 56.24 3 8.6 Hp_I02590_IG00245_L1152 H. polygyrus 
11 Aspartyl protease precursor 55.2 2 4.9 Hp_I08795_IG02482_L1340 H. contortus 
12 Intestinal acid PHOsphatase family member (pho-1) 53.45 2 6.9 Hp_I16610_IG08554_L997 C. elegans 
13 Putative Zinc Metallopeptidase 52.76 25 25.8 Hp_I12444_IG04388_L2875 H. contortus 
14 EPS (human endocytosis) related family member (eps-8) 52.01 2 16.9 Hp_I30640_IG22584_L466 C. elegans 
15 Cell Death abnormality family member (ced-10) 47.72 3 6.8 Hp_I14321_IG06265_L1411 C. elegans 
16 Multidrug resistance protein 1 46.45 2 8.5 Hp_I18648_IG10592_L810 A suum 
17 SCAVenger receptor (CD36 family) related-4 46.19 5 8.4 Hp_I13316_IG05260_L1787 C. remanei 
18 R-RAS related family member (ras-2) 45.23 2 3.8 Hp_I14240_IG06184_L1427 C. elegans 
19 G Protein, Alpha subunit family member (gpa-17) 43.17 3 6.1 Hp_I14396_IG06340_L1386 C. elegans 
20 Tetraspanin-11 40.02 2 5.9 Hp_I16310_IG08254_L1020 A suum 
21 Pepsinogen 39.99 4 7 Hp_I08139_IG02154_L1715 H. contortus 
22 Heat Shock Protein 70 39.2 16 21.9 Hp_I12624_IG04568_L2400 D. medinensis 
23 No BLASTX similarities 12097939:12099055 forward 38.7 2 7.8 Hp_I09125_IG02647_L1117 N/A 
24 Hypothetical protein CBG01308 38.13 6 23.1 Hp_I07646_IG01907_L1927 N/A 
25 Hypothetical protein CBG02206 35.14 2 3.4 Hp_I06659_IG01391_L1864 N/A 











Spp. with protein 
similarities Function Ref 
2 Protein RAL-1, isoform b 139.11 3 10.4 Hp_I14286_IG06230_L1419 C. elegans MVB biogenesis and exosome secretion [258]  
4 Zinc Metallopeptidase 1 104.65 19 19.6 Hp_I12518_IG04462_L2600 A. caninum Vesicle cargo selection 
[195, 
206]  




EPS (human endocytosis) related 
family member (eps-8) 52.01 2 16.9 
Hp_I30640_IG2
2584_L466 C. elegans Endosomal trafficking [259]  
20 Tetraspanin-11 40.02 2 5.9 Hp_I16310_IG08254_L1020 A. suum 
Ubiquitous e.g. cell adhesion, motility, membrane 
fusion, signaling and protein trafficking [173]  
22 Heat Shock Protein 70 39.2 16 21.9 Hp_I12624_IG04568_L2400 D. medinensis Ubitquitous e.g. chaperone protein/Ag presentation 
[257, 
260]  
33 ALIX 30.16 4 6.7 Hp_I13661_IG05605_L1622 C. elegans Exosome biogenesis and ESCRT-pathway protein  [172] 
34 Tetraspanin-9 protein 29.78 2 3.7 Hp_I07666_IG01917_L1781 C. brenneri 
Ubiquitous e.g. cell adhesion, motility, membrane 
fusion, signalling and protein trafficking [173]  
50 Rab-11B 19.7 3 14.5 Hp_I22717_IG14661_L625 S. salar MVB fusion and vesicle release  [261] 
63 Galectin-1 15.74 8 11.9 Hp_I04721_IG00743_L1466 H. contortus Immune regulation [255]  
94 Rab-5 7.2 2 3.4 Hp_I12868_IG04812_L2115 C. elegans Endosomal trafficking  [262] 
11
0 Heat shock protein 90 6.34 5 7.8 
Hp_I07666_IG0
1917_L1781 H. contortus 





39 Enolase 1.94 9 18.8 
Hp_I06749_IG0




Table 3.2.1B - Functions of exosomal proteins identified by LC-MS/MS  
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1% Putative%Zinc%Metallopeptidase% 29! 18.5! H.#contortus# Vesicle!cargo!selection!
2% Zinc%Metallopeptidase%1% 21! 12! A.#caninum# Vesicle!cargo!selection!
5% VITellogenin%structural%genes%(vitH6)% 8! 3.3! C.#elegans# Yolk!protein!precursors!




6! 35.5! C.#elegans# Mediates!phagocytosis/Extracellular!fluid!transport!protein!
9% VITellogenin%structural%genes%(vitH2)% 10! 3.8! C.#elegans# Yolk!protein!precursors!
15% ACTin%family%member%(actH4)% 2! 4.7! C.#elegans# Cell!motility!protein!
16% CBNHACTH5%protein% 2! 5.7! C.#brenneri# Cell!motility!protein/Intestinal!villi!structure!formation!
18% Antigen%H11% 1! 3.7! H.#contortus# Aminopeptidase!activity/Vaccine!candidate/Intestinal!molecule!
21% %Ezrin/Radixin/Moesin%family%(ermH1)% 3! 3.1! C.#elegans# Intestinal!structural!remodelling!
25% Microsomal%aminopeptidase% 1! 3! H.#contortus# Parasite!intestinal!glycoprotein!e.g.!antigen!H11!




2! 6.5! H.#contortus# Muscle!neuron!receptor!M!target!of!antiMhelminthic!drugs!




1! 5.9! C.#elegans# Regulates!channel!activity,!intercellular!signalling,!and!cell!morphology!
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34% Heat%Shock%Protein%70% 1! 2.3! A.#suum# Ubiquitous!e.g.!Chaperone!protein/antigen!presentation!
35% CREHVHAH2%protein% 1! 3.5! C.#remanei# V0!complex!of!vacuolar!ATPase!M!mediates!apical!secretion!of!exosomes!




1! 2.3! C.#remanei# Exosome!marker,!Mediates!exosome!uptake!and!phospholipid!transfer!
41% SerpinHB6% 1! 2.5! A.#suum# Regulate!serine!proteinase!activity!
47% LysozymeH2% 1! 3.2! H.#polygyrus## Antimicrobial!and!bacteriolytic!effect!






1! 13.1! M.#musculus# C3!inhibitor!in!H.#contortus.!Vaccine!candidate!in!S.mansoni!EVs!
58% KeratinHlike%protein% 1! 6.4! N.#brasiliensis# Structural!protein!








There are now a growing number of reports concerning extracellular parasite-derived 
EVs, especially from helminths, including liver flukes, [220], Schistosoma species 
[226, 261], filarial [247] and gastrointestinal nematodes [219, 262]. In this respect, a 
greater understanding and characterization of these vesicles must be developed in 
order to understand their function during infection.  
The gastrointestinal nematode, H. polygyrus, releases exosome-like vesicles 
within its excretory/secretory product. These vesicles are consistent in shape and size 
to those described in the literature as exosomes [167].  Proteomic analysis of the H. 
polygyrus ultracentrifuged pellet further confirms the identity of these vesicles, as 
they are enriched in typical exosome markers such as ALIX, Rab proteins, heat-
shock proteins and tetraspanins, proteins which are directly involved in exosome 
biogenesis and interactions [159]. In some instances of helminth infection, 
inoculation with either egg or worm stages can induce differential immune 
responses, as is shown during treatment of airway hyper-reactivity with the nematode 
S. mansoni [263]. However, we do not know currently whether other life stages have 
the capacity to secrete vesicles. Despite this, we show that exosome release does not 
appear to be gender specific, supporting most previous reports demonstrating 
exosome-like vesicles in ES from mixed male and female adult cultures [247, 261]. 
Although transmission electron microscopy suggested higher exosome abundance in 
the female worm secretory product, gel analysis showed that the protein composition 





 Current methods of exosome or EV characterization can reveal their 
molecular repertoire, concentration per sample, size and morphology [251]. Despite 
this, there are clear requirements to recapitulate the physiological ‘dose’ of exosome-
like vesicles that are released in vivo [264]. This will be an important requirement to 
take forward for our investigations of H. polygyrus-exosome mediated effects on 
cells in vitro and the dosage administered during experimentation in vivo. Indeed, 
there is limited literature available on the quantitative release of vesicles on a per cell 
basis, or their relative contents e.g. the variable numbers of miRNAs per vesicle 
[265]. An approximation of the number of vesicles secreted per worm allows us to 
hypothesise the potential number of vesicles that cells are exposed to during natural 
infection.  
                  Owing to the novel biology surrounding nematode-derived exosomes 
[188], it was of interest to determine where exosomes originate from in the adult 
worms in order to develop a greater understanding of biogenesis and function. 
Analysis by mass spectrometry of the HES pellet revealed that exosomes were 
enriched in some intestinal markers homologous to those found in other worm 
species such as C. elegans and Haemonchus contortus [266]. These included Pho-1, 
glutathione S-transferase and actin-5, the latter of which has been shown to be 
essential for the development of microvilli and other intestinal architecture [267]. 
Ultrastructural analysis revealed evidence of exosome-like vesicles or multi-
vesicular bodies (MVBs) in close proximity to the H. polygyrus intestinal tract. Some 
structures resembled MVBs found in E. caproni [220], although these cannot be 





Rats were vaccinated with exosomes plus an alum adjuvant, which generated 
polyclonal antibodies that recognize exosomes, with the aim of it having minimal 
reactivity to other components in HES.  The anti-exosome antisera recognized a 
large number of bands on exosome protein blots, but also reacted to HES that had 
been previously depleted of exosomes. This may be due to incomplete exosome 
purification from HES during ultracentrifugation, or there may be shared proteins in 
exosomes and HES. Despite this, there are several bands recognized by the antisera, 
such as those found at approximately 12 and 38- kDa, which appear to be exclusive 
to exosomes. Further characterisation of the exosome protein profile was performed 
by two-dimensional gel electrophoresis, which also highlighted the reactivity of 
exosome antisera by western blot. A comparison with total HES will be important to 
determine any spots which overlap, as many proteins in HES have already been 
identified using this method [255]. Despite the low abundance of exosomal proteins 
detected in the 2D gel (possibly owing to the low protein amount used for this assay), 
there is some overlap/localization to proteins in total HES that were visualized using 
the same method [255]. These proteins include enolase, zinc metalloprotease and 
apyrases, which are further recognized by anti-exosome polyclonal antibodies.  
 
Tetraspanins from parasites have been recently suggested as promising 
targets for vaccination, as shown in Echinococcus multilocularis, the causative agent 
of alveolar echinococcosis [173, 225]. Parasite tetraspanins have also been recently 
identified in S. mansoni EVs [226], and further implicated in similar vaccination 
strategies, whereby antibodies blocked tetraspanin-mediated uptake of O. viverrini 




may provide an important anti-parasite vaccination strategy. Consequently, 
antibodies generated against H. polygyrus TSPAN-11 also recognise exosomal 
proteins by both western blot and flow cytometry. However, given that this 
antiserum does not recognise proteins of the correct size to TSPAN11, we cannot be 
confident in their use for future studies. Flow cytometry also allowed us to determine 
surface protein expression and reactivity by polyclonal anti-exosome antibodies or 
cross-reactivity by antibodies generated against murine ALIX. However, as stated 
previously, EV observation by this particular flow cytometry method does not allow 
EV quantification, or help discriminate between different vesicle subsets [268].  
 
Crosslink immunoprecipitation and subsequent mass spectrometry analysis 
allowed for the isolation and identification of exosomal proteins that are recognized 
by polyclonal antibodies. Some of these proteins have been associated with inert 
exosome functions, including zinc metallopeptidase and ubiquitinases, which have 
been shown to mediate vesicle cargo selection in both mammalian EVs and 
pathogenic EVs [198, 209, 269]. Other exosomal proteins, such as scavenger 
receptors, vacuolar ATPase subunits or transthyretin-like proteins are associated with 
exosome lipid transfer or in secretion and uptake of EVs [223, 257, 270]. 
Furthermore, proteins such as Histone deacetylase-1 and HSP70 have been 
associated with immune modulation through epigenetic inhibition of Th2 responses, 
or in antigen presentation and immune cell activation [259, 260]. Interestingly, 
Galectin-1 has been shown to mediate effects through the induction of tolerance, 
activating T regulatory cell populations [258], and has also been shown to suppress 




helminths may use exosomes to deliver these immunomodulatory molecules to 
regulate inflammation that is induced by barrier damage and bacterial infiltration. 
Additionally, exosomes may also mediate bacterial regulation through the secretion 
of anti-microbial compounds, including lysozyme-2 [246], and PI-type proteinases 
[272]. Identification of antibody-reactive proteins in this study would allow the 
development of specific monoclonal antibodies against H. polygyrus exosomes. 
Several proteins on this list, including metallopeptidases, serpins, and the nicotinic 
acetylcholine receptor were all listed as vaccine candidates against the filarial 
nematode Onchocerca volvulus [273]. Additionally, microsomal aminopeptidases, 
such as Antigen H11, have long been associated in vaccine development against H. 
contortus [274]. More recently, glyceraldehyde-3-phosphate dehydrogenase-like 
molecules (GAPDH) have been included in the potential vaccine candidate list from 
S. mansoni EVs [226]. Finally, there are a number of studies showing the 
effectiveness of vaccination against helminthic HSP70 in protection against parasite 
challenge, including S. japonicum [275], L. sigmodontis [276], and T. spiralis [277], 
further cementing the utility of exosome-associated proteins as vaccine targets. 
It must be recognized that the proteomic characterization of H. polygyrus 
exosomes only highlights one aspect of their cargo. It has been shown that H. 
polygyrus exosomes contain a suite of small RNAs, including miRNAs [219], and 
microarray analysis showed that H. polygyrus exosomes induced regulation of 
murine genes, including DUSP1 and the IL-33 receptor. A specific cocktail of these 
miRNAs suppressed the murine phosphatase DUSP1, a key regulator of the MAP 
kinase pathway. Interestingly, cystatin molecules secreted by A. viteae promoted and 




[74]. However, despite having parasitic miRNA binding sites in the 3’ untranslated 
region (UTR) of the gene for the IL-33 receptor, a molecule associated in anti-
parasitic responses [278], it was not functionally repressed by several synthetic 
parasite miRNAs tested. This suggests that whilst some exosomal functions may be 
exerted or enhanced by miRNAs, this does not account for all suppressive mediators 
within the exosome cargo. Furthermore, analysis of the lipid repertoire of H. 
polygyrus exosomes highlights the differential enrichment of particular lipid species, 
such as plasmalogens, compared to mammalian exosomes [279]. This paper 
demonstrated that H. polygyrus exosomes had greater membrane rigidity and 
enrichment of lyso-phosphatidylserine, a molecule also secreted by S. mansoni, 
which is shown to be important in TLR2-mediated immune modulation [280]. 
 
Overall, these data provide an initial characterization of extracellular vesicles 
found in the ES products of H. polygyrus, which is geared towards the development 
of tools to detect or inhibit these complexes based on their protein markers.  These 
vesicles contain a cohort of proteins enriched in mammalian exosomes, and are 
morphologically similar to vesicles as described elsewhere [159, 220]. Their origin 
was hypothesized through imaging and the enrichment of parasite intestinal proteins. 
The development of polyclonal sera allowed for identification of H. polygyrus 
exosomes by traditional protein detection assays. Proteomic analysis of the exosome 
pellet also revealed the presence of potential immunomodulatory proteins. To 
investigate the role of H. polygyrus exosomes during infection, I determined the 
functional properties of these exosomes with both intestinal and immune cells in 





The impact of H. polygyrus exosomes on host 






 The data discussed in chapter 3 focused on the primary characterization of exosomes 
isolated from the ES of adult H. polygyrus. This revealed the presence of modulatory 
proteins and suggests a potential mechanism of cross-species regulation used by the 
parasite. The excretory-secretory products of other parasitic nematodes have been 
shown to contribute to immunomodulation, facilitating parasite evasion of host 
immunity, and enabling the establishment of chronic infection [281]. H. polygyrus 
ES (HES) contains a large cohort or bioactive molecules which have potent 
immunoregulatory functions [243]. For example, H. polygyrus secretes a functional 
TGF-β homologue, which initiates immune regulation through the induction 
FOXP3+ regulatory T cells [151, 282].  
 
Recently, our group showed that extracellular nanovesicles are present in the 
ES from adult H. polygyrus culture. This study [219], where I contributed to the 
manuscript as a co-author, highlighted the potential functions of parasite-derived 
exosomes in the host-helminth relationship. It has long been appreciated that 




cells to do so (See Table 4.1). There is evidence that some intracellular pathogens 
use EVs to subvert a host immune response, therefore promoting their survival. For 
example, the Epstein-Barr virus (EBV) has been shown to direct exosome release 
from infected B cells, which contain viral miRNAs that are used to suppress host 
anti-viral immunity [283]. Furthermore, the protozoan parasite L. donovani is shown 
to induce the production of immunomodulatory EVs from macrophages [197], and 
also release their own EVs that have an immunosuppressive effect on myeloid-
derived cells [193]. Furthermore, microvesicles secreted by Plasmodium falciparum-
infected red blood cells are shown to activate both pro-inflammatory and anti-
inflammatory cytokine responses [284]. 
At the beginning of this PhD project, there were only a handful of studies 
documenting extracellular vesicles in the ES material of extracellular pathogens, 
including the parasitic protozoan Trichomonas vaginalis [209], and the trematodes, 
F. hepatica and E. caproni [220]. The discovery of nematode-derived exosomes 
within adult ES allows us to speculate why a parasite would release such vesicles 
into harsh host environments, such as the intestine. Indeed, exosomes are shown to 
protect their contents, including miRNAs [285], from environmental factors such as 
RNases and can be therefore used as biomarkers based on their presence within a 
multitude of body fluids. The ability of exosomes to withstand the intestinal 
environment has been demonstrated through the use of grape-like EVs to treat DSS-
colitis [286]. Indeed, our group showed that H. polygyrus exosomes protect 
nematode RNA species, including miRNAs, from degradation [219]. As such, it will 




such as the the L3 or L4  larval stages, can secrete EVs within their own ES 
products. 
Over the course of this study, more data emerged on extracellular parasite-
derived EVs, highlighting their potential as immunomodulators (See Table 4.1). 
Some EV-derived molecules, such as miRNAs, are hypothesised to have direct 
immunosuppressive properties, and are found in parasites such as Brugia malayi 
[247] and trematodes including Dicrocoelium dendriticum [248] and S. mansoni 
[249]. Thus, parasite-derived EVs have potential as future therapeutics, replicating 
the immune-regulating properties of the parasites they derive from [287]. 
Additonally, other molecules, such as cathepsin L1 found on F. hepatica and Brugia 
malayi EVs, have been shown previously to interfere with monocyte pattern 
recognition and modulate T cell responses [247, 250]. Conversely, some helminthic 
EVs actually have immunostimulatory properties. O. viverrini exosomes were shown 
to induce production of the pro-inflammatory cytokine IL-6 in a cholangiocyte cells 
[227], and EVs from S. japoniucm were shown to stimulate M1 polarisation [261]. 
EVs from trematodes also contain a number of proteases [220, 248], which may 
facilitate tissue migration, expanding the potential roles of parasite EVs during 
infection. 
 
We must consider the potential interactions occurring at the parasite-host 
interface during EV-mediated responses. One of the most commonly proposed 
methods for EV uptake is endocytosis [179, 288], although this may be context 
dependent, with studies showing exosome uptake by macropinocytosis, direct fusion 




the uptake and intracellular trafficking of HEK293 exosomes by human fibroblast 
cells, and has demonstrated that uptake is initiated through filopodial contact and 
endocytosis in an actin-dependent manner [177]. Despite recent advances, a majority 
of this work has focused mammalian exosomes, both in cancer [289, 290] and 
immunity [178, 291]. However, there are a number of studies demonstrating the 
uptake of EVs from intracellular pathogens. For example, Leishmania-derived EVs 
are taken up by macrophages [292], and the uptake of microvesicles from P. 
falciparum-infected RBCs promoted the transfer of genetic material [236]. There is 
also more detailed data showing that exosomes from EBV-infected cells generate 
their function in recipient epithelial cells following internalization by caveolin-
mediated endocytosis [293]. However, evidence of helminth-EV uptake is scarce, 
with only two studies demonstrating uptake in intestinal epithelial cells [219, 220]. 
There was also a recent study showing that S. japonicum EVs can be internalized by 
murine liver cells and transfer their small RNA cargo [294]. Importantly, antibodies 
generated against EV-tetraspanins from the liver fluke O. viverrini can block their 
uptake by cholangiocytes, thus limiting their function [227]. As detailed in the 
previous chapter, exosome surface proteins are recognized by specific antibodies, 
and further analysis may identify proteins that mediate uptake. A greater 
understanding of helminth EV uptake will be crucial when designing future 
therapeutic interventions. 
 
This chapter examines the interactions between H. polygyrus exosomes and 
host cells. In particular, the effect on uptake by time and stimulatory conditions is 




can be manipulated, either by the use of chemical inhibitors or specific antibodies. 
The immunomodulatory impact of H. polygyrus exosomes on host cells is examined, 
with particular focus on cells present within the intestinal environment, including 
macrophages and epithelial cells. This study further investigated how these 
exosomes can suppress aspects of type-1 and type-2 immune responses, as both 
would be induced during a natural H. polygyrus infection. In order to add more complexity 
in our investigation of exosome-host cell interactions, and overcome the difficulties of 
isolating exosome-specific roles in intestinal environment during natural infection we 
employed the use of an ex vivo small intestinal organoid culture. The data presented from the 
organoid work highlighted some key technical challenges, as well as some interesting 
preliminary data with regards to uptake in a multicellular system.  
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Table 4.1 Pathogen-derived EVs and their proposed functions 
Pathogen Exosome origin Functional response Effector Mechanism(s) Ref 
Protozoa     
Leishmania 
amazonensis Infected macrophages Promotion of Th1 responses Naïve macrophages are primed to release IL-12, IL-1β and TNF [295] 
Leishmania 
donovani Promastigotes 
Invasion/persistance within host cells and 
delivery of virulence factors 
Leishmania elongation factor 1a and GP63 activate host protein-tyrosine 
phosphatases in monocytes. GP63-induced exosome cargo selection and 
inhibit host miRNA processing 
[193, 
194, 197, 
199, 292]  
Induction of Leishmania-peptide carrying 
exosomes from monocytes 
Increase in IL-8 secretion by macrophages. Induces release of IL-10 in 






Invasion/persistance within host cells and 
delivery of virulence factors 
Leishmania elongation factor 1a and GP63 activate host protein-tyrosine 
phosphatases in monocytes 
[196, 
198] 
Increased disease exacerbation and Th2 
polarisation in vivo 
Increase in the number of IL-4 producing CD4 T cells/decrease in the 
number of IFNϒ-producing CD4+ T cells [193] 
Stationary phase Enhanced parasite replication/Lesion exacerbation 
Increased levels or IL-4 and IFN-γ, with over-induction of IL-17A and IL-
10 in the lymph node [296] 
Leishmania 
mexicana Infected macrophages 
Immunomodulation of host signalling events 
promoting parasite survival 
Upregulation of adenosine receptor 2A by parasite-derived GP63 contained 




 Stationary phase 
Inhibition of alarmin response allowing 
survival 
GP63-mediated cleavage of NLRP3 inflammasome, abrogation of ROS 
production and IL-1β maturation [298] 
Plasmodium 
berghei Infected erythrocytes 
Activate systemic inflammation and T cell 
priming Via MyD88/TLR4 pathway and CD40/CD40L interactions [299] 
Plasmodium 
falciparum Infected erythrocytes 
Transfer of parasite material and parasite 
dissemination 
Innate cell activation. Cytokine induction in macrophages (IL-6, IL-12, IL-
1β & IL-10) in dose-dependent manner [284] 
Commitment of asexual parasites to 
gametocytes 








Higher acute fever and length of malaria 
symptoms in humans Unknown mechanism [300] 
Trypanosoma 
cruzi 
Trypomastigotes Th2 polarisation. Parasite dissemination, adhesion and enhanced parasite survival 
Increase in IL-4 and IL-10 secretion, and reduction in iNOS expression in 
CD4 T cells and macrophages. 
[201, 
301] 
Trypomastigotes Modulation of innate inflammation and chronic phase immunopathology 
gp85/trans-sialidase (TS) superfamily and α-Gal glycoprotein enriched EVs 
- TLR2/innate activation and production of IL-10 by splenic T/B cells [302] 
Infected lymphocytes 
and erythrocytes 
Parasite invasion and inhibition of 
complement-induced parasite elimination 
Plasma membrane-derived vesicles containing surface TGF-β, which 
promotes entry into host cells 
[303, 
304] 
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Pathogen Exosome origin Functional response Effector Mechanism(s) Ref 
Protozoa         
Trichomonas 
vaginalis Mature parasites Limit neutrophil migration to site of infection 
Metalloproteases downregulate IL-8 secretion in ectocervical cells. Promote 




Procyclic forms of 
the parasite 
Improved entry into host cells, enhanced 
parasite survival 






Erythrocyte invasion, increased virulence and 
host anaemia 
Transfer of SRA (serum-resistance associated protein) to other parasites to inhibit 
trypanosome lytic factors [306] 
Fungi        
Cryptococcus 
neoformans  
EVs from fungal 
cell phase   
Promote colonisation of infected tissues Release virulence factors - glucosylceramide and glucuronoxylomannan [214] 
Stimulate fungal killing Enhanced IL-10 and TGF-β secretion  nitric oxide production by macrophages [217] 
Malassezia 
sympodialis 
Yeast - skin living 





Potential to skew to a suppressive Th2 
response 
Immunogenic EVs enriched in galactose-α-1,3-galactose which may bind host 
lectins potentially improve infectivity by fungi   [210] 
Helminths        
Heligmosomoides 
polygyrus 
Intestinal tract of 
adult nematode 
Suppress classical inflammation and danger 
responses, promoting parasite survival Suppression of host targets including IL-33R and DUSP1 [219] 




viverrini Adult worms 
Host cell inflammation, tumorigenesis and 
wound healing Increase IL-6 production from cholangiocytes and stimulate protein dysregulation [227] 
Schistosoma 
japonicum Adult worms 
Polarization of host macrophages to M1 
phenotype Unknown mechanism 
[261] 
 
Host gene regulation and modulation Functional transfer of miRNAs e.g. Bantam, to host cells [294] 
Schistosoma 
mansoni Adult worms 
Nutrient acquisition and potential host 
modulation 




aDetails in each column (from left to right) describe: the parasite species, the life stage and/or cellular origin of the EV, the proposed functional 
outcome, the mechanistic data in support of this function, and the primary literature reference. 
!
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4.2 Results  
 
 
4.2.1 Tracking differential uptake of H. polygyrus exosomes  
 
Previously, it has been established that H. polygyrus exosomes can be visualized 
inside mouse epithelial cells after 24 hours [219]. Here I focused on understanding 
the timing and requirements for uptake, comparing epithelial cells and macrophages, 
two cell types highly represented in small intestinal tissue, the natural environment 
for H. polygyrus adult worms [240]. Exosomes purified from adult HES by 
ultracentrifugation were labelled with a PKH67 fluorescent dye, which incorporates 
into the lipid-rich membrane of the exosomes, and is detectable by both flow 
cytometry and confocal microscopy [219]. As an uptake control, the dye was also 
prepared without exosomes to control for any aggregates that carry over during 
ultracentrifugation that would label cells (See gating strategy Figure 4.2.1A). Any 
exosomes present on the surface of cells were removed by treating cells with trypsin 
5 min prior to acquisition, and uptake of the dye alone was detectable in <1% of 
cells, supporting the use of PHK67 positive cells as a marker of exosome uptake. By 
flow cytometry, initial observations show H. polygyrus exosome uptake steadily 
increasing in F4/80+ bone-marrow derived macrophages (BMDMs), the MODE-K 
small intestinal epithelial cell line, and the RAW 246.7 cell line (a mixed 
monocyte/macrophage cell line [238]), over the course of 24 h (Figure 4.2.1B), 
represented by the % of exosome-positive cells. Notably, this rate of uptake is not 
exosome specific, as similar uptake rates were observed using mammalian exosomes. 
By confocal analysis, H. polygyrus exosome uptake over time was also verified in 
F4/80+CD11b+ BMDMs (Figure 4.2.1C). 
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4.2.2 H. polygyrus exosome internalisation is modulated by both 
Cytochalasin D treatment and macrophage polarisation 
To test whether H. polygyrus exosome uptake occurs by an active process, BMDMs 
were co-treated with exosomes and cytochalasin D, a potent inhibitor of actin 
polymerization. Exosome uptake was effectively abolished after 1 h, and was still 
inhibited after 24 h in BMDMs in the presence of cytochalasin D co-treatment, 
evaluated by both flow cytometry (Figure 4.2.2A) and confocal microscopy (Figure 
4.2.2B). It was then established whether the polarization of macrophages to either an 
M1 or M2 phenotype affects parasite-derived exosome uptake. Both cell types are 
present in the small intestine during an immune response to both infective larval 
stages and adult H. polygyrus, as well as the bacterial infiltrate resulting from barrier 
damage [307, 308]. BMDMs were pre-treated with 20 ng/ml IL-4/IL-13 or 500 ng/ml 
LPS, or media alone for 24 h prior to the addition of H. polygyrus exosomes for 1 h, 
and cells were then assessed for exosome uptake by flow cytometry (Figure 4.2.2C) 
or confocal microscopy (Figure 4.2.2E). It was found that LPS pre-treatment 
significantly represses the ability of BMDMs to take up exosomes early on, 
compared to either stationary BMDMs or those polarised by IL-4/IL-13. A similar 
pattern of uptake was shown in LPS or IL-4 prestimulated bone marrow-derived 
dendritic cells (BMDCs) (Figure 4.2.2D). This data is consistent with previous 
reports showing that nanoparticle uptake is superior in M2-polarised compared to 
M1-polarised macrophages after 1 h [309]. Additionally, LPS repression of exosome 
uptake may suggest that some early internalisation occurs by phagocytosis, as this is 
inhibited in macrophages following LPS pre-stimulation [310].  
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4.2.3 Antibodies enhance internalisation of H. polygyrus exosomes in 
bone-marrow derived macrophages 
Recently, it has been demonstrated that epithelial cell uptake of EVs from O. 
viverrini can be inhibited using specific tetraspanin antibodies (a key exosome 
protein) [227]. In chapter 3, I demonstrated the capacity of exosomes to generate 
polyclonal antibody responses following an alum vaccination schedule. I therefore 
aimed to investigate whether antibodies generated against H. polygyrus exosomes 
would interfere with uptake. Exosomes were incubated with BMDMs stimulated 
with either LPS, IL-4/13 or media in the presence of rat polyclonal antisera for 1 h, 
and exosome uptake was assessed by confocal microscopy (Figure 4.2.3A) or flow 
cytometry (Figure 4.2.3B). Antisera treatment significantly enhanced the early 
uptake of exosomes, regardless of stimulation, even in LPS pre-treated macrophages, 
which take up few exosomes in the absence of antibody. We also noted a more 
dispersed pattern of exosomes within antiserum-treated cells after 1 h, suggesting 
that their function properties might also be altered by antibody-mediated uptake 
(tested in further studies below). After 24 h, the enhancement of uptake by 
polyclonal anti-exosome sera was still evident in either IL-4/IL-13 or LPS-stimulated 
cells. However, this was not reflected when BMDMs were co-treated with exosomes 
and TSPAN11 antibodies (Figure 4.2.3C), which may be due to the non-specificity 
of this antiserum (Figure 3.2.4D). Furthermore, attempts to interfere with exosome-
specific antibody-mediated EV uptake were not significantly diminished by using 
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4.2.4 Microarray of exosome-stimulated MODE-k epithelial cells. 
During natural infection, H. polygyrus adult worms coil around the villi in the small 
intestine, and would therefore be in direct contact with the uppermost layer of cells; 
the intestinal epithelium [307]. Thus, MODE-K cells, an immortalized small 
intestinal epithelial cell line [239], were used to address the effect of H. polygyrus 
exosomes on global gene expression of murine cells. A microarray analysis 
determined that approximately 128 genes were differentially expressed upon 
exosome treatment (using a false discovery rate (FDR) cut-off of P<0.05) [219], of 
which the top ten genes showing highest fold change are shown in Table 4.2.4A. To 
gain further insight into the potential mechanisms of the exosome gene modulation, 
the identified 128 genes were mapped to networks available on the Ingenuity 
database (Ingenuity Systems, www.ingenuity.com). The major networks within 
canonical and disease pathways, as well as biological effects, were identified and 
were ranked by the score in the p-value calculation of the IPA assay (Table 4.2.4B). 
The input array data revealed a significant link to the p38 MAPkinase pathway by 
IPA. Two genes associated with this signalling cascade, il1rl1 and dusp1 (a member 
of the IL-1 receptor family and a key MAPK regulator respectively), are significantly 
downregulated in MODE-k cells upon exosome treatment (see Figure 4.2.4A for 
schematic), further confirmed by qRT-PCR (Figure 4.2.4B). Notably, exosome-
mediated suppression of IL-33R in MODE-k cells was also evident at the protein 
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4.2.5 Transfection of MODE-k epithelial cells  
There are a number of potential mechanisms that could mediate depression of 
DUSP1 and IL-33R, as shown in the microarray analysis of MODE-k cells [219]. 
The 3′ untranslated region (UTR) of both dusp1 and il1rl1 messenger RNAs 
(mRNAs) contain conserved 7-9 nucleotide ‘seed sequences’, which provide 
available binding sites for H. polygyrus miRNAs (Figure 4.2.5A). I also tested any 
non-specific or potential downstream effects of either parasite miRNA on both target 
genes.  Of these, transfection of individual parasitic miRNAs yielded no significant 
differences in the levels of the two target genes (Figure 4.2.5B and C), whereas a 
direct DUSP1 siRNA could suppress both genes. To control for any non-specific 
effects of miRNA/siRNA delivery via transfection, I used a non-gene targeting 
control siRNA, Select Negative Control No.1 (NT1). Additionally, as a positive 
control for transfection, I used a synthetic siRNA which specifically targets dusp1, 
helping to establish a baseline for transfection efficiency and allows for comparison 
to H. polygyrus miRNA mimics which target this particular gene.  It is currently 
unknown whether the target genes discussed above could be linked in a signaling 
cascade, and is an interesting avenue for future investigation. However, transfection 
of MODE-k epithelial cells with a cocktail of parasitic miRNAs suppressed dusp1 
gene expression, but not il1rl1, as shown using a luciferase reporter assay [219], 
suggesting that secreted parasite miRNAs could work in tandem to exert maximal 
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4.2.6 Exosome modulation of type-2 immune responses in small 
intestinal epithelial cells and RAW 264.7 cells 
During intestinal helminth infection, parasite egress into the intestinal lumen results 
in epithelial cell barrier damage [311]. In response to the resulting bacterial infiltrate, 
intestinal helminths have been shown to use their ES products to limit host pathology 
and danger responses, and induce tolerance pathways to facilitate barrier repair 
[312]. Initial investigations determined whether exosomes could modulate small 
intestinal epithelial cell line responses to a large range of toll-like receptor ligands 
and stress molecules, including LPS, PAM-CSK3, Poly I:C, CpG, IFNγ and, 
HMGB1. Unfortunately, this cell line showed very little response to most types of 
TLR stimuli (data not shown). However, exosomes, total HES or HES-depleted of 
exosomes were able to induce of suppression of both LPS or PAM-CSK3-mediated 
IL-6 production (Figure 4.2.6A and B). Next, it was investigated whether exosomes 
could modulate TLR-driven inflammation in more immune-responsive cells, as 
helminth ES has been shown to impair the ability of myeloid cells to respond to TLR 
stimulation [313, 314], and these cells are also shown to internalize H. polygyrus 
exosomes (Figure 4.2.1 and 4.2.2). Exosomes were shown to suppress both the 
transcriptional (Figure 4.2.6C) and cytokine (Figure 4.2.6D) hallmarks of LPS-
activated RAW 264.7 cells, a macrophage cell line [238], including IL-6, IL-12p40 
and TNF, and expression of inducible nitric oxide synthase (iNOS). Accordingly, 
exosome modulated expression of TLR4, the receptor for LPS, and MyD88, a 
downstream signalling molecule (Figure 4.2.6E). It should also be noted that 
exosomes fail to induce toxicity in these cells, as cell-death markers such as FAS and 
! ! Chapter!4!
! ! ! ! ! Chapte!
! 111!
Lymphotoxin-Beta receptor (LTBR), were also suppressed upon exosome treatment, 
even in the presence of LPS (Figure 4.2.6F). 
 
4.2.7 Exosomes modulate classical activation in primary 
macrophages 
Whilst the RAW 264.7 macrophage cell line provides a convenient alternative to 
primary cells, it must be recognized that both phenotype and function of any 
immortalized cells may change with continuous passage and culture. Mature 
BMDMs can also be polarized to the so-called ‘M1’ phenotype upon LPS 
stimulation. These cells are able to produce pro-inflammatory cytokines and effector 
molecules to mediate anti-bacterial immunity [315]. Although LPS pre-stimulation 
inhibited initial uptake of exosomes in BMDMs, we observe around ~50% of cells 
were exosome-positive after 24 h, which is 2-fold less than cells co-treated with LPS 
and exosomes (Figure 4.2.7A). Correspondingly, exosomes were still able to 
significantly suppress TNF and IL-6 release in BMDMs that had undergone LPS pre-
treatment (Figure 4.2.7B). Thus, exosomes retain their suppressive properties even in 
cells previously primed with activating TLR4 ligands. 
In a similar pattern to what was shown in RAW 264.7 macrophages (Figure 
4.2.6C and D), H. polygyrus exosomes suppress the same classical activation 
markers, IL-12p40, TNF and iNOS, induced by LPS stimulation. This was further 
shown to be both time (Figure 4.2.7C-E) and dose dependent (Figure 4.2.7F-G). 
Moreover, like MODE-k epithelial cells, exosomes could also modulate expression 
of dusp1 and il1rl1 in BMDMs (Figure 4.2.7H-I). 
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4.2.8 Exosomes modulate alternative activation in primary 
macrophages 
In order to prevent Th2-driven immune pathology and anti-parasitic responses, 
helminths can induce an immunosuppressive environment within their host. H. 
polygyrus ES products have been shown to activate FOX P3+ T regulatory cells 
[151], and can also suppress early ILC2 responses and downstream Th2-mediated 
inflammation in a model of airway allergy [141]. In addition to the studies on 
classical activation, a key component of this thesis was to examine the potential role 
of H. polygyrus exosomes in type-2 immune responses. As alternatively activated 
macrophages are shown to play a key role in mediating anti-helminth immunity 
[316], I therefore directly tested the suppressive effects of exosomes on the 
alternative activation of BMDMs following a 24 h co-culture with exosomes and IL-
4 and IL-13, and included for comparison both total HES or HES that had been 
depleted of exosomes by ultracentrifugation (“Sup”). There was a marked ablation in 
transcriptional hallmarks of alternative activation in BMDMs [317], namely, 
RELMα, Ym1 and Arginase 1 (Figure 4.2.8A). This suppression is also reflected in 
levels of RELMα, Ym1, and the M2-associated chemokine CCL17 [318] released 
into culture supernatant (Figure 4.2.8B). To ascertain whether exosomes can also 
suppress the function and signature of cells that are already alternatively activated, 
the exosomes were also added to BMDMs at 24 h following IL-4/-13 pre-treatment. 
Subsequent production of RELMα and Ym1 were markedly reduced, as were release 
of IL-10 (Figure 4.2.8C) and surface expression of CD206 (the mannose receptor) 
(Figure 4.2.8D), further corollaries of alternative activation. Blocking exosome 
uptake by cytochalasin D (Figure 4.2.8D), in alternatively activated BMDMs 
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demonstrates a similar pattern to observations recorded in naive macrophages 
(Figures 4.2.2). Although the addition of polyclonal sera enhances uptake in IL-4/IL-
13 treated macrophages after 1 h (Figure 4.2.3), similar levels of uptake were 
observed between polyclonal sera treatment and exosomes alone in IL-4/IL-13 
treated macrophages after 24 h (Figure 4.2.8E). Importantly, both of these treatments 
abrogate the functions of exosomes, as reflected by the ability of AAMs to produce 
RELMα, Ym1 and CCL17 following co-treatment either with cytochalasin D, 
whereby exosome entry is blocked, or with polyclonal anti-sera (Figure 4.2.8F). 
These data suggest that the release of H. polygyrus-derived exosomes during 
infection could be a factor in preventing anti-parasitic host responses by 
macrophages. 
 
4.2.9 Small intestinal organoids – interactions with exosomes 
In order to generate a better understanding of how exosomes may interact with a 
variety of host cells during natural infection, I employed the use of ex vivo small 
intestinal cultures. Small intestinal organoids were derived from crypt stem cell 
isolation (see materials and methods), and either parasitic or mammalian exosomes 
(derived from the enterocyte cell line, MCICL2, [319]) were given directly into the 
culture media (Figure 4.2.9A and B), whereby uptake was measured after 1 h. To 
control for dye carry-over, the PKH67 dye was prepared in the absence of exosomes 
(Figure 4.2.9C). However, during natural infection the adult worms are situated in 
the lumen of the small intestine, and I hypothesise that the release of HES (and 
exosomes) by adult worms would also occur here. Therefore, preliminary studies 
were carried out by microinjecting exosomes into the lumen of these organoids in an 
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attempt to resemble the conditions that occur during infection. Initial optimization of 
this technique was determined using an artificial dye, which is demonstrated in 
Figure 4.2.9D. Organoids were also treated with IL-4 and IL-13 to recapitulate the 
intestinal conditions observed during a type-2 response to helminth infection [36]. 
Consistent with the previous study, recombinant IL-4/IL-13 treatment resulted in 
goblet cell hyperplasia (Figure 4.2.9E). Following exosome microinjection 
(approximating to 3 ng/organoid), I observed clustering of H. polygyrus exosomes 
within large subcellular spaces of the organoids (Figure 4.2.9F). I also observed a 
similar pattern of dispersal following microinjection of MCICL2 mammalian 
exosomes (Figure 4.2.9G). Although I hypothesise these large spaces to be goblet 
cells, I am currently unable to confirm this by co-localisation staining. However, I 
did observe the occasional exosome cluster within Paneth cells (Figure 4.2.9H), 
although this was much rarer. The ability to use multicellular tissues will provide a 
clearer picture of the fundamental interactions between exosomes and host cells, and 
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Table 4.2.4B – Ingenuity pathway analysis of major networks 






















Dusp1 Dual specificity phosphatase 1 0.001 ! 1.4 
LOC666559 PREDICTED: farnesyl pyrophosphate synthase 0.03 " 1.4 
Prpf19 PRP19/PSO4 pre-mRNA processing factor 19 homolog 0.03 " 1.4 
Akr1c18 Aldo-keto reductase family 1, member C18 0.004 ! 1.4 
Nupr1 Nuclear protein 1 0.01 " 1.4 
Anln Anillin, actin binding protein 0.03 ! 1.4 
Dgcr6 DiGeorge syndrome critical region gene 6 0.03 " 1.3 
Il1rl1 Interleukin 1 receptor-like 1, transcript variant 2 0.04 ! 1.3 
Mrps21 Mitochondrial ribosomal protein S21 0.01 " 1.3 
LOC100048530 PREDICTED: Coiled-coil domain containing 72 0.03 ! 1.3 
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Various studies have identified functions of pathogen-secreted EVs [188], 
establishing them as important mediators in cell-cell communication, especially 
during the immune response. There is still definitive gaps in the literature regarding 
EV uptake mechanisms [179], and this is especially true for helminth-derived EVs, 
with only a handful of reports demonstrating uptake in host cells [219, 220, 227, 
294]. Here, H. polygyrus EVs were used to investigate their uptake capacity into host 
cells, and to determine functional effects that occur following uptake.  
 
It is clear from these observations that H. polygyrus exosome uptake occurs 
in a time and cell-dependent manner. This finding parallels previous literature, 
showing that mammalian EV uptake is mediated in a similar way [320, 321]. As 
there appears to be improved uptake of H. polygyrus exosomes in both primary and 
cell line macrophage/monocyte populations compared to the intestinal epithelial 
cells, it was hypothesised that uptake in these could be mediated in part by 
phagocytosis or endocytosis. This is supported by the use of Cytochalasin D, a potent 
inhibitor of actin polymerization known to block endocytosis and phagocytosis and 
shown prevent exosome uptake in other systems [289, 322]. Interestingly, the role of 
cellular filopodia, actin-rich membrane protrusions which facilitate endocytosis, in 
exosome entry has recently been demonstrated using the small molecule inhibitor 
SMIFH2. This blocks formin-dependent actin polymerization [177], which has been 
suggested to be involved in viral endocytosis [323]. After a 1 h incubation of 
BMDMs with H. polgyrus EVs, there appeared to be discrete localization of EVs 
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within these cells, whereas the EVs appear to be more dispersed after 8 h. It could 
therefore be hypothesized that, after 1 h, parasite-derived EVs are still within 
endosomes, similar to previous data described in other systems showing intracellular 
endosomal aggregates shortly after EV internalisation [324, 325]. This is also further 
supported by live-cell imaging data, showing that uptake of exosomes led to direct 
entry into the endosomal sorting compartments or vesicles, with shuttling towards 
the endoplasmic reticulum [177], or the perinuclear region [288]. However, several 
questions still remain unanswered with regards to how the exosome/exosome-
containing endosomal cargo is released into the cell cytosol. From a drug delivery 
standpoint, recent work has shown that combinatorial treatment of HeLa-derived 
exosomes with cationic lipids and a pH-sensitive synthetic peptide (normally used 
for endosomal escape in other studies) can promote cytosolic release of exosome 
contents [326]. Other studies have shown a similar responsiveness to low pH, which 
can enhance EV-membrane fusion in cancer cells [327]. This may also be relevant in 
terms of fusion with host endosomal membranes, given the data showing late-stage 
endosomal trafficking of exosomes to the acidic lysosomal compartment following 
internalization [177, 288, 289]. Interestingly, this is a common occurrence in viral 
infection, whereby low pH facilitates virus-host endosomal fusion and subsequent 
cytosolic release [328]. 
 
Primary investigations were carried out in intestinal epithelial cells. These 
cells often represent the first barrier of defence during H. polygyrus infection, 
whereby adults are in direct contact with villus protrusions in vivo [307]. Microarray 
analysis from epithelial cells treated with H. polygyrus exosomes demonstrated the 
subtle modulation of murine host genes, including dusp1, a murine phosphatase 
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which regulates components of the MAPK pathway [329], and notably, the 
interleukin 1 receptor like-1 (il1rl1) gene. This gene encodes the IL-33 receptor (also 
commonly referred to as T1/ST2), which is strongly associated with initiation of 
anti-parasite and alarmin responses [34] (Discussed further in Chapter 6). 
Interestingly, it has been reported that BMDMs isolated from DUSP1 knockout mice 
(DUSP1-/-) display sustained MAPK activation and over-production of inflammatory 
cytokines such as TNF and IL-6 [330], the latter of which has been shown to enhance 
susceptibility to H. polygyrus infection [81]. Furthermore, it has been shown that not 
only do DUSP1-/- mice have significantly higher systemic levels of the 
immunosuppressive cytokine IL-10 [330], but DUSP1-/- macrophages secrete 
increased IL-10 in response to parasitic cystatins isolated from Acanthocheilonema 
viteae [74]. Furthermore, DUSP1/MKP-1 signalling is shown to promote 
macrophage arginase expression over nitric oxide synthase in response to LPS [330]. 
Hence, parasite modulation of DUSP1 could block the induction of arginase, known 
to inhibit H. polygyrus larval motility [71]. It may also be a potential mechanism 
used by other parasites, as arginase is known to suppress N. brasiliensis-mediated 
lung pathology by promoting sequestration of larvae in the skin infection site [122].  
 
The presence of an Argonaute protein and small RNAs within H. polygyrus 
exosomes may also suggest the exosomes enable cross-species RNA interference 
[219], although the mechanism of this is not yet known.  It is becoming increasingly 
evident that many helminths secrete miRNAs, many of which are associated with 
parasite-derived EVs [287]. Although H. polygyrus exosomes can induce 
transcriptional suppression of both dusp1 and il1rl1, and contain parasitic miRNAs 
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with complementarity to the 3’untranslated regions of these murine genes, functional 
repression by these small RNAs was only shown for DUSP1 [219]. Whilst a number 
of secreted parasite miRNAs could work simultaneously to repress murine dusp1 
(whereby combinatorial targeting of a single gene is a common feature of miRNAs 
[331]), il1rl1 suppression may be mediated by other bioactive molecules within 
exosomes. 
 
During nematode infection, intestinal epithelial barrier integrity is influenced 
by migration of mature adults into the intestinal lumen from the submucosa,  feeding 
of adults, and anti-helminth immunity e.g. release of IL-4 [332, 333]. The subsequent 
infiltration of bacteria can generate type-1 inflammatory or danger responses, which 
can be initiated through recognition of bacterial or alarmin molecules by PRRs e.g. 
Toll-Like receptors [334]. In order to regulate this, parasites and their ES products 
have been shown to initiate wound-healing and regulate immunity during infection 
[151, 312]. Further investigations of intestinal epithelial cells showed that exosomes 
could modulate secretion of IL-6, in response to TLR2/4 stimulation. Other than IL-
6, neither the MODE-k cells or MCICL2 cells (which have a more crypt-like 
phenotype [319]) produced any detectable traces of inflammatory cytokines such as 
IL-12p70, nor alarmin cytokines e.g. IL-25, IL-33 or TSLP with any of the stimuli. 
However, this may be due to limitations in using immortalized cell lines instead of 
primary intestinal cells, which lack previous experience and immune priming by the 
microbiota, as well as being unable to fully recapitulate the physiology of the 
intestinal epithelial cells e.g. by having a soluble mucus layer, protruding villi and 
crypts.  
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In this regard, cells present in the intestinal environment, such as epithelial 
cells and immune cells like macrophages, may be modulated by environmental cues 
during infection that could affect potential interactions with parasite-derived 
exosomes. It was therefore important to establish whether H. polygyrus exosome 
uptake could be affected by stimulation. Macrophages activated by type 1 stimuli 
(such as bacteria) or type 2 stimuli (fungi or helminths), or through Th1/Th2 
cytokines, may differ with respect to phagocytosis or endocytosis [335, 336]. H. 
polygyrus exosome uptake was enhanced in pre-polarized M2 macrophages 
compared to M1 macrophages after 1 h. These data are consistent with previous 
reports showing that nanoparticle uptake is superior in M2-polarized macrophages 
[309, 337]. Whilst LPS pre-treatment inhibited initial exosome uptake in either 
BMDCs or BMDMs, there was marked improvement of uptake after 24 h incubation. 
As such, the manner of uptake is not entirely based on polarization and may be 
context dependent, as whilst IL-4 can limit phagocytosis of bacteria [338], human 
M2-polarized macrophages display enhanced phagocytosis of apoptotic cells [339]. 
Therefore, methods of uptake must be regarded on an individual basis. Additionally, 
it was found pre-treatment of BMDMs with exosome antisera increased the rate of 
uptake, regardless of the macrophage activation status, potentially through the 
process of opsonisation. This is supported by previous studies demonstrating that 
pathogen-immunized sera can actually enhance uptake of pathogen particles by 
complement-mediated pathways [340]. However, it should be noted that, although 
FcR-mediated uptake is quantitatively enhanced/accelerated, it may also direct 
exosomes into a degradative pathway thereby ablating their functional effect. 
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Macrophages are regarded as a key player in immunity to gastrointestinal 
helminths [316] and have been commonly associated with, and modulated by, 
exosomes during parasitic infections (see table 4.1). Since H. polygyrus exosomes 
are efficiently internalized by macrophages, the functional effects were further 
examined. H. polygyrus exosomes were able to suppress secretion and the 
transcriptional expression of hallmarks of LPS/TLR4 activation in RAW 264.7 
macrophages, including inflammatory cytokines, IL-6, IL-12p40 TNF and the 
enzyme iNOS. Additionally, RAW 264.7 cells and BMDMs were shown to have 
very similar response patterns to TLR stimulation. The finding that H. polygyrus 
exosomes mediate suppression of classical/type-1 inflammation is unsurprising, 
given previous data showing that HES can modulate dendritic cell maturation and 
responses to various TLR stimuli [341, 342]. Interestingly, H. polygyrus exosomes 
modulate expression of both tlr4 and it downstream adaptor, myd88, in response to 
LPS stimulation. Although MyD88-deficient mice have been shown to be more 
resistant H. polygyrus infection [343], this adaptor can be required for responses to 
fungal allergens [344], but not adjuvant-induced [242] type-2 airway inflammation. 
As HES can modulate immune responses in both settings [141, 242], it is possible 
that the suppressive properties of exosomes could also act in a TLR/MyD88-
dependent and independent manner. LTBR and Fas are markers associated with 
macrophage apoptosis [345, 346], and both are show to be downregulated by H. 
polygyrus exosomes, which may be a potential mechanism used to induce host 
tolerance. Since H. polygyrus exosomes also suppress il1rl1 expression in 
macrophages this suggests that they have multi-faceted functions to modulate 
bacterially-induced classical activation in these cells. 
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Although helminth ES can directly modulate bacteria/TLR-driven 
inflammation in immune cells, other data demonstrate the roles of helminth ES 
products in driving the propagation of FOXP3+ regulatory T cells [151], and in 
promoting induction of alternatively activated M2 macrophages during acute 
infection and in vitro [244]. AAMs are known to play a key role in driving and 
establishing immunity to helminth infection, secreting anti-inflammatory factors 
such as IL-10 and RELMα, well as facilitating wound-healing to parasite-mediated 
tissue damage [316]. Based on the strong associations between M2 macrophages and 
H. polygyrus infection [71, 115], these cells were studied in more detail in this 
chapter. Exosome treatment caused both mRNA and protein suppression of a number 
of M2 macrophage hallmarks, including the mannose receptor (CD206), IL-10, 
arginase, RELMα and Ym1. It is rather interesting that exosomes could suppress 
markers of M2 activation, given their role in tissue repair and mediation of anti-
inflammatory responses [347], which is normally adventitious to parasite survival. 
However, some of the molecules suppressed e.g. arginase-1 may normally facilitate 
an anti-helminth response. As discussed previously with regards to exosome-
mediated dusp1 suppression, parasite modulation of DUSP1 could block the 
induction of arginase, known to inhibit larval motility, limiting migration and 
infectivity of helminths [71, 122]. Similar to the effects of exosomes shown here in 
vitro, total HES was shown to modulate levels of both Ym1 and RELMα found in 
the bronchoalveolar lavage during a model of airway inflammation [242]. 
Importantly, Ym1-induced neutrophilia contributes to worm killing in N. brasiliensis 
[86], suggesting that H. polygyrus could use exosomes to suppress Ym1 in an 
attempt to limit parasite expulsion.  Furthermore, expression of CD206 is known to 
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correlate with nematode resistance, as S. mansoni ES products can be internalized 
following CD206 binding on macrophages [348]. This is a mechanism that may be 
used by H. polygyrus exosomes to suppress of Th2-mediated immunity during 
infection. It should be noted that exosome-mediated suppression could be generated 
when macrophages have been pre-primed for 24 h with IL-4/13 and have already 
begun polarizing to M2-like macrophages. Hence, exosomes do not only suppression 
the onset of alternative activation, but have the capacity to modulate cells during an 
on-going type-2 immune response. In addition, treatments that interfere with 
exosome uptake in alternatively activated macrophages, such as cytochalasin D or 
anti-exosome sera, prevent any exosome-suppressive effects in these cells, 
highlighting the potential importance of exosomes in macrophage 
immunomodulation. The comparative suppression by either total HES or HES 
depleted of exosomes in both the mRNA transcripts and protein production suggest 
that there are other factors in HES (out with the vesicle fraction) that can modulate 
alternative activation of macrophages. Thus, in this study, helminth-derived 
exosomes are shown to suppress a type-2 immune response in macrophages, and our 
data suggest that the release of H. polygyrus-derived exosomes during infection 
could be a factor in preventing anti-parasitic host responses by AAMs. 
 
Finally, the use of the ex vivo organoid culture system has provided 
preliminary evidence of potential exosome-host cell interactions within the intestinal 
environment [36, 349]. These multicellular structures phenotypically and functionally 
resemble the small intestinal niche that a number of parasitic helminths occupy, 
including H. polygyrus [307]. Both mammalian and H. polygyrus exosomes were 
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detectable in somewhat discrete cellular compartments after 24 h post microinjection 
into the lumen (although their identity has not been fully clarified). It has still to be 
determined whether this is by an active or passive process, but this could be clarified 
by microinjection of beads or artificial vesicles (used in [350]). If parasite-derived 
exosomes become internalised by specialised intestinal cells, such as paneth cells or 
goblet cells, this could indicate another target for cross-species regulation. Paneth 
cells and goblet cells are known to be associated with anti-helminth immunity [351] 
[307, 308], and also undergo hyperplasia during helminth infection or from the 
influence of type-2 cytokines [36]. It will be interesting to assess the effects of 
parasite-derived exosomes on the function of these cells, which could be determined 
by the presence of effector molecules in the supernatant of organoid culture, or the 
proportion of these cells within intestinal organoids. Furthermore, given the 
complexity of cellular responses within these organoids, future studies should aim to 
determine potential exosome association with other cells in these ultrastructures, such 
as tuft cells [36]. These cells are shown to be a potent source of IL-25 during both rest 
and infection, initiating a strong ILC2 response and the differentiation of epithelial 
cell progenitors which could support parasite expulsion [35, 36].  
 
Collectively these data suggest that exosomes function as modulators of host 
immunity. A majority of the in vitro studies described in this chapter are limited by 
having a single cell type. These often form monolayers in culture and do not 
represent the diversity of immune cells present in the intestine during helminth 
infection, nor recapitulate the environmental cues induced by the presence of a 
parasite. During helminth infection, a mixed type-1/type-2 response is established 
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due to both barrier damage and the presence of the parasite. In order to circumvent a 
strong host response, parasites release ES products to modulate or suppress active 
immunity, and parasite-derived EVs are fast becoming a key aspect of host 
regulation [188]. Whilst the organoid studies provide a framework for analysing 
more complex intestinal responses, the data is still preliminary. Therefore, the next 
step of this study was to analyse the effects of H. polygyrus exosomes in vivo, testing 






















Interactions and functions of H. polygyrus 




The data from chapter 4 demonstrated that H. polygyrus exosomes have the capacity 
to interact with, and suppress host immune cells in vitro.  I focused on cells that 
would be present in the intestinal environment during H. polygyrus infection, namely 
epithelial cells and macrophages, that have both previously associated with anti-
helminth immunity [307]. However, responses to helminth infection require a range 
of innate and adaptive effector mechanisms that collaborate to amplify immunity and 
induce parasite expulsion. The complex nature of these responses must be considered 
when investigating the immunoregulatory properties of H. polygyrus exosomes, and 
this chapter will focus on their potential functions in vivo.  
 
Studying the immunomodulatory properties of helminths during natural 
infection can be immensely challenging, owing to the complex mechanisms of 
immune evasion induced by the parasite. These methods include: anatomical 
sequestration to sites of immune privilege [146], shedding of antigenic surface 
proteins by cuticle turnover [145], and active suppression of the host immune 
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response to helminth antigens, producing a state of parasite-specific immune 
tolerance [281]. During chronic helminth infection, the host requires an additional 
network of cells to regulate active type-2 immunity and initiate tissue repair. The 
induction of an immunosuppressive state within the host, coordinated by both 
regulatory T and B cells [111, 352] as well as alternatively activated macrophages 
[58], limits immune pathology to the parasite, and can often result in bystander 
suppression of both autoimmune disease and allergy [353]. The potency of this 
modulation has been exploited by the helminth, as it creates a host environment 
permissive for survival.    
This effect is becoming of growing interest due to the increasing rates of 
autoimmune and allergic diseases, such as asthma, in western society [354], which 
gives basis to the hygiene hypothesis as discussed in Chapter 1 [134]. The potential 
benefits of parasite immunodulation have led to the use of helminths, their ova or 
excretory-secretory products (ES) in clinical trials for the treatment of atopy [138] 
and autoimmunity, such as inflammatory bowel disease (IBD) and multiple sclerosis 
(MS) [139, 355, 356]. The laboratory model, H. polygyrus, has previously been used 
to investigate the effects of gastrointestinal nematode infection on other co-
morbidities such as allergy and autoimmune disease. H. polygyrus infection is shown 
to have strong immunosuppressive effects on type-1 diabetes [357], a murine model 
of MS [358], experimental colitis [359] and asthma [360]. Although rodent model 
systems can recapitulate some aspects of human immune disease models, 
extrapolating these findings to human study has obvious limitations [361]. 
Experimental infection trials in humans have been carried out on several helminths, 
including Trichuris suis (the pig whipworm) and N. americanus (the human 
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hookworm), and a case report has been published of an individual self-infecting with 
the human whipworm T. trichiura [362]. These trials have given variable results 
demonstrating the potential of live helminth infection as a therapeutic in asthma, 
autoimmune disease and allergy (comprehensively reviewed in [363] and [364]).  
Although live-helminth based therapy has shown some promise, with limited 
side effects [365, 366], there are some clear disadvantages to using this as a long 
term treatment. Ethical considerations limit both the dose size and number of times 
that patients are given parasites for each respective trial, which may affect their 
potency as immunomodulators [143]. Furthermore, the potential development of co-
infection with other pathogens could be detrimental in immunocompromised 
individuals, as would the continual remodelling/fibrosis of tissues that would occur 
to circumvent host damage during chronic infection [361, 367].  
A less controversial/restrictive alternative to live-helminth therapy is to use 
helminth-derived immune-modulatory molecules. A number of in vitro studies have 
pointed to the modulatory capacity of helminth excretory-secretory products, on both 
human [368] and murine immune cells [155, 369], limiting inflammatory immune 
responses and cell activation. Furthermore, there are data demonstrating that H. 
polygyrus ES (HES) [242], or ES-62 (a single molecule isolated from 
Acanthocheilonema viteae ES) [370], can modulate airway inflammation in vivo. 
Indeed, the effects of whole HES, or isolated components have been characterized. 
These include; a TGF-β mimic which facilitates T regulatory responses [282], 
cystatins which suppress myeloid cell activation [155], and calreticulin, which was 
demonstrated to induce strong Th2 polarisation in vivo [94]. More recently, a study 
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from our lab showed that exosomes isolated from HES by ultracentrifugation were 
shown to modulate innate responses in a model of allergic asthma [219], and this will 
be discussed later in this chapter in more detail. 
Conversely, the suppressive nature of helminth ES, whilst prolonging parasite 
survival within the host, actually represents an attractive vaccine target for 
prevention of infection. This research has been pursued in the livestock parasite, 
Haemonchus contortus, whereby vaccination against isolated proteins from ES, 
included antigen H11 [274] and venom allergen-like proteins (VALs) [371], induced 
immunity in ruminants. Furthermore, combinatorial formulations of ES proteins 
from S. mansoni larvae are shown to drive antibody-induced host protection [372]. 
Additionally, previous studies have shown that vaccination against total H. polygyrus 
ES induces sterile immunity against a larval challenge [255], which is now 
appreciated to be directed via humoral IgG1 responses and innate IL-25/IL-4-driven 
immune cell types [108].  
The work in this chapter illustrates the immunomodulatory properties of H. 
polygyrus exosomes in models of airway allergy, examining their capacity to prevent 
or ameliorate responses to a fungal antigen. In addition, I investigated the role of H. 
polygyrus exosomes during infection, determining whether vaccination against H. 
polygyrus exosomes could induce the same host protection as shown with total HES 
[108]. Proteins enriched in exosomes from other parasites, such as testraspanins, are 
now considered in prospective vaccine studies [226, 227] thus highlighting the 
potential of exosomes as targets for treatment against helminth infection.  
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5.2.1 Alternaria-induced allergic inflammation to ovalbumin 
challenge is suppressed by H. polygyrus exosomes 
Both enteric H. polygyrus infection [353] and HES [373] have been previously 
demonstrated to modulate airway inflammation in sensitized mice challenged with 
allergens in the respiratory tract. To investigate whether H. polygyrus exosomes 
could recapitulate these protective responses, cellular immunity was assessed in a 
model of ovalbumin (OVA)-specific airway inflammation induced by co-
sensitization with the fungal allergen, Alternaria alternata (Figure 5.2.1A), in a 
similar manner as described in [141].  
In these experiments, exosomes, Sup (HES depleted of exosomes) or HES 
were co-administered at the time of sensitization, and mice were challenged with 
OVA alone 14-16 days later. Co-administration did not alter the marked increase in 
total numbers of both bronchoalveolar lavage and lung cells compared to OVA-
challenged mice (Figures 5.2.1B and D), but there was significant modulation of 
airway eosinophilia (shown by absolute counts in the BAL and lung) (Figures 5.2.1C 
and E), and a modest suppression of total lung neutrophils (Figure 5.2.1E) by each of 
the interventions. Neither alveolar macrophages, nor CD4+ T cells, were 
significantly modulated following co-treatment with any of the preparations. 
Additionally, the proportion of Foxp3+ regulatory T cells were also unaffected by 
co-treatment with either HES, Sup or exosomes (data not shown), suggesting that 
exosome modulation of allergic airway responses was potentially confined to the 
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innate compartments of the lung, and not mediated by OVA-specific T 
helper/regulatory cell responses.  
 
5.2.2 H. polygyrus exosomes suppress type 2 innate lymphoid cells, 
but not adaptive T helper cell responses to Alternaria 
During allergic asthma responses, airway eosinophilia is strongly correlated with the 
presence of type-2 cytokines, such as IL-5 and IL-13, which are known to promote 
eosinophil recruitment and induce lung pathology, such as fibrosis [374, 375]. Two 
major cellular sources of these cytokines during this response are type-2 innate 
lymphoid cells (ILC2s) and T helper cells (Figure 5.2.2A). These populations were 
isolated from the lung to investigate whether modulations in innate or adaptive 
sources of these cytokines by exosomes could be responsible for the suppression of 
airway eosinophilia in this model. Although it was found that the proportion of IL-5 
or IL-13-producing CD4+ T cells were unaffected by exosomes, Sup or HES (Figure 
5.2.2B), there was significant suppression of both IL-5 and IL-13-producing innate 
lymphoid cells in mice co-administered with any of the HES fractions compared to 
Alternaria-sensitised mice alone (Figure 5.2.2C). ILC2s are also known to express 
ST2, the subunit of IL-33R which works in conjunction with the IL-1R accessory 
protein (IL1RAP) to respond to IL-33 signalling [39]. This is shown in previous 
chapters to be modulated by exosomes in both MODE-k epithelial cells and primary 
macrophages in vitro. In the in vivo allergy model tested here, exosomes could also 
suppress both ST2 expression on ILC2s (Figure 5.2.2D), and total lung transcript 
levels of the gene for IL-33R (il1rl1) (Figure 5.2.2E). Additionally, exosomes could 
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also modulate total transcriptional levels of dusp1 in the lung, which again, had been 
shown in vitro to be suppressed by exosomes [219] (chapter 4). 
 
5.2.3 H. polygyrus exosomes suppress early type-2 responses to 
Alternaria-induced allergic lung inflammation 
As exosome modulation of allergic airway inflammation appears to target innate 
rather than adaptive responses, a short-term model of innate allergic responses to 
Alternaria exposure was tested (Figure 5.2.3A). In this protocol, mice were co-
treated intranasally with exosomes, Sup or HES plus Alternaria extract in the 
absence of ovalbumin antigen, and innate immune responses were characterised after 
48 h. At this time point, absolute numbers of bronchoalveolar lavage eosinophils, 
neutrophils and alveolar macrophages were suppressed in exosome/Alternaria co-
treated mice compared to Alternaria challenged mice (Figure 5.2.3B-D). 
Additionally, lung transcriptional levels of Retnla and Arg1, hallmarks of type-2 
myeloid cell activation present in Alternaria-driven inflammation [376], were 
suppressed in exosome co-treated mice (Figures 5.2.3E and F), although levels of 
Ym1 were unaffected (Figure 5.2.3G). Finally, co-treatment with either HES, Sup or 
exosomes suppressed both the absolute number of ILC2s (Figure 5.2.3H), as well as 
the expression of ST2 on these cells (Figure 5.2.3I). These data, although 
preliminary, highlight the modulatory capacity of exosomes (comparable to both Sup 
and HES), in early responses to allergic airway challenge.  
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5.2.4 Prophylactic exosome treatment suppresses early innate and 
type-2 responses to Alternaria  
In order to assess the prophylactic potential of exosomes compared to total HES or 
Sup, mice were administered intranasally with a dose of exosomes 24 h prior to 
Alternaria airway challenge (Figure 5.2.4A). In this protocol, innate reactions were 
assessed 24 h following allergen administration, a time point at which responses are 
broadly similar to those at 48 h ([141] and personal communication with H 
McSorley). 
In this prophylactic setting; exosomes, Sup and HES all exhibit strong 
modulation of airway eosinophilia (Figure 5.2.4B), reducing eosinophil numbers in 
the BAL by 72.3%, 71.9% and 70.2% respectively. Both exosomes and Sup fail to 
modulate levels of BAL neutrophils induced 24hr post-Alternaria challenge, with 
only a modest suppression induced by HES (Figure 5.2.4C). In addition, exosome 
co-treatment suppressed both the number of alveolar macrophages present in the 
BAL (Figure 5.2.4D), as well as the levels of myeloid-derived cytokines, RELMα 
and Ym1 (Figure 5.2.4E and F). Broad profiling of cytokines present from both the 
BAL and lung homogenate (data not shown) revealed no significant changes in 
alarmin/inflammatory cytokine responses (including IL-1α/β, IL-6 and IL-17A) nor 
modulatory cytokines (such as IL-10). However, levels of type-2 cytokines, IL-5 and 
IL-13, were significantly lower in mice co-treated with exosomes, Sup or HES 
(Figures 5.2.4G and H). These data suggest that exosomes can serve as preventative 
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treatment against airway inflammation, and have the same modulatory capacity as 
either total HES or HES depleted of exosomes. 
5.2.5 Prophylactic exosome treatment suppresses ILC2 responses to 
Alternaria-induced lung inflammation and modulates ST2 
expression in a cell-specific manner 
 
During innate responses to airway challenge, ILC2s are a major source of type-2 
cytokines, such as IL-5 and IL-13 [377], and were modulated by exosomes (Figures 
5.2.2 and 5.2.3) and HES [141] in both long and short-term models of Alternaria-
induced airway inflammation.  The activation and expression of the ILC2 population 
was therefore measured in the same experiment of prophylactic administration. It 
was found that 24 h following Alternaria administration, there was a profound 
suppression in the proportion of IL-5 and IL-13-producing ILC2s in recipients of 
exosome, Sup or HES treatment (Figure 5.2.5A and B). The modulation of ILC2 
cytokine expression may contribute to the reduction of IL-5 and IL-13 observed in 
the BAL following prophylactic exosome treatment (Figure 5.2.4G and H). 
Similar to the previous models in this chapter, exosomes can also suppress 
the expression of ST2 on ILC2s (Figure 5.2.5C), as well as demonstrating modest 
suppression of il1rl1 mRNA in total lung (Figure 5.2.5D). However, the suppression 
of ST2 does appear to be cell specific, as expression of this receptor is unchanged in 
lung epithelial cells (CD45.2-EpCAM+), regardless of treatment (Figure 5.2.5E). 
Previous work has shown that HES can modulate levels of the alarmin cytokine IL-
33 [141], which is also known to regulate expression of ST2 in ILC2s [378]. 
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Interestingly, although prophylactic treatment by either total HES and Sup can 
suppress lung homogenate levels of IL-33, exosomes alone failed to do so (Figure 
5.2.5F). Finally, consistent with previous data, exosomes can also modulate dusp1 
transcript in total lung, confirming the model-wide suppression of this target gene 
by exosomes. This data suggest that exosomes, like total HES, can modulate the 
early events that occur during an allergic airway response, with preferential 
suppression of the ILC2 compartment, as well as downregulating expression of the 
alarmin receptor subunit ST2. 
 
5.2.6 Exosomes provide sterile immunity against H. polygyrus larval 
challenge in C57BL/6 mice 
It was important to establish whether vaccination with exosomes could engender 
protective immunity in mice in vivo. This is based on previous data demonstrating 
that vaccination against total HES could induce sterile immunity against H. 
polygyrus infection [255]. Using an alum-adjuvant model, C57BL/6 mice were 
vaccinated against either exosomes, HES depleted of exosomes or total HES prior to 
subsequent larval challenge (Figure 5.2.6A). Any protective immunity induced in 
this model was assessed by parasitological outcomes.  
Faecal egg counts were suppressed by over 90% from days 14 to 28 post-infection in 
mice vaccinated with either exosomes, Sup or HES compared to PBS/alum 
vaccinated mice (Figures 5.2.6B-D).  Additionally, worm burden was reduced ~82% 
for exosomes, ~78% for Sup and ~98% for total HES (Figure 5.2.6E). A summary of 
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egg and worm burdens in vaccinated mice are shown Table 5.2.6. the protection 
induced showing that exosome vaccination can generate significant protection 
against parasitic infection, and is comparable to total HES despite only representing 
approximately 10% of the ES from H. polygyrus.  
 
5.2.7 H. polygyrus exosomes induce specific antibody responses in 
vivo 
Previous work has shown that antibodies play a key role in the secondary immune 
response to helminth infection [277, 379]. In addition, HES vaccination was shown 
to elicit a strong antibody response [255]. In chapter 4, I also demonstrated that anti-
exosome antibodies block the immunomodulatory effects of exosomes on 
macrophages in vitro (Figure 4.2.8F). Thus, I sought to define the humoral response 
generated against exosomes in vivo, as it may be a factor which contributes to host 
protection. I examined the repertoire of total serum antibodies elicited by exosome, 
Sup or HES vaccination alone, prior to challenge infection, in comparison to the 
PBS-alum mouse control. (Figures 5.2.7A and B). I also determine the serum titres 
of exosome-specific IgM, IgG1, IgA and IgE, as shown by ELISA (Figure 5.2.7C-F). 
I also assessed the serum titres of Sup- or HES-specific IgM or IgG1 by ELISA 
(Figure 5.2.7 G-H). Interestingly, I observed there were significant antibody titres 
induced between the groups, regardless of whether mice were immunized with 
exosomes, Sup or HES. This indicates a response to either shared molecular 
components or to cross-reactive epitopes. 
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Table 5.2.6 – Degree of protection elicited by exosomes, Sup 










Percentage reductions in egg/worm burden in exosome vaccinated mice. Each group is pooled from 3 








Percentage reductions in egg and worm burden 
 Exo/Alum Sup/Alum HES/Alum 
Day 14 Egg counts 72.61% 45.21% 90.90% 
Day 21 Egg counts 96.21% 88.80% 97.95% 
Day 28 Egg counts 97.99% 93.25% 99.44% 
 
Day 28 Worm burden 82.08% 77.68% 98.73% 
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5.4 Discussion 
The importance of parasite-derived extracellular vesicles during natural infection is 
becoming increasingly well-established [188]. As such, defining the immune-
modulatory mechanisms generated by exosomes, and their role as a helminth 
excretory-secretory product, could contribute to the generation of new therapeutics 
against inflammatory disease, replicating the suppressive effects shown during 
helminth infection [358, 380, 381]. Here H. polygyrus exosomes were examined for 
their potential contribution to the suppression of airway allergy, since this had 
previously been shown during either infection with H. polygyrus [360], or by 
treatment with total HES [141, 373].  
Exosomes, like HES, are able to modulate airway eosinophilia (present in 
both the bronchoalveolar lavage and lung tissue), induced by ovalbumin recall 
following allergic antigen sensitization. These effects are not targeted at adaptive 
immune responses, as the proportion of IL-5 and IL-13-producing Th2 cells were not 
suppressed by exosomes or total HES. Furthermore, despite previous data showing 
that helminth infection can promote Foxp3+ T regulatory cells to modulate airway 
inflammation [353, 360], the levels of these cells were unaffected by exosome co-
treatment. Although it has been shown previously that HES can modulate type-2 
cytokine producing T helper cells in this model [141], both the previous study and 
the current one record a more potent modulation of cytokine producing-ILC2s by 
either exosomes or total HES.  
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ILC2s are innate cells, which are known to initiate early type-2 immunity to 
airway allergen challenge following tissue damage/recognition of alarmin cytokines 
[377, 382-384], and as well as being a potential biomarker in human asthmatic 
patients, are suggested to sustain airway eosinophilia through the release of type-2 
cytokines [385]. The findings of this study suggest that exosomes modulate 
eosinophilic responses to Alternaria antigen by targeting ILC2 cell populations, 
supporting previous data in similar models with total HES [141], and that this 
response is independent of adaptive immunity. As such, exosome co-treatment can 
recapitulate these effects 24-48hr after intranasal allergen challenge and more 
promisingly, exosomes can also exert their modulatory properties in a prophylactic 
manner, representing a potential target for development of preventative agents 
against allergy or inflammation.  
Like previous in vitro studies [219], H. polygyrus exosomes were able to 
suppress mRNA levels of the MAP-kinase regulator, dusp1. Neither IL-6 nor IL-10 
levels were modulated significantly by exosome co-treatment, despite the prominent 
association of these cytokines with DUSP1 (as shown in studies with DUSP1-/- mice 
[330]). However, this could be due to other factors, including timing, the limited 
potency of suppression by exosomes in this model, and the nature of the antigen 
stimulation (given the cited paper refers to LPS-mediated responses in DUSP1-/- 
mice).  
 The exosome-mediated suppression of ST2 in vivo, either measured at the 
mRNA level in whole lung tissue, or at the protein level on ILC2s was evident in 
both long and short-term models of airway inflammation. This also compliments the 
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in vitro studies in macrophages and intestinal epithelial cells, which are shown in 
chapter 4. However, the expression of ST2 on EpCAM+ lung epithelial cells was not 
significantly altered following exosome treatment. As intranasal induction may not 
induce equal distribution of either the allergen or exosomes in the lung, modulations 
in epithelial ST2 expression may be lost in a population that account for such a large 
proportion of the lung microenvironment. Furthermore, the modulation of whole 
lung il1rl1 mRNA by exosomes is very subtle, and may not reflect changes at the 
protein level if only a subset of cells received treatment. It may also be, as shown in 
both cancer and viral studies [293, 386], that exosomes preferentially target/interact 
with other cells, such as ILC2s or macrophages, which were shown in the previous 
chapter to demonstrate superior uptake compared to intestinal epithelial cells in vitro. 
Interestingly, exosome treatment also suppressed the levels of alveolar macrophages 
in early responses to Alternaria, as well as modulating the levels of myeloid-derived 
cytokines, Ym1 and RELMα (replicating effects shown in alternatively activated 
macrophages in the previous chapter). The suppression of type-2 cytokine 
producing-ILC2s could directly affect macrophage polarisation in the lung, and/or be 
enhanced by a loss of eosinophils, whom are also shown to drive macrophage 
polarisation in airway responses to allergy [387].  
Overall, I hypothesise that exosome-mediated suppression of these responses 
in the lung could be attributed to a loss of ST2. Although exosomes, unlike total 
HES, fail to suppress IL-33, it may be reasonable to suggest that different 
components of HES differentially target aspects of the IL-33/ST2 signalling cascade, 
given that HES depleted of exosomes can modulate IL-33 levels in the lung. In an 
experimental model of lung inflammation in T1/ST2-/- mice, both ILC2s were 
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virtually absent from the lung, and macrophages were unable to polarise nor 
contribute to pulmonary fibrosis [388]. Additionally, innate IL-5 and IL-13 
responses, as well as airway eosinophilia, were drastically reduced in T1/ST2-/- mice 
in response to Alternaria challenge. Importantly, ST2 expression has been shown to 
correlate with protection against helminth infection [39, 389]. 
In combination with alum adjuvant, vaccination of mice with exosomes 
induce high titres of exosome-specific IgM, IgG1, IgA and IgE serum antibodies, 
compared to the PBS-alum control. The generation of strong exosome-specific IgG1 
antibody responses may be responsible for downstream resistance to H. polygyrus. 
Previous work has shown that passive immunization using antibodies raised against 
VAL proteins or glycans (originating from HES) failed to protect against H. 
polygyrus infection. However, these components are not highly enriched in 
exosomes compared to Sup [219], so antibody responses may still be key to the 
immune protection elicited by exosome vaccination. Despite this, recent data does 
illustrate the role of IgG1 antibody responses during H. polygyrus infection [108]. 
Generation of these antibodies against the total ES (HES), was essential for the 
generation of specific type-2 immune responses against a larval challenge and also 
helped to limit migration of the parasite from the sub-mucosa.  
 
C57BL/6 were vaccinated with exosomes, total HES, Sup or PBS following 
the same alum-vaccination protocol as stated previously. The resulting egg clearance 
and successful expulsion of the adult parasite in exosome or HES, and Sup-
vaccinated animals demonstrate the potential of H. polygyrus secreted products to be 
a key source of vaccine candidates, as well as playing an important role during 
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natural infection.  Promisingly, the exosome-vaccinated mice, in which the exosome 
fraction consists of a smaller repertoire of peptides/antigens, could generate similar 
protection to infection compared to mice vaccinated with total HES or Sup. It is 
interesting that exosomes and Sup can exert similar effects (in this study and others 
in this thesis), given that the antibody data suggests that they are distinct in their 
composition. It will of interest in future studies to ascertain the degree of immune 
modulation or protective capabilities of either component, and whether there are any 
responses specific to exosomes.  
Understanding the immune-modulatory properties of H. polygyrus exosomes 
serves two purposes. Firstly, they can be exploited for therapeutic treatments in 
inflammatory or allergic responses. Secondly, targeting exosomes by vaccination can 
circumvent the immunosuppression that H. polygyrus normally induces to prevent 
expulsion by the host. The data from chapter 4, and the results from the Alternaria 
experiments have illustrated the capacity of exosomes to suppress the ST2 subunit of 
IL-33 receptor, and the mRNA levels of il1rl1 both in vitro and in vivo. Therefore, 
the next chapter will discuss the relationship between exosomes and this receptor in 
more detail. 
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The role of the IL-33 receptor subunit,  ST2, 




There is increasing evidence for the role of innate or alarmin responses and their role 
in anti-helminth responses [390]. The initial interactions between a helminth and its 
host generally occur at barrier surfaces e.g. the intestinal epithelium, often resulting 
in host cell damage mediated by parasite migration through the tissue. One 
consequence of this damage is the concurrent inflammation that occurs at barrier 
sites where, for example, bacterial translocation could accompany helminth invasion. 
Host recognition of these invaders is mediated though pattern recognition receptors 
(PRRs) such as Toll-like receptors (TLRs), that drive inflammatory cytokine 
production. Although generally shown to detect microbial components, some data 
has described the detection of helminth products by PRRs (as discussed in chapter 1 
and [391]). Another major aspect of this response is mediated through the release of 
alarmins, which are secreted from host cells following a breach of the host 
epithelium.  The key alarmins associated with helminth-mediated barrier damage 
include; IL-25, IL-33 and TSLP [32, 33, 392], each of which are linked to the 
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induction of a Type 2 pro-allergic and anti-helminth mode of immune response. 
Helminths can also partially or entirely circumvent this threat; for example, the 
response of dendritic cells (DCs) to TLR ligation is effectively negated by products 
from Nippostrongylus brasiliensis and other helminths, with IL-12 production being 
especially inhibited [393-396], while epithelial cell release of IL-33 is directly 
blocked by products released by H. polygyrus [397].  
 
 In previous chapters, I have demonstrated the suppression of ST2, an IL-33R 
subunit, and the gene encoding ST2, il1rl1, in intestinal epithelial cells, macrophages 
and ILC2s during a model of airway allergy. ST2 is a subunit of the IL-33R, which 
forms a complex with IL1RAcP to respond to the IL-33 cytokine, both in vitro and in 
vivo [398]. IL-33/ST2 interactions are closely associated with the initiation of 
responses in allergy and infection [34, 399], with the receptor being expressed on a 
variety of cells, such as innate lymphoid cells, T helper 2 cells, macrophages and 
epithelial cells. Among these cell types,  it is widely accepted that macrophages play 
a key role in driving and establishing immunity to helminthic infection [57, 71], and 
are also known to promote type-2 immunity and strongly polarize to M2-like 
macrophages following activation of T1/ST2 [62]. In addition, the essential 
requirement for IL-33/ST2 signalling in macrophages is shown during responses to a 
chronic H. polygyrus infection, whereby previous work has demonstrated that the 
transfer of IL-33-stimulated macrophages into mice can mediate worm expulsion 
[400].  
More broadly, expression of ST2 is associated with host protection from 
other helminthic diseases, whereby T1/ST2-deficient mice have impaired immune 
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responses, shown initially during challenge with S. mansoni [278] or during infection 
with T. spiralis, T. muris or N. brasiliensis [39, 389, 401]. Later studies show that 
T1/ST2 deficiency leads to increased susceptibility to a wide range of infectious 
pathogens, including filarial infections [402] protozoan infections such as 
Toxoplasma gondii [403], fungal disease such as Cryptococcus neoformans [404], 
and more recently, during the development of cerebral malaria [405].  
Owing to their importance in both immunity and infection, both the 
regulation and induction of the IL-33/ST2 cascade has been investigated. As a 
member of the TLR/IL-1R (TIR) superfamily, ST2 forms a heterodimer with 
IL1RAcP following recognition of IL-33. This initiates signaling through 
components of the MyD88 complex, leading to activation of the MAPK pathway, 
and transcription factors such as NF#B (reviewed in [406]). Depending on the cell 
type, activation of this pathway can induce the release of pro-inflammatory 
cytokines, e.g. in mast cells and basophils, or type-2 cytokines in ILC2s or Th2 cells 
[407, 408]. The transcription factor, GATA-3, which is highly expressed in ILC2s 
and Th2 cells, is also associated with the induction and regulation of downstream IL-
33 signalling. This transcription factor binds to the promoter of type-2 cytokines, 
including IL-5 and IL-13, shown to enhance TH2/ILC2 responses to airway allergy 
[409, 410]. The expression of ST2 on Th2 cells was previously shown to be IL-
33/GATA3-dependent [411]. Other work has demonstrated that oxidation of the IL-
33 cytokine itself disrupts the ST2 binding site, and may be a form of self-regulation 
to limit excessive inflammation by limiting the activity of IL-33 in space and time to 
the site of invasion [412].  
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Other forms of regulation have also been investigated, such as microRNAs, 
which are gaining prominence for their involvement in a wide range of 
immunological processes [413]. For example, mir-155 is expressed in a number of 
lymphocytes, including T regulatory cells, B cells and myeloid cells, regulating a 
number of signaling cascades in adaptive immunity [414]. With regards to innate 
immunity, a recent study has also shown that IL-33-driven induction of miR-155 in 
ILC2s can regulate ST2 expression, whereby ILC2s isolated from miR155-/- mice had 
abrogated GATA-3 expression and type-2 immunity to allergen-mediated airway 
inflammation [415]. Although H. polygyrus exosomes contain miRNA with binding 
sites that recognize the il1rl1 transcript, these miRNAs alone were unable to 
modulate the expression of ST2 when transfected into epithelial cells [219]. It is 
possible that these miRNAs may induce subtle changes, and work in tandem with 
other bioactive molecules in exosomes to mediate ST2 suppression. 
Characterising the molecular mechanisms involved in ST2 suppression by 
exosomes would provide essential information on how H. polygyrus could target this 
pathway during infection. Using the T1/ST2 knockout mouse model [278], I 
investigated the potential effects of exosomes in this system during the alternative 
activation of macrophages. Later studies established the importance of ST2 during a 
primary H. polygyrus infection, before subsequently assessing the effects of exosome 
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6.2 Results 
6.2.1 Exosomes suppress ST2 in alternatively activated macrophages 
and in ex vivo cultured ILC2s 
It has been previously shown during a model of airway allergy that HES could 
suppress IL-33 release [141], mitigating the alarmin response resulting from 
epithelial damage caused by the fungus Alternaria alternata. Both exosomes [219], 
and HES could also suppress ST2 in this model (Chapter 5), but the role of this 
receptor subunit in alternatively activated macrophage-exosome interactions had yet 
to be investigated.  The effect of exosomes on in vitro generated bone marrow 
derived macrophages (BMDMs) was therefore tested. 
When BMDMs were co-cultured with IL-4/IL-13 and either exosomes, HES 
or HES depleted of exosomes, there was marked suppression of ST2 surface 
expression (6.2.1A), whereas mammalian exosomes induced no discernible effect. A 
similar pattern was observed in the transcriptional levels of il1rl1 in which the 60-
fold increase induced by IL-4/-13 was almost completely ablated by HES products 
(Figure 6.2.1B).  
The addition of polyclonal anti-exosome sera together with exosomes 
preserved ST2 expression in AAMφ (Figure 6.2.1C). This effect was lost when using 
rat IgG, which blocks the Fc Receptor (FcR) of cells, out-competeing the antibodies 
present in anti-exosome sera. Thus, the modulatory effects of exosomes were 
restored.  Interestingly, abrogation of exosome uptake using cytochalasin D 
demonstrated a potential correlation to ST2 expression, (Figure 6.2.1C-D). The 
response of macrophages lacking ST2 expression was then tested, and it was found 
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that exosome uptake was only modestly suppressed in T1/ST2-/- macrophages after a 
24 h incubation (Figure 6.2.1E), suggesting that uptake does not necessarily require 
this receptor.  
 
6.2.2 ST2 deficiency does not affect exosome modulation of IL-4/IL-
13-mediated immune responses by macrophages 
In order elucidate whether exosome blockade of alternative activation is a 
consequence of ST2 inhibition, primary macrophages were isolated from T1/ST2-/- 
mice. Exosomes significantly suppressed the expression of intracellular RELMα 
(Figure 6.2.2A) and surface CD206 (Figure 6.2.2B) in both ST2-deficient and wild-
type BALB/c macrophages following co-stimulation with IL-4/-13. Additionally, 
exosomes could still suppress these markers in wild-type macrophages when 
polarisation was enhanced by addition of IL-33. Finally, a similar pattern was 
observed in the release of Ym1, RELMα and CCL17, whereby exosome co-treatment 
suppressed the release of these proteins in IL-4/IL-13 activated wild-type and ST2-
deficient macrophages alike (Figure 6.2.2C). 
!
6.2.3 T1/ST2 -/-  mice are highly susceptible to primary H. polygyrus 
infection 
It is well established that ST2-deficient mice have compromised resistance to 
helminth infection [278]. However, surprisingly little data have been published on 
the course of H. polygyrus infection in this knock out strain, with only one report 
describing adult worm burden in these mice at day 45 post-infection [37]. The 
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susceptibility of this genotype in the earlier stages of infection were confirmed 
following H. polygyrus larval challenge, with higher egg counts observed throughout 
28 days of infection (Figure 6.2.3A) and higher worm burdens at the final time point 
(Figure 6.2.3B) than the partially-resistant wild-type BALB/c genotype. Consistent 
with previous data from T1/ST2-/- mice during S. mansoni infection [278], there was 
a significant difference in the number of granulomas found in the small intestine, 
with lower abundance in T1/ST2-/- mice (Figure 6.2.3C). 
 
 
6.2.4 T1/ST2 -/-  mice exhibit reduced innate and adaptive cell 
responses during primary H. polygyrus infection 
In order to identify factors correlating with susceptibility of T1/ST2-/- mice, both 
mesenteric lymph nodes and peritoneal cell populations were isolated 28 days post H 
.polygyrus infection. Significantly fewer numbers of key cell populations were 
recovered from the mesenteric lymph nodes (MLN) isolated from ST2-deficient 
mice, including macrophages, ILC2s and CD4+ T cells (Figure 6.2.4A-C), whereas 
the T regulatory cell population were unaffected (Figure 6.2.4D). The paucity of 
ILC2s from T1/ST2-/- mice is not unexpected, as lower levels of ILC2s were reported 
in these mice in the lung during both allergic airway inflammation [404] and N. 
brasiliensis infection [416].  
As we encountered a marked reduction in T cell MLN numbers, these cells 
were harvested 28 d post infection and re-stimulated ex vivo with either media, 
1µg/ml anti-CD3/CD28 or 1µg/ml exosomes. There was a significant increase in the 
release of IL-13 (Figure 6.2.4E) or IFNγ (Figure 6.2.4F) following exosome 
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stimulation, and this response was significantly higher overall in wild type cells 
compared to T1/ST2-/- cells, but no other T cell cytokines; e.g. IL-4 or IL-17 could 
be detected (data not shown).  Thus, not only are there fewer CD4+ Th cells in the 
draining lymph nodes of ST2-deficient mice, but those cells display weaker 
responses to H. polygyrus exosome antigens. In the peritoneum, as in the MLN, there 
were significantly lower numbers of macrophages isolated by lavage in T1/ST2-/- 
mice (Figure 6.2.4G), and correspondingly, lower levels of proteins normally 
secreted by alternatively activated macrophages (AAMΦ), Ym1, RELMα and 
CCL17 (Figure 6.2.4H). 
 
 
6.2.5 Vaccination against exosomes in T1/ST2-/- mice does not 
protect against a subsequent H. polygyrus larval challenge 
As it was previously shown that immunisation of wildtype mice with exosomes was 
sufficient to generate a high degree of immunity to H. polygyrus infection (Chapter 
5), the ability of T1/ST2-/- mice to mount an anti-exosome response was 
investigated.  Using the same alum-adjuvant model of vaccination as previously, 
either wild type BALB/c mice or T1/ST2-/- mice were vaccinated against H. 
polygyrus exosomes, or PBS as a control, before subsequent challenge with infective 
third-stage larvae and monitoring the course of infection for 28 d. Wild-type mice 
vaccinated with alum-exosomes had potent immunity to helminth infection, as 
shown by faecal egg counts (Figure 6.2.5A) and intestinal worm burden (Figure 
6.2.5B), summarized in Table 6.2.5. In contrast, T1/ST2-/- mice harbored higher 
worm numbers with no significant effects induced by exosome vaccination, with 
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only gradual loss of parasites over time. However, there is a discernable trend, as 
adult worm burden is reduced by 52% in T1/ST2-/- mice on day 28 (compared to 
79% reduction in wild-type mice). Additionally, given the variance, and low animal 
numbers in this study, these analyses require a larger cohort of mice to confidently 
assess the data. ). Consistent with previous data from T1/ST2-/- mice during S. 
mansoni infection [278], there was a significant difference in the number of 
granulomas found in the small intestine, with lower abundance in T1/ST2-/- mice 
(Figure 6.2.5C).  
 
 
6.2.6 Exosome vaccination induces antibody specific responses in H 
.polygyrus infected T1/ST2 -/- mice 
Finally, the profile of total (Figure 6.2.6A), and exosome-specific serum antibodies 
(Figure 6.2.6B-E), generated in mice during the vaccination/challenge model were 
determined by ELISA. As antibody responses were shown to facilitate host 
protection to H. polygyrus [108, 255], and other helminths [372], it was important to 
assess their induction in parasite-susceptible T1/ST2-/- mice following exosome 
vaccination. Notably, both ST2-/- and wild-type mice generated comparable titres of 
IgM, IgG1, IgG2a and IgA specific to exosomes, arguing that susceptibility in the 
absence of IL-33 signalling is due to a deficiency in a cellular, rather than a humoral 
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Table 6.2.5 Parasitology of T1/ST2-/- mice following exosome or HES 
vaccination and subsequent H. polygyrus larval challenge 
 
Exo/Alum)vs)PBS/Alum) !! HES/Alum)vs)PBS/Alum)
! BALB/c ST2 KO   BALB/c ST2 KO 
Day 14 Egg counts 72.61% 45.21%   72.61% 45.21% 
Day 21 Egg counts 96.21% 88.80%   96.21% 88.80% 
Day 28 Egg counts 97.99% 93.25%   97.99% 93.25% 
!! !! !! !! !! !!
Day 28 Worm burden 82.08% 77.68%   82.08% 77.68% 
 
*Percentage reductions in egg/worm burden in exosome vaccinated mice. Each group is pooled from 
2 independent experiments (n= 6-7 mice per group). Total HES group data represent one experiment 















As detailed previously, exosomes can suppress transcript levels of il1rl1 (the gene 
for ST2) in intestinal epithelial cells in vitro, and the intensity of its surface 
expression in ILC2s during an allergic airway response (chapter 5). Data in this 
chapter illustrate the ability of exosomes, Sup or HES to suppress ST2 expression in 
alternatively activated macrophages, suggesting an intrinsic mechanism shared 
amongst the different preparations. 
 
It has been previously shown that signalling through the IL-33 receptor 
enhances AAMΦ polarization, whereby ST2 is induced in macrophages during type-
2 allergic airway responses [62, 417]. However, data in this chapter demonstrate that 
alternative activation is maintained in wild-type and T1/ST2-/- BMDMs stimulated 
via the IL-4 receptor-α pathway.  In support of this, a recent study has demonstrated 
that disruption of T1/ST2 signalling had no effect on type-2 mediated responses, 
including IL-4 release, following challenge by S. mansoni [38]. As such, exosomes 
may modulate ST2 expression to dampen any alarmin responses induced by the 
parasites during infection. This could be a mechanism used to prevent the activation 
of ILC2s and/or recruitment of other innate cells during early type-2 immunity (as 
shown in airway allergy in Chapter 5 and [141]), rather than responses associated 
with adaptive immunity and wound repair. 
 
Given the correlations between exosome uptake and ST2 expression, it could  
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be hypothesized that exosomes form a complex with this receptor and be co-
internalised. Receptor-mediated endocytosis is a common method of exosome 
uptake, which is shown across a number of mammalian systems [179], and may be 
utilized in a similar manner with parasite-derived exosomes. This could also parallel 
previous data showing the internalization of the mannose receptor (CD206) with S. 
mansoni ES products in macrophages [348]. Despite this, exosome uptake is only 
modestly reduced in naïve T1/ST2-/- BMDMs, suggesting that, whilst this receptor is 
not the direct mediator of exosome uptake, deficiency may modulate the total 
phagocytic capacity of these cells. To support this, there are data demonstrating that 
IL-33 is shown to enhance the phagocytic activity of macrophages responding to the 
fungal pathogen Candida albicans [418], or during cerebral malaria [419]. However, 
it was not determined whether uptake of mammalian exosomes was affected in 
T1/ST2-/- BMDMs, and represents an area that will need to be addressed in future 
studies, as this could establish whether the IL-33R facilitates uptake of a broader 
range of vesicles. 
 
Through characterizing the susceptibility of T1/ST2-/- mice to H. polygyrus 
infection, it was also observed that the immune cell repertoires were broadly 
compromised compared to those isolated from wild-type mice, with MLN cells 
unable to respond significantly to re-stimulation by exosomes, or through activation 
by CD3/CD28.  The decrease in ILC2s may be a contributing factor in the 
susceptibility to infection, as previous data has shown that IL-33 supports the 
expansion of ILC2s and activation of macrophages (dependent on the STAT6/IL-
4R$) during N. brasiliensis infection [416]. As ILC2s are a potent source of type-2 
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cytokines, the low numbers present in T1/ST2-/- mice may correlate to the reduced 
alternative activation and numbers of macrophages during H. polygyrus infection. 
Although, given recent data demonstrating that IL-33R-driven local proliferation of 
macrophages can occur independently of IL-4R$ during both filarial nematode 
infection and airway allergy [435], it may be the combinatorial effect of losing both a 
prominent source of IL-4, as well as the complete absence of the IL-33R, which 
contributes to the low numbers of macrophages observed during H. polygyrus 
infection in T1/ST2-/- mice. Furthermore, as macrophages are known play a key role 
in mediating immunity to H. polygyrus [307], this may explain the susceptibility 
observed in these mice during infection. The overall lower number of granulomas 
detected in the small intestine of H. polygyrus infected T1/ST2-/- mice are consistent 
with reports showing a reduction of granulomas during S. mansoni infection in 
T1/ST2-/- mice [278]. Both this, and the reduced numbers of both peritoneal and 
MLN-derived macrophages observed in these mice, may also correlate with data 
showing that liver granulomas in L. donovani-infected mice contained many ST2+ 
infiltrating macrophages and B cells, whereas T1/ST2-/- mice had a decreased influx 
of monocytes and polymorpho-nuclear cells to the liver [420].  
 
Unlike the almost sterile immunity induced either in vaccinated wild-type 
C57BL/6 mice or BALB/c mice, there was no significant protection induced in the 
same experiment using parasite-susceptible T1/ST2-/- mice. These mice could not 
control infection following vaccination with exosomes-alum, responding similarly to 
the control PBS-alum group. These data demonstrate both the essential requirement 
for IL-33 signalling during resistance to this parasite and the potential role of 
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exosomes in ST2-mediated anti-parasite responses. This is also relevant given 
previous work showing that the transfer of IL-33-stimulated macrophages can 
mediate worm expulsion [400]. Notably, ST2-deficient mice mount antibody 
responses as powerful as wild-type mice, yet are unable to clear the parasite; hence 
even in the presence of specific antibody, an IL-33-dependent cell population is 
necessary for effective immunity.  
 
In conclusion, this chapter reveals that ST2 expression is not required for the 
development of alternatively activated macrophages, nor the suppressive function of 
exosomes in this model. However, given the importance of IL-33/ST2 axis during 
infection [39, 278, 389], it may explain why the parasite targets this pathway with 
blockade of both the ligand [141] and as I show here, the receptor, to neutralise the 
host’s ability to expel the parasite. Defining the molecular mechanisms that occur 
during ST2-exosome interactions may be a future objective for therapies that intend 
to drive innate immunity and expel parasitic infection. It will be particularly 
interesting to determine whether extracellular-like vesicles secreted by other 
parasites modulate the IL-33/ST2 axis (owing to their role in susceptibility [34]) or 
are a specific feature of H. polygyrus EVs, especially given recent data showing that 
total ES from the liver fluke, Fasciola hepatica, actually enhanced ST2 expression 











The correlative relationship between helminthic burden and autoimmune or 
inflammatory disease is one that has generated increasing interest in the last ~20 
years. The ‘hygiene hypothesis’ [132] has illustrated the ability of helminths to 
modulate the host immune system during infection, preventing their clearance, 
promoting wound repair and, consequently, inducing bystander suppression of 
autoimmune disease or atopy [380, 422]. The complex mechanisms by which 
helminths evade host immunity range from shedding of surface antigens [145], to the 
secretion of a large range of excretory-secretory molecules, which often have potent 
immunomodulatory properties [391]. Thus far, the literature would suggest that EVs 
produced from protozoan parasites enhance pathogenesis and suppress host 
immunity to support parasite survival [188]. It is therefore interesting to note the 
growing number of publications demonstrating that EVs are also a ubiquitous 
component of the secretion products of metazoan helminth parasites, including 
trematode flatworms [220], as well as both human and veterinary nematodes [247, 
249, 262, 423, 424]. EVs represent a new type of complex encompassing a set of 
packaged cargo that has the potential to interfere with host immunity, and represents 
novel targets for future investigation.  
This body of work had two major arcs; the first being to characterize 
exosomes isolated from H. polygyrus excretory-secretory products, investigating 
their potential origin from the parasite, their antigenic surface markers and 
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optimizing tools for their detection. The second was to elucidate their role in host-
parasite communication: how they interact with host cells, their function during the 
natural infection, and the effect of parasite-derived exosomes on host immunity.  
 
 
7.1 Exosomes exhibit broad immunomodulatory functions on host cells 
correlating to uptake in a dose and time-dependent manner 
 
There is limited literature describing the internalisation and intracellular trafficking 
of parasite-derived EVs, and the impact this may have on their function within host 
cells. The uptake studies in Chapter 4 demonstrate that H. polygyrus exosomes are 
internalized by host cells at a similar rate to mammalian exosomes (derived from 
macrophages or small intestinal epithelial cells). This correlates with other data 
published by our group, showing that nematode exosomes demonstrate similar 
fusogenic properties to mammalian exosomes, despite having different biophysical 
characteristics [350]. However, in order to clarify this further, an assay determining 
the proportion of vesicles which may be taken up by direct fusion, such as shown in 
[178], is required in future analyses. I have demonstrated that macrophages 
preferentially internalize H. polygyrus-derived exosomes, most likely through a 
phagocytic or endocytic pathway that can be blocked by cytochalasin D and 
enhanced by specific antibodies (presumably through opsonisation). This was 
validated by confocal microscopy, which revealed the presence of potential 
endosomal aggregates of H. polygyrus EVs within BMDMs after 1 h. Thus, in the 
early events of uptake parasite-derived EVs are likely still within the endosomal 
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compartment, which accords with previous observations demonstrating intracellular 
endosomal aggregates following EV uptake [288, 325].  Whilst uptake might initially 
be interpreted as a host mechanism for removal of parasite exosomes, I have shown 
that the nematode-derived exosomes exert functional properties on the recipient 
macrophages, dependent on the mode of uptake. 
 
7.1.1 Suppression of inflammatory responses to TLR stimulation as a 
mechanism of host immune evasion 
During nematode infection, the breakdown of intestinal integrity can lead to systemic 
inflammatory or alarmin response through the presence of infiltrating bacteria [307, 
308]. In order to regulate this, H. polygyrus ES products is shown to modulate 
immune reactivity during infection [151], for example, preventing responses to TLR 
stimuli [341, 342]. H. polygyrus exosomes can induce similar effects on LPS-
mediated macrophage activation, suppressing effector molecules such as iNOS, pro-
inflammatory cytokines and downstream signaling molecules such as MyD88. 
Interestingly, MyD88 is also known mediate innate IL-33-driven responses to 
helminth infection [389], as it can bind the intracellular Toll/IL-1 receptor (TIR) 
domain of the IL-33 receptor (ST2). The association of ST2 with this adaptor is 
consistent with the exosome-mediated suppression of il1rl1 in both epithelial cells 
and macrophages. Finally, H. polygyrus exosomes also suppress markers of cell 
death, such as FAS. Interestingly, FAS activation has been shown to enhance LPS-
mediated IL-1R1-signalling to promote chronic inflammation [425]. Thus, exosomes 
can modulate a number of components associated with type-1 immunity to limit 
inflammation and prevent alarmin responses.  
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7.1.2 Modulation of type-2 immunity to inhibit host clearance 
H. polygyrus EVs generate potent suppression of AAMΦs, modulating type-2 
effector molecules, such as RELM-α and Ym1 when administered during or after the 
onset of alternative activation by IL-4/13. It was rather surprising that exosomes 
could suppress markers of M2 activation, given their role in tissue repair and 
mediation of anti-inflammatory responses [58, 347]. However, one of the molecules 
suppressed, arginase-1, is known to be an essential component of protective 
immunity to intestinal helminths [115, 122]. The complexity of type-2 immune 
responses, and the variable roles of type-2 effector molecules [58] may explain why 
parasites can suppress aspects of this response depending on context or stage of 
infection. Importantly, treatments that alter the manner of exosome uptake in 
alternatively activated macrophages, such as cytochalasin D or anti-exosome 
antibodies, abrogated exosome-suppressive effects in these cells, highlighting the 
requirement for specific exosome-macrophage interactions during infection. 
Interestingly, previous data demonstrate that S. mansoni ES products can be 
internalized following CD206 binding on macrophages. This leads to diminished 
Th2 cell responses and the establishment of a chronic infection [348], and may be a 
receptor pathway exploited by H. polygyrus exosomes. 
 
7.1.3 Small intestinal organoids – bridging the gap between in vitro and in vivo 
studies using H. polygyrus exosomes  
The small intestinal organoid system provides a new and exciting link between in 
vitro and in vivo studies using H. polygyrus exosomes. During natural infection, it is 
hypothesized that adult worms release ES (and potentially, exosomes) into the 
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intestinal environment to induce systemic immune suppression of the host [307]. 
Exosomes were microinjected into the luminal centre of the organoids in an attempt 
to replicate these conditions in vitro. Each organoid was injected with ~3 ng 
exosomes (equating to roughly 1 x 106 vesicles) and left for a 24 h period. In chapter 
3, I show a working model to calculate the number of vesicles potentially secreted by 
an adult worm over a two-week period (equating to over 7 x 105 vesicles per day, per 
worm). It also important to note that these are just approximations, and are also 
based on the number of vesicles released during culture, and not what may be 
released in the intestinal environment. This reflects the difficulties in calculating a 
physiological dose of exosomes, an issue that is faced by the EV community at large 
[264]. A further unanswered question remains the potential heterogeneity of parasite 
exosomes on a per vesicle basis, and whether this is affected by environmental cues 
or the status of the worms themselves (see future work).  
 
Although the organoid data is preliminary, it suggests potential localization 
of H. polygyrus exosomes to specialized intestinal compartments, such as goblet 
cells or Paneth cells. Both cell types release anti-microbial effector molecules, such 
as defensins, mucins and resistin-like molecules, which are shown to which influence 
parasite viability and expulsion [52, 54, 351]. If exosomes are internalized by these 
innate effector cells, they could potentially induce suppression of their responses, in 
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7.2 The immunosuppressive properties of exosomes can be exploited as 
a therapeutic treatment in airway inflammation 
 
The interactions between host cells and parasite ES offer a potential target for future 
interventions, aiming to prevent uptake of parasite products or inhibit 
skewing/modulation of host immunity [391]. As a newly discovered component of 
H. polygyrus ES [243], exosomes were the focus of several studies to determine their 
contribution to the modulation of airway allergy that has been demonstrated 
previously by total HES [141, 373]. Exosomes were able to suppress the early 
cellular responses induced by the airway allergen Alternaria alternata, but they did 
not influence adaptive recall responses to this antigen. Parasite-derived exosomes, 
used prophylactically or by co-administration, modulated airway eosinophilia and the 
secretion of type-2 effector molecules, such as Ym1 and RELM-$. Interestingly, this 
appears to be mediated through ILC2s, given their function as an immediate source 
of type-2 cytokines, such as IL-5 and IL-13 [40], which promote both innate 
eosinophil responses [41] and adaptive Th2 responses to H. polygyrus [43]. 
Furthermore, exosomes can also suppress the expression of the IL-33 receptor (IL-
33R) on ILC2s. Prospective studies should aim to determine how exosomes induce 
suppression of ILC2 function, and whether this is linked to modulation of the IL-33R 
response.  This receptor has been shown throughout the thesis to be modulated by 
exosomes, in intestinal epithelial cells and in activated macrophages. Thus, 
exosomes, like HES, possess immunomodulatory properties which can be used to 
suppress host immunity and alarmin responses to fungal allergens. Whether 
exosomes can replicate the immunosuppressive functions of adult H. polygyrus 
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shown in other models of inflammation, such as type-1 diabetes and colitis [357, 
426], remains to be seen.  
 
 
7.3 H. polygyrus exosomes modulate the IL-33R-driven alarmin 
response to circumvent host immunity 
 
A recurring observation during this study was the modulation of the IL-33R by H. 
polygyrus exosomes both in vitro and in vivo. As seen in Chapters 4, 5 and 6, 
parasite-derived exosomes were able to mediate the suppression of il1rl1, the gene 
for IL-33R, in MODE-k cells and primary macrophages, as well as modulating 
surface expression of T1/ST2 on type-2 innate lymphoid cells in vivo. Although this 
modulation is also induced by HES depleted of exosomes, data in Chapter 6 
demonstrated a correlation between ST2 expression and exosome uptake. Thus, 
suppression of this receptor may be mediated by several different mechanisms in 
HES. Although exosome modulation of type-2 immunity can occur independently of 
ST2, this receptor is important for resistance to parasite infection, as demonstrated 
previously in other helminths [34]. Interestingly, sterile immunity to infection can be 
induced in wild-type mice by immunisation with an exosome-containing vaccine 
(Chapter 5). However, the same exosome vaccination in T1/ST2 deficient mice 
failed to clear the infection. Hence, the activation of IL-33 signalling is essential for 
immunity to infection, and requires neutralisation of exosomes to take place in wild-
type mice for parasite expulsion. In summary, H. polygyrus secreted exosomes could 
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be used by the parasite to circumvent host ‘danger’ immune responses initiated upon 
IL-33 receptor signalling that would normally lead to their expulsion. 
 
 
7.4 Exosomes and exosomal components represent a new target for 
vaccination against parasitic infection 
 
The ability of parasite-derived exosomes to modulate host immunity [188], they offer 
an attractive target for vaccination [226]. Exosome-alum adjuvant vaccination 
induces potent IgG1 antibody responses in mice, which was shown previously to 
promote resistance during H. polygyrus infection [108, 255]. Given the comparable 
levels of protection elicited by vaccination with either HES, exosomes, or HES-
depleted of exosomes, it seems reasonable to suggest that the immunogenic epitopes 
could be shared amongst all preparations. Using cross-linked immunoprecipitation, I 
isolated the exosome antigens bound to sera from exosome-immunized mice, and 
determined their identity via mass spectrometry.!This analysis found an!enrichment 
of proteins observed in total exosomes, and it has been interesting to identify 
exosome antigens that raise antibody responses (shown in Chapter 3). Tetraspanins 
are transmembrane proteins which are suggested to have important roles in EV 
biogenesis via cargo selection, targeting and cellular uptake [173]. Notably, a large 
number of studies have attempted to vaccinate against tetraspanins, or highlighted 
them as important candidates, in a number of pathogenic diseases, including filariasis 
[427], schistosomiasis [428], and echinococcosis [429]. Tetraspanin-11, highly 
enriched on H. polygyrus exosomes [219], could potentially be facilitating a number 
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of the processes that are mentioned above, and deserves further investigation to 
demonstrate its viability as a target for vaccination.  
 
 
7.5 Future Directions 
 
Given the youth of the EV field and the starting point of this project, there are a 
number of areas still to be investigated. Although we have followed a standard 
regimen for isolating vesicles by ultracentrifugation [251], we may be collecting a 
heterogeneous population of EVs, potentially consisting of both exosomes and larger 
microvesicles. Recent work has described the heterogeneity of EVs secreted by F. 
hepatica, isolated by differential ultracentrifugation (with larger vesicles collected 
from a 15,000 g spin, and smaller vesicles with a subsequent 120,000 g spin), which 
are shown to differ both in size and molecular cargo [250]. It is therefore prudent for 
future studies to attempt either differential centrifugation or sucrose gradient 
centrifugation with HES, in order to determine whether EVs of different sizes can be 
isolated. It will be interesting to see whether H. polygyrus EVs are similarly diverse 
to [250], and how this may relate to their function during infection. Another key area 
of research will concern mechanisms of parasite-derived EV uptake and release, in 
which data are still limited for both pathogens and mammalian EVs [177, 188, 288]. 
Tetraspanins offer an attractive target for therapeutic intervention, given their 
important roles in EV cargo selection, target cell fusion and uptake [173]. This is 
supported by a recent study which demonstrated that antibodies generated against O. 
viverrini EV tetraspanins blocked subsequent EV uptake into host cells [227]. In 
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addition to tetraspanins, H. polygyrus exosomes also contain a suite of immunogenic 
molecules that induce host antibody responses, providing a number of vaccine 
candidates that should be investigated in the future.  
Moreover, the intestinal organoid system provides an excellent physiological 
model for studying localized H. polygyrus exosome-host cell interactions, and is 
likely to provide important information about the intracellular fate of helminth-
secreted exosomes. Based on current literature, host immune manipulation appears to 
be a prevalent function of parasite-derived exosomes [188]. However, it is expected 
that EVs could also play a prominent role in parasite-to-parasite communication, 
which has been less well studied to date. It will be fascinating to determine if H. 
polygyrus exosomes possess this function, as previous data have demonstrated the 
influence of adult worms on the establishment of commensal bacteria in the intestine 
[135]. Additionally, there may be scope for H. polygyrus worms using EVs to 
communicate with each other, a mechanism which has been reported in protozoan 
parasites [206, 209, 236]  and other microbes (reviewed in [237]). This mechanism 
has been used by the blood stages of P. falciparum [206, 236] to facilitate sexual 
maturation, and T. vaginalis to promote invasion by improving host cell adherence 
[209]. Future work could examine the properties of H. polygrus EVs on different life 





In conclusion, these results contribute to our current knowledge of exosomes as 
! ! Chapter!7!
! ! ! ! ! Chapte!
! 189!
functional components of H. polygyrus ES, establishing them as an important new 
vehicle to mediate cross-species communication. The rapidly expanding body of data 
demonstrating that extracellular vesicles are secreted by diverse parasites brings with 
it many questions related to how exosomes and other EVs function in host cells. The 
fundamental interactions between parasite-derived exosomes and host cells that are 
characterised in this thesis establishes an important framework for future study. 
Given their biological complexity, a deeper understanding of the different properties 
of parasite-derived exosomes will be key to determining how these packages of 
information operate. Suck insights will be crucial to determine how we can interfere 
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In mammalian systems RNA can move between cells via vesicles. Here we demonstrate that
the gastrointestinal nematode Heligmosomoides polygyrus, which infects mice, secretes vesi-
cles containing microRNAs (miRNAs) and Y RNAs as well as a nematode Argonaute protein.
These vesicles are of intestinal origin and are enriched for homologues of mammalian exo-
some proteins. Administration of the nematode exosomes to mice suppresses Type 2 innate
responses and eosinophilia induced by the allergen Alternaria. Microarray analysis of mouse
cells incubated with nematode exosomes in vitro identifies Il33r and Dusp1 as suppressed
genes, and Dusp1 can be repressed by nematode miRNAs based on a reporter assay. We
further identify miRNAs from the filarial nematode Litomosoides sigmodontis in the serum of
infected mice, suggesting that miRNA secretion into host tissues is conserved among
parasitic nematodes. These results reveal exosomes as another mechanism by which
helminths manipulate their hosts and provide a mechanistic framework for RNA transfer
between animal species.
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Parasitic nematodes are ubiquitous pathogens of plants andanimals, including species that infect over 2 billion peopleand generally reside in extracellular niches in their hosts.
H. polygyrus is a parasite related to human hookworm that
naturally infects mice, and is in the same nematode clade as
Caenorhabditis elegans1. Within the mouse host, the parasite life
cycle is exclusively intestinal: following ingestion, the larvae
invade the small intestine, moult into adult worms and emerge
into the lumen of the duodenum to mate and to produce eggs
expelled in the faeces. The infection induces Type 2 innate and
adaptive (Th2) immune responses in parallel with a large
expansion of regulatory cells that mediate immunosuppressive
effects2–4, some of which have beneficial properties in allergy and
auto-immunity5. Immune suppression has been shown to be
mediated in part by a suite of immunomodulatory proteins
actively secreted by the nematodes6,7. Given the burgeoning body
of data detailing extracellular small RNAs in mammalian systems,
and emerging evidence that these can mediate cell-to-cell
communication8, it is intriguing to think this mechanism could
also be used by parasites. Small RNAs derived from bacteria,
plants and parasites have been detected in human body fluids9–12;
however, the mechanism by which these are secreted or excreted
is unknown, and the meaning of their extracellular existence
unclear13. We show here that H. polygyrus secretes a specific set
of miRNAs and full-length Y RNAs that are stabilized against
degradation by encapsulation within vesicles. The vesicles are of
intestinal origin and are enriched for homologues of mammalian
proteins found in exosomes, including heat shock proteins,
tetraspanins and ALIX, a protein associated with exosome
biogenesis14,15 as well as a nematode Argonaute (Ago) protein.
Local administration of the nematode exosomes to mice by the
intranasal route suppresses Type 2 innate responses and
eosinophilia induced by the allergen Alternaria in vivo. The
nematode vesicles are internalized by mouse intestinal epithelial
cells in vitro and suppress genes involved in inflammation and
immunity, including the receptor for the alarmin IL-33 and a key
regulator of mitogen-activated protein kinase (MAPK) signalling,
DUSP1. This work identifies exosomes as a new class of
immunomodulatory complex produced by helminths and
provides the first steps towards a mechanistic framework for
RNA-mediated communication between animal species.
Results
Small RNAs in H. polygyrus secretory products. Total RNA was
extracted from the secretory products of H. polygyrus and com-
pared with the profile of small RNAs in adult nematodes, eggs
and infective larvae. A heterogeneous population of small RNAs
o25 nucleotides (nt) was observed in all samples and several
additional species between 25 and 30 nt were apparent in the
secretion product (Fig. 1a). Small RNA sequencing (o30 nt)
identified miRNAs as the dominant class of secreted parasite
small RNA (Fig. 1b) and also identified RNA fragments mapping
to nematode stem-bulge RNAs, herein referred to as Y RNAs
based on their recognized homology to this class of small RNA16
(Fig. 1b). In contrast, piRNAs (or ‘21-U’ RNAs) were exclusively
identified in the adult library (B14% of reads; Supplementary
Fig. 1 and Supplementary Data set 1) with no evidence of
secretion. RNAs between 70 and 100 nt were also present in the
secreted product (Fig. 1a) and sequencing identified full-length
Y RNAs as the major component of this fraction, with two
predominant classes of structure identified (Fig. 1c and
Supplementary Fig. 2).
A total of 263 ‘high confidence’ miRNAs were classified from
the combined libraries based on representation of reads from
both 5p and 3p arms of the hairpin and/or homology with known
miRNAs in other nematodes (Supplementary Data set 1). Each of
these matches DNA sequences in the H. polygyrus whole genome
currently under assembly. Many also show stage-specific expres-
sion patterns: for example, miR-35 family members are
exclusively expressed in the egg library, consistent with their
functions in embryogenesis17 (Fig. 2a, boxed). The secretory
products are dominated by miRNAs with identical seed sites to
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Figure 1 | H. polygyrus secretory products contain miRNAs and Y RNAs. (a) Size distribution of 30-end labelled (pCp) total RNA extracted from
the life stages (1 mg total RNA) or secretion product of H. polygyrus (total RNA from equivalent of 15 mg protein secretion product). (b) Proportion of
H. polygyrus small RNA biotypes (o30 nt) identified in sequencing libraries from adult worms and the secretion product. (c) Predicted secondary
structures of the two families of Y RNA identified in H. polygyrus secretion products based on RNAfold, the conserved UUAUC motif is noted in blue.
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Eumetazoa (lin-4/miR-125 and five miR-100 family members,
Fig. 2a, red) and five among Bilatera (miR-79/miR-9, miR-83/
miR-29, miR-263/miR-183 and two let-7 family members, Fig. 2a,
blue). In addition, five bantam family members dominate the
secretory products along with miR-87 and miR-60, which also are
shared among Protostomia (Fig. 2a, green) and three miRNAs
that evolved in the nematode lineage: miR-63, miR-239 and miR-
77 (Fig. 2a, orange). miR-63 shares an identical seed site to
mammalian miR-425, although it is not of common ancestry18,
Fig. 2b. On the basis of their sequences, many of the secreted
parasite miRNAs could therefore hijack existing mouse miRNA
target networks if taken up by host cells.
Nematode vesicles are associated with secreted RNA. In
mammalian systems, miRNAs have been found in body fluids in
association with specific proteins or in extracellular vesicles8.
To determine whether these RNAs could be present in vesicles,
the H. polygyrus secretory products were ultracentrifuged and
quantitative reverse transcription–PCR (qRT)–PCR used to
measure miRNA levels in the pellet and supernatant, revealing
the majority to be present in the pellet (Supplementary Fig. 3).
Transmission electron microscopy (TEM) identified vesicle-like
structures between 50 and 100 nm in diameter in the pelleted
material (Fig. 3a). Label-free quantification of proteins in the
vesicles and supernatant by liquid chromatography-electrospray
tandem mass spectrometry LC-MS/MS identified 362 proteins,
of which 139 were specifically enriched in the vesicle fraction
(Po0.05, Fig. 3b, Supplementary Data set 2) including
homologues of mammalian proteins present in exosomes: heat
shock proteins, Rab proteins, tetraspanins19 and Alix, which is
associated with exosome biogenesis14,15 (Table 1). The venom
allergen-like proteins (members of the CAP superfamily,
Pfam00188), which were previously identified as the dominant
proteins in the H. polygyrus secretory products20, are almost
exclusively in the supernatant fraction (Fig. 3b, orange), further
demonstrating specificity in the molecular composition of the
vesicles and possibly indicating distinct routes of secretion. On
this note, nematode intestinal proteins are enriched in the vesicle
fraction (Fig. 3b, green and Supplementary Data set 2) and,
consistent with an intestinal origin of the nematode exosomes,
vesicles of similar size are observed in the intestinal tissue of
adult H. polygyrus analysed immediately ex vivo (Fig. 3c). One
Argonaute protein was identified in both vesicle and supernatant
fractions (Fig. 3b, red) that belongs to the clade of Worm-specific
Agos (WAGO). Phylogenetic analysis suggests that homologues
to this WAGO are present in many parasitic nematodes but may
have been lost in Caenorhabditis (Fig. 3d).
miR-87              --               P 
miR-63 miR-425   **
miR-79 miR-9        B
miR-100 miR-100    E
miR-190 miR-190    B               
miR-235 miR-25      B
miR-87         --               P
miR-87         --               P
miR-63       miR-425      **
miR-63 miR-425
miR-250      --               N
miR-239            --               N
miR-83 miR-29      B
lin-4 miR-125a   E
bantam             --                 P
bantam             --                 P
bantam             --                 P
bantam             --                P
miR-60              --                P
let-7 let-7           B
let-7 let-7           B
miR-100            miR-100    E
miR-100            miR-100    E
miR-263 miR-183    B
miR-100      miR-100     E
miR-100 miR-100     E
bantam --                 P   
miR-71 --                B
miR-1 miR-1          E
miR-45 --                  P
miR-45 --                  P
miR-45 --                  P
miR-100 miR-100      E
miR-43 ---                P
miR-790 miR-96        B
miR-35 --                 P
miR-35 --                 P
miR-35 --                 P
miR-35 --                 P
miR-35 --                 P
miR-35 --                 P
miR-35 --                 P












Figure 2 | Many secreted nematode miRNAs have identical seed sites to mouse miRNAs. (a) Temporal expression of highly abundant miRNAs
(410,000 reads per million in at least one of the libraries) across the life stages. Nematode and mouse names are listed according to identical seed sites
and miRNAs of high abundance in the secretion product are coloured according to their conservation level18: Eumetazoa (red), Bilateria (blue), Protostomia
(green), Nematoda (orange). (b) Sequence alignment of abundant secreted parasite miRNAs that contain identical seed sites between mouse and
H. polygyrus; all families shown are of common ancestry18 apart from miR-425/63.
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Nematode RNAs are protected from degradation by exosomes.
To determine which RNAs identified in the total secretion pro-
duct (Fig. 1) are specifically associated with vesicles, small RNA
sequencing of replicate vesicle and nonvesicle (supernatant)
fractions of the secretion product was carried out. Results from
three biological replicates demonstrate that the parasite miRNAs
are enriched in the vesicle fractions (75% of reads compared with
10% in supernatant, which is dominated instead by rRNA and Y
RNA fragments, Fig. 4a). This analysis also identified three mouse
miRNA homologues: miR-193, miR-10 and miR-200, within the
top five most abundant secreted miRNAs. These were ranked
much lower in the initial Illumina analysis (Supplementary
Table 1) likely because of the sequencing bias of the different kits
and platforms21, underscoring the importance of comparing both
approaches. Overall the three replicates showed the same profile
of miRNAs in each vesicle sample (Supplementary Table 2) and
neither vesicle nor supernatant contained intact large ribosomal
RNA (Supplementary Fig. 4). Northern blot analysis confirmed
the specificity of small RNA biotypes in vesicles versus
supernatant, showing miR-100 to be exclusively present in the
vesicles and the Y RNA fragment to be exclusively present in
the supernatant (Fig. 4b). Notably, on the same blot
the full-length Y RNA was detected in the vesicles and both
the miRNA and full-length Y RNA were largely resistant to
degradation by RNases in untreated samples but became
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Figure 3 | H. polygyrus secretes exosomes of intestinal origin that contain a WAGO protein. (a) TEM of purified ultracentrifugation pellet
(100mg ml! 1 total protein) from H. polygyrus secretion product, scale indicates 0.5 mm. (b) Scatter plot of proteins enriched in ultracentrifugation pellet or
supernatant based on LC-MS/MS, n¼ 3, using Po0.05 (one-way ANOVA) and FC 41.5 as cutoffs. Noted in the legend are homologues of intestinal
nematode proteins (green), mammalian exosome proteins (purple), Venom Allergen-Like (VAL) proteins (orange) and an Argonaute protein (red).
(c) TEM of adult worm intestine noting vesicles of comparable size to exosomes, scale indicates 1.0mm. (d) Phylogenetic relationship of the secreted
Argonaute protein identified in H. polygyrus secretion product in relation to other nematode Argonautes. The analysis was performed on the same data set
described in ref. 28 with the addition of the H. polygyrus-secreted argonaute sequence, using the same method (Bayesian analysis using MrBayes v3.2).
Table 1 | Table of nematode proteins enriched in vesicle




P-value Organism Blast E value
Tetraspanin-11 40.0 o0.005 A. suum 2e!46
Hsp-70 32.2 o0.005 D. medinensis 0.0
Alix 30.2 0.006 C. elegans 1e! 79
Rab-11b 19.7 0.011 S. salar 1e! 71
Rab-5 7.2 0.005 C. elegans 2e! 205
Hsp-90 6.3 0.016 H. contortus 0.0
Naming is based on best blast hit and P value based on n¼ 3.
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these results demonstrate that mature miRNAs and full-length Y
RNAs are secreted by a parasitic nematode and are protected
through encapsulation within vesicles of intestinal origin that
share similar size and protein composition to mammalian
exosomes.
H. polygyrus exosomes suppress innate immunity in vivo.
Helminths are well known to suppress pathogenic immune
responses in both the gastrointestinal tract and airways5. To
examine the functionality of the parasite-derived exosomes
in vivo, they were administered intranasally in combination
with extracts of the allergenic fungus Alternaria, which induces
rapid IL-33 release as part of the Type 2 Th2-like innate immune
response that leads to lung eosinophilia22. Pre-treatment
with parasite-derived exosomes before Alternaria extract
administration led to a sharp reduction in bronchoalveolar
lavage eosinophilia (Fig. 5a), and suppressed expression of the
Type 2 cytokines interleukin (IL)-5 and IL-13 by innate lymphoid
cells (ILCs; Fig. 5b,c). Neutrophilia, which does not depend on
Type 2 cytokines, was undiminished by exosome administration
(Fig. 5d). Intriguingly, the overall expression of the IL-33 receptor
(also known as ST2) was also suppressed in recipients of
exosomes (Fig. 5e).
Internalization of nematode exosomes and RNAs by mouse
cells. To determine whether the nematode-derived exosomes can
enter mammalian cells, uptake was examined in mouse small
intestinal epithelial cells, a cell type that is naturally in direct
contact with H. polygrus in vivo. Exosomes were labelled with the





























































Figure 4 | Secreted miRNAs are protected from degradation through encapsulation within exosomes. (a) Classification of H. polygyrus small
RNAs in the secretion product following ultracentrifugation. (b) Northern blot analysis of RNA extracted from ultracentrifuge pellet or supernatant
(from equivalent 10mg protein) using probes complementary to H. polygyrus miR-100 or the 50 arm of nematode Y RNA; * indicates the processed Y RNA
and ** indicates the full length Y RNA. (c) Northern blot of RNA extracted from the pelleted secretion product following RNase treatment (0.5 Unit RNace-
IT, 1 h at 37 !C) in the presence or absence of 0.05% Triton-X-100.


























































































































**** N.S. N.S. ***
Figure 5 | H. polygyrus exosomes suppress a Type 2 innate immune response in vivo. H. polygyrus exosomes (10 mg) were administered intranasally to
BALB/c mice 24 h before administration of 50mg Alternaria extract and a further 5mg exosomes, or controls that received PBS. (a) SiglecfþCD11c!
eosinophils in the bronchoalveolar lavage; (b) IL-5 and (c) IL-13 expression in PMA/ionomycin-stimulated lineage-negative, ICOSþST2þ group 2 innate
lymphoid cells in digested lung tissue were measured 24 h after Alternaria extract administration; (d) Gr1þCD11bþ neutrophils in the same lavage
samples; (e) the mean fluorescence intensity (MFI) of ST2 (IL33R) staining in ILCs from each group of mice. Data are representative of two independent
experiments, n¼4–6 per group; error bars are mean±s.e.m. Data analysed by ANOVA and Tukey’s post test, ****Po0.0001, ***Po0.001, **Po0.01,
*Po0.05.
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Uptake was analysed by fluorescence-activated cell sorting
(FACS) and confocal microscopy. Over 60% of the cells were
PKH67-positive after 1 h of incubation with H. polygyrus vesicles
compared with 1.5% when incubated with background dye
(Supplementary Fig. 5). These results are unlikely to be due to
nonspecific association with the cell membrane as treatment with
trypsin did not eliminate the signal (Supplementary Fig. 5).
Confocal analysis confirmed uptake to the cytoplasm and
demonstrates that this requires physiological temperature
(Fig. 6a). qRT–PCR analysis of the treated cells detects the
parasite-specific miRNAs in cells after 20 h of incubation, with no
change in the endogenous miR-16 (Fig. 6b). The full-length
parasite-derived Y RNA could also be detected by northern blot
analysis in cells which were treated directly with exosomes fol-
lowed by washing (Fig. 6c).
Regulation of mouse genes by nematode exosomes. To deter-
mine the function of these vesicles in mouse cells, gene expression
analyses were carried out on MODE-K cells following incubation
with H. polygyrus exosomes. A total of 128 genes were differen-
tially expressed upon treatment (false discovery rate (FDR)
Po0.05). Relatively subtle changes in gene expression were
observed (Fig. 7a); however, the most strongly downregulated
gene was Dusp1 (also known as MKP-1 in human), a key reg-
ulator of MAPK signalling associated with dampening the type 1
pro-inflammatory reaction to Toll like receptor (TLR) ligands.
Another gene significantly downregulated by exosomes is Il1rl1
(also known as IL33R in human and so referred to here as Il33r),
the ligand-specific subunit of the receptor for IL-33, a key alarmin
cytokine required for protection against multicellular parasites,
which is produced by innate cells to drive early type 2 immune
responsiveness23 and is suppressed by the exosomes in ILCs
in vivo (Fig. 5e). The effects of the exosomes on Dusp1 and Il33r
were validated by RT–qPCR and are unlikely to reflect a
nonspecific response to vesicle uptake as exosomes derived
from mouse intestinal cells showed similar uptake but did not
alter Dusp1 and Il33r levels (Fig. 7b and Supplementary Fig. 5).
There are a number of potential mechanisms that could
mediate the decrease in Dusp1 and Il33r levels. The 30untranslated
region (UTR) of Dusp1 is highly conserved and contains 7mer
binding sites for the parasite homologues of mouse miR-200 (aka
miR-8) and let-7 as well as a 6mer site for miR-425 (aka miR-63)
in between these sites (Supplementary Fig. 6). We therefore
examined whether the parasite miRNAs could suppress transla-
tion of a reporter vector containing the 30-UTR of Dusp1 fused to
luciferase. Synthetic parasite miRNAs were transfected into
MODE-K cells, resulting in 1.2- to 2.0-fold reduction in luciferase
levels for the Dusp1 reporter but not control (Fig. 7c). Notably,
transfection of a cocktail of three of the miRNAs (at the same
total RNA concentration) resulted in an increased reduction in
luciferase activity (3.1-fold). This is consistent with enhanced
repressive effects of miRNA sites in close proximity and suggests
that secreted parasite miRNAs could work in cooperation to exert
maximal effects on host genes. In contrast, the 30-UTR of the
IL33R-encoding gene Il1lr1 is not conserved and, although
binding sites for some of the secreted miRNAs were identified,
we did not observe repression of a Il1rl1 30-UTR reporter by
transfection of miR-71, which contained two 7mer sites (Fig. 7c
and Supplementary Fig. 6).
Circulating nematode miRNAs in serum. To establish whether
the secreted nematode miRNAs naturally circulate in host tissues
in vivo, we examined serum from mice infected with H. polygyrus
(which resides in the gut lumen) or the filarial nematode
L. sigmodontis (which resides in the pleural cavity). No
H. polygyrus miRNAs were detected in the serum; however, a
total of 1,188 reads mapped perfectly and unambiguously to the
L. sigmodontis draft genome and 761 of these derived from
16 nematode miRNAs (Table 2 and Supplementary Table 3).
Although we cannot rule out the possibility that some of the
miRNAs in serum could derive from dying worms, the most
abundant miRNAs detected are homologues of those found in H.
polygyrus exosomes, including miR-100, bantam, miR-71 and
miR-263 (Table 2, Fig. 8). These data confirm the in vivo secre-
tion of parasite miRNAs and are consistent with the idea that
exosomes and associated RNAs operate locally in the host’s body
such that their detection in body fluids will be dictated by the life
stage and localization of the parasite in the host.
Discussion
In summary, we have shown that nematode parasite-derived
miRNAs and Y RNAs are transported into mammalian host cells
via exosomes that regulate host genes associated with immunity
and inflammation and suppress an innate Type 2 response
in vivo. Extracellular vesicles are emerging as a central









































































Figure 6 | H. polygyrus exosomes and RNAs are internalized by mouse cells. (a) Confocal analysis of murine epithelial cells incubated for 1 h with
PKH67-labelled H. polygyrus exosomes at 37 and 4 !C, scale indicates 8.0mM. (b) Relative expression of parasite-derived miRNAs in murine epithelial
cells at 20 h post incubation with 5mg H. polygyrus exosomes following PBS washes. Signal observed in untreated host cells represents the background
detection of the probe; for parasite-derived miRNA, the data are normalized to the input detection level of miRNAs in 5 mg of exosomes, whereas
miR-16 levels in exosome-treated cells are normalized to untreated cells. (c) Northern blot analysis of RNA extracted from murine epithelial cells
following 20 h incubation with H. polygyrus exosomes (5 mg total protein) compared with untreated cells following PBS washes, using a probe against
the loop of the nematode Y RNA or mouse miR-16.
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and our report of their secretion by a nematode species is within
the setting of vesicle secretion by an increasingly diverse range of
pathogens24–26. We have demonstrated for the first time that
nematode-derived RNAs are a key component within exosomes
that can be transferred to host cells. Nematodes are ubiquitous
pathogens of both plants and animals and we anticipate that RNA
secretion is a conserved phenomenon, supported by the fact that
we detect miRNAs from the filarial nematode L. sigmodontis in
host tissue, consistent with a recent report12. In fact, RNA
secretion may be a ubiquitous feature across a range of parasites;
an initial report suggests that miRNAs are also associated with
vesicles in the trematode Dicrocoelium dendriticum27.
Given that many of the nematode miRNAs are homologues to
mouse miRNAs, it is tempting to speculate that these could tap
into existing miRNA regulatory networks in host cells. In support
of this, we show with a reporter assay that three of the secreted
nematode miRNAs that have identical seed sites to mouse
miRNAs can together downregulate DUSP1 through conserved
sites in its 30UTR. Many questions remain, however, regarding
the mechanism by which the nematode miRNAs can operate in
host cells. The exosome is a functional ensemble and immune
suppression is likely to require a combination of protein and
miRNAs for fusion and gene regulation. It will be challenging,
therefore, to pin point the individual contributions of each. For
example, a nematode Ago protein is secreted with the miRNAs
that may be required for functionality. This Ago belongs to the
WAGO clade of Agos that evolved in the nematode lineage. The
WAGOs mediate diverse RNA interference mechanisms in
nematodes and can operate at epigenetic, transcriptional and
post-transcriptional levels28; it is intriguing to now consider how
these possibilities could extend to their hosts.
An exciting finding in this study is the fact that the exosomes
can suppress an innate Type 2 response in vivo, identifying
vesicles as another class of immunomodulator used by the
parasite and opening the door to further exploitation of exosomes
in a therapeutic context. Our previous work has shown that
H. polygyrus-secreted material suppresses IL-33 release and it is
likely that a combination of soluble proteins and exosomes
together suppress this important pathway22. From analyses
in vitro we identify Il33r and Dusp1 as host genes directly
suppressed by the exosomes. Although DUSP1 has been broadly
viewed as an attenuator of immune activation, it is known to
preferentially downregulate IL-6 that has recently been shown to
promote susceptibility to H. polygyrus29, while upregulating
IL-10, which acts as a broadly immunosuppressive cytokine30.
Hence, parasite survival is likely to be favoured by reduced
DUSP1 levels. Further, DUSP1/MKP-1 dampens the acute
inflammatory response to lipopolysaccharide, promoting
macrophage arginase expression over nitric oxide synthase31.
Hence, parasite repression of DUSP1 could block the induction of
arginase, a known mediator of killing of H. polygyrus in the
mouse32. These possibilities are now being investigated in our
laboratories. Our reporter assays suggest that Dusp1 could be
directly targeted by the parasite miRNAs; however, we do not
observe repression of Il33r when transfecting the parasite
miRNA, miR-71, that is predicted to target its 30UTR. It may
be that additional parasite-derived RNAs or proteins could
regulate Il33r expression, or that the effect operates indirectly
through a separate target gene. For example, reduced expression
of Dusp1 or other regulators of MAPK signalling could result in
GATA-2 phosphorylation, which might inhibit its ability to
promote Il33r transcription33,34.
Finally, our work has revealed not only secreted miRNAs that
are packaged in exosomes but also full-length Y RNAs that are
transferred to host cells at an abundance level detectable by









































































































































































































FDR < 5% and FC > ± 30%
FDR < 5%
Other
Figure 7 | Mouse Il33r and Dusp1 are suppressed by H. polygyrus
exosomes and the secreted miRNA repress target sites in Dusp1.
(a) Volcano plot of mouse genes up- or downregulated upon incubation
with H. polygyrus-derived exosomes; red¼ FDR Po0.05 and FC430%.
(b) Levels of Dusp1 and Il1rl1 in mouse epithelial cells (5$ 104) following
48 h treatment with 5 mg H. polygyrus exosomes or MODE-K-derived
exosomes, n¼ 8, error bars are mean±s.e.m. Data analysed by ANOVA
and Tukey’s post test, *Po0.05, **Po0.01, ***Po0.005, ****Po0.001.
(c) Repression of Psicheck reporter vector containing Dusp1 or Il1rl1 30UTRs
fused to Renilla luciferase by co-transfection with individual or pooled
synthetic H. polygyrus miRNAs (50 nM), data represent renilla/luciferase
ratios, normalized to the values obtained for untreated samples; n¼ 3,
***Po0.005, *Po0.05.
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silencing but were recently shown to be packaged into exosomes
secreted from dendritic cells35 and play roles in RNA quality
control and DNA replication in humans36. Further work is
required to understand whether and how each of these classes of
secreted parasite RNA can contribute to the capacity of this
parasite to manipulate its environment within the host.
Methods
Purification of vesicles from secretion product. For collection of H. polygyrus
secretion product, CF1 mice are infected with infective-stage larvae by gavage and
adult parasites collected from the small intestine 14 days post infection. The worms
are maintained in serum-free media in vitro as described elsewhere37; secretion
product is collected every 3 days for a maximum of 3 weeks (samples used here
were from the first week of collection) and purified as follows: eggs are removed by
spinning at 400 g before filtering of the secretion through 0.2-mm filter (Millipore).
Filtered media is then processed following a modified protocol from that described
in ref. 38, by being spun at 100,000 g for 2 h in polyallomer tubes at 4 !C in a SW40
rotor (Beckman Coulter). Pelleted material is washed two times in filtered PBS at
100,000 g for 2 h. The supernatant is concentrated using Vivaspin 6 5000 MWCO
tubes (Fisher) at 5,000 g and washed two times with PBS.
Small RNA library preparation and analysis. For the analysis of small RNAs in
the life stages and total secretion products, total RNA was size-selected on 15%
denaturing PAGE and libraries prepared from the 18 to 30 nt fraction using
Illumina Small RNA preparation kit version 1.5 and sequenced on an Illumina
GAIIX instrument in Edinburgh Genomics (http://genomics.ed.ac.uk/). To identify
larger RNAs in the secretion product, separate libraries were also prepared for RNA
size selected between 60 and 100 nt and sequenced in parallel. For analysis of
vesicle and nonvesicle fractions, small RNA libraries were prepared using the
TruSeq kit and sequenced on MiSeq platforms, without prior size fractionation of
the RNA. All libraries were analysed by first clipping the 30 sRNA adapter using
cutadapt, searching for at least a six-base match to the adapter sequence. For
analysis of small RNAs only reads that contained the adapter were 16–40 nt in
length and were present at more than two copies were retained for further analysis.
For analysis of RNAs 460 nt in the secretion product, sequences present at 4100
reads in the library (out of 490,614 reads sequenced) were aligned in Clustalw and
manually inspected for sbRNA (Y RNA) content in terms of secondary structure
and location of a UUAUC motif in the terminal loop as described in16 (Fig. 1c and
Supplementary Fig. 2). The Y fragments in the small RNA libraries (o40 nt) were
then identified based on criteria that they aligned to these full-length Y RNAs.
The draft genome assembly for H. polygyrus was created with the CLC de novo
assembler using two lanes of Illumina GAII data with 50 bp paired-end and 100 bp
paired-end reads from Edinburgh Genomics (http://genomics/ed.ac.uk/); the raw
and assembled data are available at http://heligmosomoides.nematod.es/. This
version was used to map the sequences around small RNA reads to identify
structures consistent with miRNA precursors (according to prediction programmes
detailed below). Reads matching the genome were aligned to a set of RNA
sequences consisting of known H. polygyrus 18S, 28S and 5.8S rRNA sequences
(Genbank AJ920355.1, AM039747.1 and DQ408618.1:527-678), 5S rRNA from a
closely related species (Trichostrongylus colubriformis, Genbank U32119.1) and
Rfam sequences (version 10, obtained from ftp://ftp.sanger.ac.uk/pub/databases/
Rfam/10.0/Rfam.fasta.gz). The best hit with at most two edits was used to classify
the reads. Any reads that matched an rRNA or non-microRNA Rfam family were
filtered before miRNA analysis. The analysis of piRNAs was carried out with reads
that did not match known Rfam classes or miRNAs; initial identification was based
on the presence of a ‘GUUUCA’ between 35 and 65 nt upstream of the 50 RNA
alignment start site39. Inspection of the distribution plot identified the region
42–45 nt upstream of the 50 RNA alignment start site as being the key area for
subsequent analyses (Supplementary Fig. 1).
Two miRNA prediction programmes were used to identify miRNAs in the data
sets: miRDeep2 (ref. 40) and mireap (http://sourceforge.net/projects/mireap/). Both
programmes use miRNA biogenesis to model the expected alignment of sRNA
reads to a potential miRNA precursor. For miRDeep2, the following default
settings were used: (a) requirement that reads match the genome perfectly,
(b) removal of reads that match to more than five places in the genome and
(c) cutoff -v 1, (d) the ‘-s option’ was employed, using all mature sequences
from mirbase (version 19). The default settings of minimum free energy
(o! 20 kcal mol! 1) and read length (18–30) were employed. In both
programmes, precursor predictions with fewer than 10 reads were discarded.
Where multiple precursor loci predicted identical mature miRNAs, only the
precursor with the largest number of matching reads was reported.
pCp end labelling and northern blot. For 30 end-labelling, total RNA was
extracted from the life stages and secretion product using the miRNAeasy kit
(Qiagen): 1 mg total RNA was used from life stages and RNA extracted from a
volume of secretion product equating to 15 mg protein (the total RNA concentra-
tion was too low to detect by nanodrop or qubit). The 30-end labelling was carried
out at 4 !C overnight in 10ml using RNA ligase I (NEB) according to the manu-
facturer’s instructions with 3,000 Ci mmol! 1 32P PcP (Perkin Elmer). Reactions
were quenched by the addition of 2$ loading buffer (8 M urea, 0.5% TBE) and 4 ml
run on an 18% PAGE at 350 V for 8 h, which was then visualized by phosphor-
imaging using a Typhoon Scanner (GE Healthcare). For northern blot analysis,
total RNA was extracted from volumes of vesicle and nonvesicle fractions that
contained equivalent protein (10mg) and then separated by denaturing 15% PAGE,
transferred to Hybond-Nþ membrane (GE Healthcare) and chemically cross-
linked as described previously41. Blots were prehybridized in PerfectHyb (Sigma)
for 1 h at 42 !C before overnight incubation with DNA probes (Invitrogen) that
were perfectly complementary to the miRNA or Y RNA: miR-100: 50-ACACAA
GTTCGGATCTACGGGTT-30, YRNA-5P: 50-ACCCTACGACTCCGGACCA
AGCGCG-30, YRNA-3P: 5p-GCGCCGGTCGAGCTTTTGTCGAAGGGAAT-3p,
Y RNA-loop: 5p-AAGGGAATTCGAGACATTGTTGATAAC-3p. The probes
were labelled with T4 PNK (NEB) and 6,000 Ci mmol! 1 32P ATP (Perkin Elmer)
according to the manufacturers’ protocols.
miRNA RT–qPCR. Analysis of miRNA levels in ultracentrifugation fractions was
carried out using the miScript system (Qiagen) with unmodified DNA probes
Table 2 | Litomosoides sigmodontis-derived miRNAs found in
mouse serum.




















miRNAs that map exclusively to the L. sigmodontis but not mouse genome, which were identified
in the sera of mice infected with L. sigmodontis (40 infective larvae were injected subcutaneously
and allowed to migrate to the pleural cavity where they developed naturally for 60 days). The





























Figure 8 | Venn Diagram of overlap in miRNAs identified in H. polygyrus
secretion product or serum of mice infected with L. sigmodontis.
The H. polygyrus miRNAs for comparison are taken from Supplementary
Table 1 (top 20 most abundant in at least one platform). The miRNAs
that are perfectly conserved between nematodes and mice are excluded,
since the origin in serum cannot be deduced.
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identical to the full-length parasite miRNA (Life Sciences): miR-100: 50-AACCCG
TAGATCCGAACTTGTGT-30, miR-71: 50-TGAAAGACATGGGTAGTGAGAC-30 ,
let-7: 50-TGAGGTAGTAGGTTGTATAGTT-30 and miR-60: 50-TATTATGC
ACATTTTCTGGTTCA-30 . For analysis of parasite-derived miRNA levels in host
cells, qRT–PCR was carried out using the miRCURY LNA microRNA PCR system
(Exiqon) and LNA probes were custom-designed by Exiqon to minimize cross
hybridization with mouse sequences, and efficiency of probes was measured
between 90 and 100% (data not shown). Analysis of mouse gene expression levels
was carried out using the Sybr green I master mix (Roche), with the following
primers: gapdh_F: 50-CATGGCCTTCCGTGTTCCTA-30 , gapdh_R: 50-GCGGCA
CGTCAGATCCA-30 Dusp1_F: 50-GTGCCTGACAGTGCAGAATC-30 , Dusp1_R:
50-CACTGCCCAGGTACAGGAAG-30 , Il33R_F: 50-AGACCTGTTACCTGGGC
AAG-30, Il33R_R: 50-CACCTGTCTTCTGCTATTCTGG-30 . Data were collected
on a Light Cycler 480 System (Roche) following temperature profiles recom-
mended by each manufacturer. The delta Ct method was used for quantification as
described in ref. 11 using GAPDH as the normalizer. Data were analysed using
one-way analysis of variance (ANOVA) followed by Tukey’s post test and variance
within groups assessed by Brown Forsythe test.
LC-MS/MS. Five micrograms of total protein from the secretion product ultra-
centrifuge pellet or supernatant were loaded on a 12% Tris-Bis NuPAGE gel
(Invitrogen) and electrophoresis carried out for 5 min before in-gel digestion as
described in ref. 42. Capillary-HPLC-MS/MS analysis was performed using an
online system consisting of a micropump (1,200 binary HPLC system, Agilent, UK)
coupled to a hybrid LTQ-Orbitrap XL instrument (ThermoFisher, UK). Data were
searched using MASCOT Versions 2.4 (Matrix Science Ltd, UK) against an in-
house H. polygyrus transcriptome assembly of 454 sequences43 using a maximum
missed-cut value of 2. Variable methionine oxidation and fixed cysteine
carbamidomethylation were used in all searches; precursor mass tolerance was set
to 7 p.p.m. and MS/MS tolerance to 0.4 a.m.u. The significance threshold (p) was
set below 0.05 (MudPIT scoring). A peptide Mascot score threshold of 20 was used
in the final analysis, which corresponds to a global FDR of 4.6% using a decoy
database search. LC-MS label-free quantitation was performed using Progenesis
(Nonlinear Dynamics, UK) as described elsewhere42 where the total number of
Features (that is, intensity signal at a given retention time and m/z) was reduced to
MS/MS peaks with the charge of 2, 3 or 4þ and we only kept the five most intense
MS/MS spectra per ‘Feature’. The subset of multicharged ions (2þ , 3þ and 4þ )
was extracted from each LC-MS run. For a specific protein, the associated unique
peptide ions were summed to generate an abundance value that was transformed
using an ArcSinH function required for the calculation of the P value. A total of
362 proteins were identified in either the supernatant or pellet based on
requirement of at least two peptides present; of these, 122 were enriched in the
supernatant and 139 in the pellet, while the remaining 101 did not show
statistically significant enrichment and were detectable in both samples. The
within-group means were calculated to determine the fold change and the
transformed data were then used to calculate the P values using one-way ANOVA.
Differentially expressed proteins were considered meaningful under the following
conditions: detected by two or more peptides, with an absolute ratio of at least 1.5
and Po0.05 associated with the protein change. Classification of intestinal proteins
is based on homology to proteins identified in other nematodes, described in ref. 44.
TEM. For visualization of the vesicles, the purified ultracentrifuged pellet from
H. polygyrus secretion product (100 mg ml! 1 protein concentration) was fixed in
2% paraformaldehyde (PFA), deposited on Formvar-carbon-coated EM grids and
treated with glutaraldehyde before treatment with uranyl oxalate and methyl cel-
lulose as described in ref. 38. For analysis of adult H. polygyrus parasites, samples
were washed with PBS before fixation in 2.5% glutaraldehyde solution in 0.1 M
sodium cacodylate buffer overnight. Parasites were rinsed three times with 0.1 M
Na cacodylate buffer, and post-fixed in 1% osmium tetroxide for 1 h. After rinsing
in 0.1 M Na cacodylate buffer, they were sequentially dehydrated in a graded
acetone series. Finally, samples were sequentially incubated for 30 min in an
araldite:acetone solution left to evaporate overnight at 60 !C and then embedded in
fresh araldite resin and polymerized at 60 !C for 48 h. Ultrathin sections, 60-nm
thick, were cut from selected areas, stained in uranyl acetate and lead citrate, and
then viewed in a Philips CM120 TEM. Images were taken on a Gatan Orius CCD
camera.
Flow cytometry and confocal analyses of uptake. Purified exosomes from
H. polygyrus or MODE-K cells (measured as 5 mg of total protein) were labelled
with 2 mg of PKH67 dye (Sigma) for 5 min at room temperature following the
manufacturer’s protocol. The staining reaction was stopped by adding an equal
amount of 1% bovine serum albumin (BSA), and exosomes were washed in PBS
and pelleted by ultracentrifugation (1 h at 100,000 g). A probe solution was pre-
pared with the PKH67 following the same protocol but mixed with PBS solution in
the absence of exosomes. MODE-K cells45 were obtained from Dominique
Kaiserlian (INSERM) and grown following the standard protocol in DMEM
(Invitrogen) medium supplemented with 10% fetal bovine serum (Invitrogen), 1%
penicillin–streptomycin (Lonza), 1% L-glutamine (Lonza), 1% non-essential amino
acids/sodium pyruvate (Gibco). These were mycoplasma-free based on testing
every 4 weeks. On the day of the experiment, cells were seeded in 24-well plates
(1$ 105 cells per well) using advanced DMEM serum-free medium (Invitrogen)
supplemented with 1% L-glutamine and subsequently incubated (1 h at 37 !C)
either in the presence of PKH67-labelled H. polygyrus-derived exosomes (5mg of
total protein) or in the presence of the probe alone. After incubation, cells were
harvested, washed twice in FACS buffer (PBS 1$ , 2.5% FBS, 0.1% BSA, 0.05%
NaN3) and finally resuspended in 500 ml of the same buffer. A subset of the samples
were then incubated with 50 ul of 0.25% Trypsin/EDTA (Gibco) for 5 min before
analysis (indicated in Supplementary Fig. 5). Samples were analysed using the BD
FACS Canto II flow cytometer (BD Bioscience). Data files were acquired from the
cytometer, with 5,000 events collected for each tube and the data analysis was
performed using the FlowJo software (Tree Star Inc.). For confocal analyses,
MODE-K cells were seeded on round microscope cover glasses in 24-well plates
(2.5$ 104 cells per well) in media described above. Cells were allowed to attach on
to the coverslips overnight and the following day shifted to advanced DMEM
medium supplemented with 1% L-glutamine. Cells were incubated (1 h at 37 or
4 !C) either in the presence of labelled exosomes or probe only. After incubation,
medium was aspirated, cells were washed twice in PBS and fixed with 4% PFA, with
residual PFA quenched with 50 mM glycine. Slide coverslips were washed
extensively in PBS, and nuclei were stained with 40,6-diamidino-2-phenylindole-
supplemented ProLong Fade Gold (Invitrogen) mounting media. Samples were
examined on the Leica SP5 II (Leica Microsystems, lasers exciting at 405 and 488,
$ 63 objective) using the LAS AP software (Leica). Images were analysed using the
Volocity software (Improvision).
Microarray analysis. MODE-K cells were grown in DMEM media as described
above and seeded into 24-well plates at 20,000 cells per well. The following day,
cells were incubated with H. polygyrus-derived exosomes (5mg total protein per
well) for 20 h before washing twice with PBS and total RNA extracted. RNA was
prepared for microarray analysis using the Illumina TotalPrep RNA Amplification
kit and run on MouseWG-6 v2.0 (Illumina) at the Wellcome Trust Clinical
Research Facility (University of Edinburgh). The raw SampleProbeProfile file
was processed within R, using ‘lumi’ and ‘lumiMouseAll.db’ Bioconductor
packages46–48. Quality control was performed using Multi-Dimensional Scaling,
and one of the control samples that behaved as an outlier was removed. Raw
expression values were processed with the Variance Stabilizing Transformation and
the Robust Spline Normalization49. An InterQuartile Range was calculated across
all samples for each probe, and used to select the most variable probe of those that
mapped to the same transcript. Probes without a gene or transcript annotation
were excluded, leaving a total of 30,708 nonredundant annotated probes.
Differential expression was performed using the ‘limma’ package50, fitting a linear
model for each probe and using an empirical Bayes method to obtain moderated
t-statistics. In order to reduce the multiple-test problem and focus on the most
interesting genes, ‘present’ probes with an Illumina detection P value o0.05 in at
least three samples were selected, leaving 12,276. The Benjamini and Hochberg
method was used to calculate FDRs51.
In vivo analysis of exosome function in Alternaria model. BALB/c mice were
bred in-house at the University of Edinburgh and accommodated according to
Home Office regulations. Female mice were used when they were 6–10 weeks old.
For all experiments presented in this study, the sample size was large enough to
measure the effect size. No randomization and no blinding were performed in this
study. H. polygyrus exosomes (10 mg) were administered intranasally (under iso-
flurane sedation) in 50 ml PBS, or 50 ml PBS alone to controls, 24 h before intranasal
administration of 50mg Alternaria extract with a further 5 mg of exosomes. Mice
were killed 24 h after Alternaria administration, and bronchoalveolar lavage and
lung cell suspensions stained for flow cytometry as described previously22. Briefly,
cells were counted, then surface stained for SiglecfþCD11c! (eosinophils) or
stimulated with phorbol myristate acetate (PMA) and ionomycin for 4 h in the
presence of BrefeldinA and surface stained as negative for lineage markers
(CD3/CD4/CD5/CD19/CD11b/CD11c/CD19/GR1) and positive for CD45, ICOS
and ST2 (ILC2s), and assessed for staining of IL-5 and IL-13. Samples were
acquired on a Becton-Dickinson LSRII flow cytometer.
Data were analysed using Prism 6 (Graphpad Prism, La Jolla, CA, USA).
Variance within groups was assessed by Brown Forsythe test and data were
log-transformed and analysed by one-way ANOVA, with a Tukey’s multiple
comparisons post test. Unless otherwise indicated, differences are not significant.
****Po0.0001, ***Po0.001, **Po0.01, *Po0.05, N.S. not significant P40.05.
Luciferase assays. The 30UTRs of Dusp1 and Il33r were cloned behind Renilla
luciferase in the Psicheck2 vector (Promega) at NotI and XhoI restriction sites as
described in ref. 41 using the following primers: Psi-Dusp_F: 50-CTTTAC
TCGAGAGGTGTGGAGTTTCACTTGC-30 , Psi-Dusp_R: 50-CTTTAGCGGC
CGCAGCTACAAACCTACACTGGC-30 , Psi-Il33r_F: 50-CTTTACTCGAGGA
CTGTGTGTTGTAGCTTGG-30 , Psi-Il33r_R: 50-CTTTAGCGGCCGCCAGA
GGGAGGCTTTATAAGG-30 .
For reporter assays, 15,000 cells were reverse transfected into a 96-well plate
with 0.3% lipofectamine (Invitrogen) and 50 ng of each Psicheck reporter in the
absence or presence of 50 nM synthetic miRNA mimic (Thermofisher). Luciferase
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measurements were carried out at 48 h post transfection, using the Dual Glo
Luciferase assay system (Promega) and Luminensence measured on a Varioskan
plate reader (Thermofisher). Data shown in Fig. 7b represent n¼ 3 replicates
(separate transfection experiments of the MODE-K cell line) measured in parallel
to control for consistent Renilla and Luciferase ratios using the same kit; data were
analysed by one-way ANOVA, with a Dunnett’s post test, ****Po0.0001,
***Po0.001, **Po0.01, *Po0.05.
MicroRNA target prediction. A custom Perl script was used to identify seed-
matching sites for the H. polygyrus miRNAs identified by sRNA-Seq. All the 30UTR
sequences corresponding to probes on the microarray were scanned, and the results
were passed to the TargetScan (v6.2) context scores Perl script. Targets for each
miRNA were ranked by ‘Contextþ Scores’. Conservation scores for relevant
30UTRs (Dusp1 and Il33r) were obtained from the UCSC Genome Browser, using
the ‘rtracklayer’ package to access the ‘phastCons60wayPlacental’ table52,53.
Sequencing analysis of serum from infected mice. F1 mice were infected with
H. polygyrus (400 L3 larvae introduced by oral gavage) and serum collected on day
14 post infection. The presence of adult parasites was confirmed by visual
inspection of the mouse gut lumen. Six-week-old BALB/c mice were infected with
L. sigmodontis (subcutaneous inoculation of 40 L3), and gel-separated serum (BD
Microtainer) was collected by arterial exsanguination at 60 days post infection,
which was confirmed by detection of adult worms in the mouse pleural cavity and
microfilarie in peripheral blood. For library preparation, 200 ml of serum was
extracted with the miRNAeasy kit (Qiagen) and libraries generated following the
Trueseq protocol and sequenced on the Illumina Rapid HighSeq in Edinburgh
Genomics. Data were processed as described above and analysed for perfect
alignment to the mouse or L. sigmodontis genome (reads mapping to both genomes
were not analysed). Reads that aligned were then categorized by matches to Rfam
or prediction as miRNAs with miRdeep2, as described in ref. 11.
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The New Communicators in
Parasite Infections
Gillian Coakley,1,2 Rick M. Maizels,1,2 and Amy H. Buck1,2,*
Extracellular vesicles (EVs) have emerged as a ubiquitous mechanism for trans-
ferring information between cells and organisms across all three kingdoms of
life. In addition to their roles in normal physiology, vesicles also transport
molecules from pathogens to hosts and can spread antigens as well as infec-
tious agents. Although initially described in the host–pathogen context for their
functions in immune surveillance, vesicles enable multiple modes of communi-
cation by, and between, parasites. Here we review the literature demonstrating
that EVs are secreted by intracellular and extracellular eukaryotic parasites, as
well as their hosts, and detail the functional properties of these vesicles in
maturation, pathogenicity and survival. We further describe the prospects for
targeting or exploiting these complexes in therapeutic and vaccine strategies.
Host–Parasite Interactions: Do We Know it All?
More than 1 billion people worldwide are burdened by parasitic disease, including malaria [1] and
neglected tropical diseases such as leishmaniasis, Chagas disease and helminthiases (http://
whqlibdoc.who.int/hq/2012/WHO_HTM_NTD_2012.1_eng.pdf), with most prevailing in devel-
oping regions such as eastern Asia, sub-Saharan Africa, and the Americas [2]. The prospects for
drug resistance are alarming, with an increasing incidence in livestock that highlights a potential
threat to the human population through zoonotic transmission as well as having strong
economic and social implications [3]. There is a clear need for more efficacious therapies,
which require an improved understanding of how these parasites adapt to, and manipulate, their
host environment. Most parasites at some stage in their life cycle rely on the ability to communi-
cate with one another and with their hosts, but the mechanisms underpinning this communica-
tion are still coming to light. Research in this area has largely focused on the soluble proteins
secreted by parasites, many of which down-modulate the host immune response (reviewed in
[4,5]). For example, in the case of helminths, the egg stage of Schistosoma mansoni secretes an
omega-1 glycoprotein, demonstrated in several studies to promote type 2 helper (Th2) skewing
of dendritic cells (DCs) and T cells during infection [6,7]. The immunomodulatory lipoprotein
antigen B is secreted by Echinococcus granulosus and facilitates Th2 polarization and limits
migration of neutrophils to the site of infection [8]. The ES-62 protein from Acanthocheilonema
viteae has potent anti-inflammatory properties on mast cells [9]. Protozoan parasites similarly
secrete a range of immunomodulatory molecules; for example, Trypanosoma cruzi mucins have
been associated with suppression of active T cell immune responses by inducing arrest in the
cell cycle [10]. Secreted parasite proteins have also been proposed to be involved in metabolic
adaptation to the host environment [11] and tissue invasion, where proteases play a major role
[12]. In the past 5 years, EVs have been revealed as another component of parasite secretion
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products that provide a previously unrecognized mechanism to package and protect a set of
parasite cargo for uptake and integration into other cells. EVs are known to play a role in
communication and genetic exchange between microbes [13]. The functional niches in which
EVs operate in eukaryotic parasites and other pathogens are still emerging and are summarized
in Table 1.
Table 1. Proposed Functions of Pathogen or Host-Derived Exosomes during Infectiona
Pathogen EV origin Host or
parasite?


















Promastigotes Parasite Monocytes and/or
macrophages
Invasion and persistence
within host cells and
delivery of virulence factors
Leishmania EF-1/ and GP63
activate host PTPs in
monocytes responding to
IFNg. GP63 can also influence
exosome cargo selection and
inhibit host miRNA processing.
[35–37,39,
40,42]





Overall increase in IL-8
secretion by macrophages,
which promotes neutrophil
recruitment. Induces release of
IL-10 in human monocytes





Promastigotes Parasite Monocytes/macrophages Invasion and persistence
within host cells and
delivery of virulence factors
Leishmania EF-1/ and GP63




Parasite Immune cells, including




Increase in the number of IL-4-
producing CD4+ T cells/
decrease in the number of







Parasite Macrophages Immunomodulation of host
signaling events promoting
parasite survival







Infected erythrocytes Host Macrophages Activate systemic
inflammation and T cell
priming





Infected erythrocytes Parasite Monocytes and
macrophages
Transfer of parasite material
and parasite dissemination
Innate cell activation. Cytokine
induction in macrophages (IL-
6, IL-12, IL-1b, and IL-10) in a
dose-dependent manner.
[49]
Parasite Infected erythrocytes Commitment of asexual
parasites to gametocytes
Transfer of genetic information
between parasites and







Host Human immune cells,
erythrocytes, endothelial
cells
Higher acute fever and






Mature parasites Parasite Ectocervical cells Limit neutrophil migration to
site of infection
Parasite-derived exosomes
downregulate IL-8 secretion in
ectocervical cells
[54]
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Exosomes and Other Extracellular Vesicles: Origins and Functions
In mammalian systems EVs represent a mechanism of cell-to-cell communication through the
direct stimulation of cells by receptor-mediated contact and/or through the transfer of genetic
material, proteins, and lipids. Several distinct types of EV have been described, including those
derived from the endocytic pathway, exosomes, versus those derived from shedding of the
plasma membrane. We refer to the latter as microvesicles but note that these have been called
by many names in the literature, including ectosomes, plasma membrane-derived vesicles, and
microparticles [14]. Exosomes are endocytic vesicles approximately 40–100 nm in size that are
released from most cell types [15]. Their biogenesis is initiated by inward budding of multi-
vesicular endosomes (Figure 1). Consequently, exosomes express markers of their parent cells,
but are also specifically enriched in other molecules associated with their biogenesis or that are
selectively packaged into them; for example, by the endosomal sorting complexes required for
Table 1. (continued)
Pathogen EV origin Host or
parasite?
EV target Functional response Effector mechanism Refs





















Trypomastigotes Parasite CD4+ T cells and
macrophages
Th2 polarization leading to
parasite dissemination and
enhanced parasite survival
Increase in IL-4 and IL-10
secretion and reduction in







Parasite Recipient immune cells and
monocyte-derived
complement factors
Parasite invasion of host












during the fungal cell
phase
Pathogen Host cells – unknown Promote colonization of
infected tissues
Release virulence factors –
glucosylceramide and GXM
[72]
Pathogen Macrophages Stimulate fungal killing Enhanced IL-10 and TGF-b








Pathogen PBMCs Exacerbation of atopic
dermatitis







Pathogen Immune cells Potential to skew to a
suppressive Th2 response
Enriched in /-Gal, which may
bind host lectins potentially













Suppression of host targets








aDetails in each column (from left to right) describe: the parasite species, the life stage and/or cellular origin of the EV, the proposed beneficiary (host or parasite), the
proposed target and functional outcome, the mechanistic data in support of this function, and the primary literature reference.
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transport (ESCRT) pathway (reviewed in [16]). Microvesicles can be difficult to distinguish from
exosomes, but are generally up to 1 mm and bud from the plasma membrane, incorporating
certain lipids, surface proteins, and other molecules before fission [17]. As reports in the literature
do not always identify vesicular origin, here we refer to parasite exosomes or ‘exosome-like
vesicles’ if they have been described as such in the primary literature or parasite microvesicles if
they are suggested to derive from the plasma membrane, or ‘EVs’ if the origin is unclear.
In recent years, the literature surrounding EV function has exploded as their ubiquity in many
biological and disease contexts has been realized [18]. Historically, these were first identified in
reticulocytes as a mechanism to release transferrin receptors during maturation [19,20] and then
became of interest to immunologists as they contain MHCs and can present antigens [21].
However, following the report that functional mRNAs and miRNAs are transferred between mast
cells via exosomes [22], there was further momentum in studying EVs as a mechanism of cell–
cell communication. In this context, they have been shown to have various functions in immune
cell activation and suppression [23,24] and are also proposed to play a role in disease
development and tissue homeostasis, [25]. An ever-expanding literature has also demonstrated



















Figure 1. The Biogenesis and Transfer of Different Extracellular Vesicles (EVs). (A) Early endosome formation
within the parent cell, surrounded by a range of different bioactive molecules [e.g., nucleic acids, proteins, lipids (denoted by
different colors and/or shapes)]. (B) On development into a late endosome, inward budding allows capture of some of the
host cell cytosolic contents in intraluminal vesicles (ILVs). The late endosome is also referred to as a multivesicular body
(MVB). (C) Some mature MVBs fuse with the hydrolytic lysosome, where the vesicle cargo is subsequently degraded. (D)
MVBs can also fuse directly with the plasma membrane, releasing their ILVs, now known as exosomes, into the extracellular
space. (E) Release of exosomes into the extracellular environment. (F) Other microvesicles are released into the extracellular
space following direct budding from the host cell plasma membrane. There are at least three mechanisms by which EVs
interact with recipient cells: (G) direct fusion with the plasma membrane of the recipient cell; (H) receptor-mediated
endocytosis following receptor–ligand interactions between EVs and the recipient cell; and (I) signaling via direct interactions
of receptor and ligand on the recipient cell surface.
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oncogenes [26], such as those seen in gastrointestinal stromal tumor cell lines [27]. Exosomes
and other EVs are now part of larger clinical initiatives to test their properties in drug delivery, their
use as diagnostic biomarkers, and their potential as therapeutics. While most of this work has
focused on oncology [28,29], these vesicles also have exciting implications across a range of
infectious diseases [30]. Here we detail the recent literature describing their roles in eukaryotic
parasite infection, focusing on the communicative relationship between parasites and hosts.
Furthermore we highlight the importance of EVs in the future identification of novel therapeutic
targets and the development of vaccine strategies.
Intracellular Protozoan Parasites: Host Manipulation by EVs
Several protozoan parasites have been shown to release exosomes and/or microvesicles,
including Leishmania species [31] and T. cruzi [32–34], the parasites that cause human
leishmaniasis and Chagas disease, respectively. Seminal reports showed that promastigote
and amastigote forms of Leishmania donovani and Leishmania major can release exosomes that
are detected in host cells and selectively induce IL-8 secretion from macrophages [35,36]
(Figure 2A). The subsequent chemokinetic recruitment of neutrophils has been proposed as a
‘Trojan horse’ effect, whereby Leishmania can invade these cells and gain access to macro-
phages on phagocytosis of the infected neutrophils [37,38]. Leishmania exosomes have also







































Figure 2. Schematic Representation of the Different Functions of Parasitic Extracellular Vesicles (EVs). (A)
Leishmania spp. promastigotes release exosomes, which can modulate immune properties of monocytes, shown by an
increase in the production of IL-8 and IL-10 and a decrease in tumor necrosis factor (TNF) and nitric oxide [35–37]. Infected
monocytes also release exosomes that have immunomodulatory properties in recipient cells (indicated by broken line), such
as the induction of protein tyrosine phosphatases (PTPs) and changes in gene expression [39,41]. (B) Trypanosoma cruzi
trypomastigote-shed microvesicles can induce type 2 helper (Th2) polarization [seen by an increase in IL-4 and IL-10 and a
decrease in inducible nitric oxide synthase (iNOS)] and invasion of cardiac tissue (indicated by broken line) [34]. Infected
erythrocytes and lymphocytes release microvesicles containing surface transforming growth factor beta (TGF-b) [47]. (C)
The extracellular protozoan Trichomonas vaginalis secretes exosomes, which can promote better adherence of weaker
strains to ectocervical cells [54]. (D) Adult Heligmosomoides polygyrus worms secrete exosomes as part of their excretory–
secretory product in the lumen of the small intestine. These are potentially taken up by intestinal epithelial cells, where they
modulate gene expression of the mitogen-activated protein (MAP) kinase regulatory phosphatase gene dusp1 and the IL-33
receptor (ILRL1) and can have downstream suppressive effects on antiparasite type 2 responses [59].
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inflammatory cytokine tumor necrosis factor (TNF) in human monocyte-derived DCs in response
to interferon gamma (IFNg). Pretreatment of mice with exosomes derived from L. major and L.
donovani resulted in exacerbated infection and pathogenesis in vivo, associated with enhanced
IL-10 production and a skewed Th2 response, preventing parasite expulsion as a type 1
response is normally required for clearance [37]. Specific components of Leishmania exosome
cargo have also been identified and shown to be involved in immunomodulation, including
elongation factor 1 alpha (EF-1/) and the membrane-bound metalloprotease GP63 [39]. These
have both been associated with a depression in signalling events during a proinflammatory IFNg
response by monocytes (and potentially subsequent Th1 polarization) [36,40]. GP63 is also
associated with numerous downstream modulatory effects during Leishmania infection, includ-
ing the modulation of inflammation by activating macrophage protein tyrosine phosphatase
(PTP) signaling. This metalloprotease has also been shown to impact protein sorting into
exosomes and to inhibit miRNA processing in host cells by targeting the endoribonuclease
DICER [39,41,42].
At least two types of EV have been identified from the infective (metacyclic trypomastigote) and
noninfective (epimastigote) forms of T. cruzi parasites; both forms release microvesicles from the
plasma membrane as well as exosomes presumed to derive from the endocytic pathway [32].
Following their initial identification [43], these EVs were further shown to contain a cohort of
proteins associated with immune modulation and virulence and include the homolog to the
multifunctional metalloprotease GP63, described above [32]. Notably, following inoculation of
the parasite microvesicles and subsequent infection with T. cruzi, mice develop heightened
cardiac parasitism and increased inflammatory infiltrates associated with higher levels of IL-4
and IL-10 [34]. These cytokines induce the polarization of a Th2 response as well as lower levels
of inducible nitric oxide synthase (iNOS) in the tissue, suggesting that these microvesicles may
serve to promote parasite dissemination and enhance survival (Figure 2B). Acid phosphatases
involved in the adherence and infection of various trypanosome strains have also been shown to
be present in the microvesicles [44].
In addition to the direct secretion of exosomes and microvesicles by these parasites, both
Leishmania spp. and T. cruzi induce the release of exosomes from the cells that they infect. A
study of Leishmania mexicana-treated macrophages in vitro showed that exosomes released
from infected cells are capable of inducing phosphorylation of signaling proteins and significantly
upregulating immune-related genes including adenosine receptor 2a (Adora2a) on macro-
phages [40]. Interestingly, Adora2a receptor activation on these cells by Escherichia coli, another
pathogen that drives type 1 immune responses, has been associated with increased IL-10 and
down-modulated TNF [45]. Conversely, a recent study suggests that exosomes from Leish-
mania amazonensis-infected macrophages can prime other naïve macrophages to initiate
antiparasitic Th1 responses through the release of the inflammatory cytokines IL-12, IL-1b,
and TNF [46]. T. cruzi also induces the release of microvesicles from infected host cells, including
lymphocytes and monocytes in vitro and erythrocytes in vivo. These microvesicles express
surface transforming growth factor beta (TGF-b), which has been shown to facilitate eukaryotic
cell invasion by the parasite and leads to maturation and continuation of the life cycle [47]. The
microvesicles also protect extracellular life cycle stages of T. cruzi, including epimastigotes from
the vector and trypomastigotes from ruptured cells, from complement-mediated attack, thus
facilitating parasite invasion of host cells [48]. More specifically, monocyte-derived microvesicles
develop a complex with the complement C3 convertase C4b2a on the parasite surface, limiting
the interaction with its substrate C3. The inhibition of this crucial step prevents complement-
mediated lysis, opsonization, and the release of anaphylatoxins, subsequently leading to
increased parasite survival [47]. In an analogous manner, erythrocytes infected with the malaria
parasite Plasmodium falciparum produce microvesicles that enhance dose-dependent secre-
tion of proinflammatory cytokines such as IL-1b, IL-6, and IL-12 from monocytes following
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phagocytosis [49]. In the context of infection, it has been hypothesized that these cytokines may
aid endothelial cell activation and erythrocyte sequestration. As with many immunomodulatory
mechanisms, however, it can be difficult to distinguish whether vesicle secretion by host cells
during infection is controlled by the host and/or the parasite, as both may benefit. This is
discussed further later in this review.
Interspecies Communication between Intracellular Protozoan Parasites
In addition to manipulation of the host immune response, EVs can also mediate intercellular
communication between parasites. It has been reported that microvesicles traffic between P.
falciparum-infected erythrocytes and increase the commitment of asexual parasites to the
sexual stages, gametocytes, to promote transmission [49,50]. Furthermore, it is suggested
that EVs (described by Regev et al. as ‘exosome-like’ [50]) secreted by red blood cells following
infection with transgenic P. falciparum parasites can rescue parasitic growth by transferring DNA
encoding a drug resistance marker to other P. falciparum in infected cells under conditions of
drug selection. Thus, genetic material can be transferred between the infected erythrocytes via
EVs, and this may also contribute to the sexual development mentioned above. This pathway
has been shown to be dependent on trafficking mechanisms that transport parasite-encoded
proteins to the host-erythrocyte membrane through membranous structures called Maurer's
clefts in infected erythrocytes [50].
This is one of the few examples to date of vesicle involvement in parasite-to-parasite communi-
cation (a further example is provided below in the case of the extracellular parasite Trichomonas
vaginalis). This is likely to represent a bias in the literature, which focuses largely on the
immunomodulatory properties of parasite secretion products. In the microbial context, it is well
established that secreted vesicles play a role in microbe–microbe communication and genetic
exchange (reviewed in [13]). Many gaps remain in our understanding of how different eukaryotic
parasites communicate with one another to regulate aspects of their life cycles, including
reproduction or commitment to transmission stages. It will be interesting to see whether this
is a functional niche occupied by EVs that extends beyond malaria parasites.
Extracellular Protozoan Parasites: Communication within Their Environment
An obvious function of EVs in extracellular pathogens is their ability to protect cargo and move
this into host cells. However, mechanistic aspects of this are not understood, including whether
and how there is specificity in the uptake by certain cell types, whether the parasite cargo is
recognized by the host immune system, and how communication is conducted between two
phylogenetically distant species. Among extracellular protozoan parasites, comparative analysis
of the secretome of Trypanosoma brucei subspecies, the causative agent of African sleeping
sickness, identified several exosome-associated proteins such as enolase, heat-shock protein
70, and the clathrin heavy chain. Different members of the metallopeptidase family are also found
in the secreted microvesicles and may serve as potential drug targets or even diagnostic
biomarkers during stages of African trypanosomiasis [51,52]. Complimentary studies on the
T. brucei secretome also demonstrate the presence of 50–100-nm microvesicles budding from
the plasma membrane of the infective parasite [53]. The parasitic protozoan T. vaginalis, which
can cause infertility through sexual transmission, has been shown to release functional exo-
somes that can play a role in both parasite-to-parasite and parasite-to-host communication [54].
Virulence products are present within the exosomes that are able to specifically downregulate IL-
8 secretion by ectocervical cells (potentially limiting neutrophil migration to prevent pathogen
clearance). Furthermore, preincubation with exosomes released from a more adherent strain of
the parasite, B7RC2, can induce better adherence of weaker strains, such the laboratory strain
G3, in a dose-dependent fashion, which is not seen in the converse scenario (Figure 2C). The
mechanisms underpinning these effects and the cargo within the exosomes involved are not yet
known.
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Extracellular Parasites: Interactions at the Cell-to-Parasite Interface
Helminth worms are ubiquitous pathogens of plants and animals that have coevolved with their
hosts for hundreds of millions of years and use sophisticated mechanisms for manipulating them
[55]. It has only recently been demonstrated that these complex parasites also secrete exo-
somes, and potentially other classes of EV, into the environment that can be internalized by host
cells. Electron microscopy images of EVs derived from diverse helminths are shown in Figure 3,
including studies in the trematodes Fasciola hepatica and Echinostoma caproni, which release
EVs that can be detected on the tegumental surface. Marcilla et al. [56], showed that these EVs
are internalized by rat intestinal epithelial cells in vitro and contain protein homologs of proteins
found in mammalian exosomes. Notably, earlier work examining the glycocalyx of S. mansoni
cercariae demonstrated the potential presence of structures similar to multivesicular bodies
adjacent to the schistosomula tegument [57]. A recent study has detailed the presence of
exosome-like vesicles secreted by Schistosoma japonicum adults that were shown to induce
macrophage polarization to a M1 phenotype, thereby highlighting the potential immunomodu-
latory properties of Schistosoma-derived exosomes and their potential role during infection [58].
We recently demonstrated that the gastrointestinal nematode Heligmosomoides polygyrus
secretes exosomes that are internalized by host cells (Figure 2D). These are enriched in specific
proteins, including those associated with exosome biogenesis (e.g., alix, enolase, HSP70), as
well as many proteins of unknown function and contain miRNAs and other classes of noncoding
RNA [59]. The presence of an Argonaute protein and small RNAs within nematode exosomes
may suggest the existence of cross-species RNA interference, although the mechanism of this
remains unknown. Several of the H. polygyrus exosome-derived miRNAs have target sites in the
30 untranslated region (30UTR) of the mouse dusp1 gene, which encodes a mitogen-activated
protein (MAP) kinase regulatory phosphatase. We showed that transfection of three nematode-
derived miRNAs could suppress a luciferase reporter containing the 30UTR of DUSP1. Although
relatively little is known about this phosphatase in helminth infection, DUSP1!/! macrophages
have previously been shown to have sustained IL-10 expression in the presence of helminth
cystatins [60]. IL-10 is an immunoregulatory cytokine that could prevent an antiparasitic or

















Figure 3. Electron Micrographs Demonstrating Exosome-Like Vesicles Derived from Extracellular Helminths.
(A) Presence of exosome-like vesicles contained within the multivesicular body (MVB) on the tegument of Echinostoma
caproni. Reproduced, with permission, from [56]. (B) Potential MVBs close to the tegumental surface of Schistosoma
mansoni cercariae, microvilli (m), tegument (t), spines (s), and multilaminate vesicles (mv) are noted. Reproduced, with
permission, from [57]. (C) Cross-section of Heligmosomoides polygyrus adult worms revealing numerous potential
extracellular vesicles (EVs) within the intestinal lumen. Reproduced, with permission, from [59]. (D) Anterior opening of
H. polygyrus covered in structures similar in size to exosomes, labeled as EVs.
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demonstrated that the H. polygyrus exosomes could suppress an inflammatory airway response
in vivo: during the first 24 h of an innate atopic ‘danger’ response to the fungus Alternaria
alternata in vivo, H. polygyrus exosomes block activation of type 2 innate lymphoid cells and
have downstream effects on eosinophilic recruitment. Furthermore, H. polygyrus exosomes
suppressed expression of IL1RL1/ST2 (the IL-33-specific receptor subunit) following treatment
in vitro in intestinal epithelial cells and in vivo during the allergic asthma response to Alternaria. As
the IL-33 ligand–receptor interaction is known to be important in antihelminthic responses
[63,64], these data suggest the ability of H. polygyrus exosomes to modulate aspects of the host
cell response to prevent pathogen clearance. A previous report demonstrated that the model
free-living nematode Caenorhabditis elegans releases peptide-containing exosomes using a
defined apical secretion pathway [65] and it is expected that exosomes may be used by all
nematodes, either as a mechanism of cell-to-cell communication within the organism or, when
exported outside the organism, as a mode of communication with other species.
In addition to the above reports, analyses of the secretion products of other helminths suggest
the presence of exosome-associated proteins, including CD63-like tetraspanins from the
cestode E. granulosus [66]. Tetraspanins have been implicated in the formation and targeting
of exosomes to recipient cells [67]. Interestingly, tetraspanins have independently been sug-
gested as promising targets for vaccination against another parasite, Echinococcus multi-
locularis, the causative agent of alveolar echinococcosis [67,68]. This suggests that
targeting exosomes and their surface proteins may provide an important antiparasite vaccination
strategy.
EVs from Microorganisms and Ectoparasites: More Players at the
Extracellular Surface
Other eukaryotes, such as the pathogenic fungus Paracoccidioides brasiliensis, release highly
immunogenic EVs that are detectable in the sera of paracoccidioidomycosis patients [69]. One
such immunogenic epitope is the cellular membrane carbohydrate galactose-/-1,3-galactose
(/-Gal), which is not found in human cells. Although /-Gal-enriched EVs may generate a robust
immune response in the host, they are suggested to be beneficial to the pathogen, both by binding
to host lectins and, potentially, by stimulating a suppressive type 2 response. This is in accordance
with previous literature showing that /-Gal-enriched T. cruzi exosomes are able to stimulate IL-4/
IL-10 expression in cardiac tissue and splenocytes [34]. Many types of opportunistic fungi,
including Cryptococcus neoformans, Candida albicans, and Histoplasma capsulatum, release
EVs [70], which have been suggested to contain virulence-associated factors including poly-
saccharides and lipids (reviewed further in [71]). The EVs released by C. neoformans, for example,
are enriched in virulent capsular components such as glucosylceramide and glucuronoxylo-
mannan (GXM) [72]. Interestingly, a recent study has shown the importance of phospholipid
translocases (flippases) in C. neoformans exosome packaging and transport, whereby mutant
Apt1 flippase-knockout fungi have diminished levels of GXM and are consequently unable to
successfully colonize the lung and brain of infected mice [73]. Furthermore, the yeast Malassezia
sympodialis, a component of natural human flora, is able to release EVs capable of generating IL-4
and TNF secretion from peripheral blood mononuclear cells, enhancing an inflammatory response
in patients afflicted with atopic dermatitis [74]. Fungus-released EVs may also induce antimicrobial
activity by host cells: EVs released by C. neoformans are taken up by macrophages in vitro and
stimulate TNF, IL-10, TGF-b, and nitric oxide production [75].
A recent study in the argasid tick, Ornithodoros moubata, suggests that some immunomodu-
latory proteins may be secreted in arthropod saliva, and it is tempting to speculate that EVs
would also be found in this environment. Proteomics of the tick saliva reveal several exosome-
associated proteins (e.g., aldolase, enolase) as well as anti-inflammatory lipocalins, which serve
as scavengers of leukotrienes, and adenosine nucleotides at the location of the bite [76]. It is
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clear that we are only at the beginning of many new discoveries with extracellular parasites and
the functionally diverse EVs they might secrete. There are a growing number of reports
containing proteomic matches to exosome proteins in parasite secretomes and this should
cement the idea that these are probably used by most, or all, pathogens at some stage in their life
cycle. The effects that these EVs may exert at this interface will be of particular importance in the
context of antiparasite treatment, and conversely, based on the ability to suppress an innate
immune response [59], they may also be useful tools to ameliorate inflammation-associated
disease [4].
Host Exosomes in the Context of Pathogen Infection: A Useful Therapeutic
Strategy?
As parasites have evolved to secrete exosomes that are able to effectively interact with the host,
it is only logical that the host would also use this pathway as a defense mechanism. During
infection with a rodent malaria parasite, Plasmodium berghei, plasma cell-derived microvesicles
induce CD40 on antigen-presenting cells, generating a potent inflammatory response through
potential T cell priming and effector initiation [77]. Subsequently, macrophage activation may be
responsible for clearance of the parasite. This is further supported by studies in Plasmodium
vivax infection in humans, whereby immune cell-derived microvesicles are associated with
greater acute inflammation in the pursuit of parasite eradication [78]. These mechanisms
can be exploited in a therapeutic context; for example, murine reticulocytes infected with the
nonlethal Plasmodium yoelii X strain can significantly attenuate pathogenesis when transferred
into mice that are then infected with the lethal strain P. yoelii XL [79]. On a separate note, intestinal
epithelial cells were shown to increase the release of antimicrobial peptide-containing exosomes
in response to Cryptosporidium infection, which is driven by enhanced toll-like receptor 4
signaling following recognition of the protozoan parasite [80]. The facultative intracellular bacte-
rium Mycobacterium tuberculosis induces exosome release from infected macrophages, which
consequently promotes recruitment of lymphocytes through heightened inflammatory chemo-
kine secretion (such as RANTES and MIP-1/) [13,81]. Exosomes derived from Mycobacterium
bovis-infected macrophages are able to promote DC activation as well as generating an
antibacterial T cell response in vivo [82].
Host-derived exosomes also play important roles in antigen presentation. DCs pulsed with
Toxoplasma gondii antigens are able to induce both a systemic and a local humoral response
against the parasite in vivo, thereby serving as an efficient vaccine against toxoplasmosis [83,84].
Similar results are seen in a vaccine trial with L. major-pulsed DC exosomes, showing that DC-
derived exosomes are able to mediate protective Th1 immunity against cutaneous leishmaniasis
in a cell-independent manner [85]. Importantly, several studies have emerged using DC-derived
exosomes for protection against common livestock parasites. Vaccination of chickens with
Eimeria parasite antigen-loaded DC exosomes was able to successfully ameliorate symptoms of
avian coccidiosis caused by several species (Eimeria tenella, Eimeria maxima, and Eimeria
acervulina) as well as reduce mortality rates [86].
Concluding Remarks and Future Perspectives
From this review, it is clear that exosomes and other EVs can be used by both parasite and host
to influence the outcome of an infection. Vesicles can function by transmitting signals between
parasites, from parasite to host, or from host to the environment for antigen presentation and
other aspects of host defense. The ability of vesicles to transport and deliver diverse populations
of molecules in a specific package might occupy a range of niches in biology. There has been a
surge of reports in the past 5 years detailing the presence of parasite-derived vesicles and it
seems likely that this will only increase with the appreciation that all organisms are likely to
secrete these [13]. Based on the literature, immune manipulation appears to be a prevalent
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function of parasite-derived exosomes, which feeds into numerous cell-to-cell interactions within
the human body [87]. However, it is expected that EVs could also play a prominent role in
parasite-to-parasite communication, which has been less well studied to date (see Outstanding
Questions Box). The molecules within exosomes that mediate their functions require further
investigation. We and others have detailed the small RNAs present in pathogen-derived
exosomes [59,88–91] and previous reports have shown the functionality of exosomal RNA
in an immune context [24,92,93]. One concern in this field at present, however, is the lack of
quantitative data to determine the abundance and stoichiometry of RNA within EVs and whether
this is sufficient for effective gene silencing under physiological conditions [94]. Intriguingly, we
found that an Argonaute protein is also secreted with exosomes derived from H. polygyrus, and
it could be expected that ribonucleoprotein complexes, rather than individual molecules, might
underpin functionality. In addition to nucleic acids, there are many immunomodulatory proteins in
exosomes, [87,95–97], as well as lipids that might have immunomodulatory properties [98].
During the preparation of this manuscript, two additional papers demonstrated EV secretion by
helminths: the liver fluke Opisthorchis viverrini [99] and pig whipworm Trichuris suis [100].
Chaiyadet et al. [99] show that EVs produced by O. viverrini drive IL-6 production and
proliferation of human cholangiocytes, and may link to the chronic periductal fibrosis associated
with this pathogen. Additionally, they demonstrate that uptake of these EVs by host cells is
blocked by Ab directed against a surface tetraspanin. A deeper understanding of the biochemi-
cal properties of exosomes will be key to interrogating how these complicated packages of
information operate and how we can interfere with or mimic these processes to treat infectious
disease.
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Helminths  are  metazoan  organisms  many  of  which  have  evolved  parasitic  life  styles  dependent  on  sophis-
ticated  manipulation  of  the  host  environment.  Most  notably,  they  down-regulate  host  immune  responses
to  ensure  their  own  survival,  by exporting  a range  of  immuno-modulatory  mediators  that  interact  with
host cells  and  tissues.  While  a number  of  secreted  immunoregulatory  parasite  proteins  have  been  defined,
new work  also  points  to the  release  of  extracellular  vesicles,  or exosomes,  that  interact  with  and  manip-
ulate  host  gene  expression.  These  recent  results  are  discussed  in the overall  context  of  how  helminths
communicate  effectively  with  the  host  organism.
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1. Introduction
Helminth parasites generally establish long-term infections in
their host, reflecting their ability to drive a new physiological and
immunological homeostasis that best accomodates the invader [1].
Over eons of evolutionary time, parasites have developed a remark-
able suite of finely-tuned molecular adaptations that manipulate,
inhibit or activate different host cells or pathways in order to max-
imise parasite success [2,3]. In this review, we discuss some of
the more recent and exciting developments that shed light on the
molecular pathways of host-parasite communication.
Helminths are parasitic worms belonging to the lower inver-
tebrate phyla of nematodes (roundworms) and platyhelminths
(flatworms). A wide variety of helminth species are able colonise an
extraordinary array of niches and host organisms, in each case cir-
cumventing host defence and expulsion mechanisms. Interestingly,
the strategy of helminths is not to outpace the immune system
through rapid multiplication or antigenic variation, but to manipu-
late and modulate immunity in order to defuse immune defences,
meaning the host fails to eliminate the parasites [4]. Helminths
essentially take hold by stealth, first inactivating host detection
systems that would otherwise raise the alarm, and then effectively
∗ Corresponding Author.
E-mail address: rick.maizels@glasgow.ac.uk (R.M. Maizels).
tolerizing the immune system to parasite antigens, and in doing
so, also dampening responses to bystander antigens in allergy or
autoimmunity [5].
The softly–softly strategy of helminths has implications for how
they communicate with their hosts and the immune system of their
host, suggesting that there must be a continual dialogue to maintain
the state of tolerance. Because infection comprises relatively stable
populations of long-lived parasites, it is logical to deduce that the
dialogue is conducted by products continuously released from live
parasites that address different specific components of the immune
system [2]. This notion is supported by observations that most of
the immunomodulatory effects of helminth infections are reversed
following drug-mediated parasite clearance [6–8].
Correspondingly, much attention has been paid to the
“excretory-secretory” (ES) antigens of helminths, a pragmatic
approach to collect mixtures of released proteins that dates back
over 60 years [9]. Much more recently, of course, the application
of genomics, transcriptomics and mass spectrometry has trans-
formed our understanding of these complex and heterogeneous
preparations by defining the individual molecular components that
parasites release to modify their environment [2]. As discussed
below, these products are not only proteins, but also include gly-
cans, lipids and nucleic acids, in particular miRNAs, as well as small
molecules and metabolites, and are released in a variety of “pack-
ages”, including lipid vesicles.
http://dx.doi.org/10.1016/j.molbiopara.2016.06.003
0166-6851/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Pathogen recognition systems in helminth infection. Innate mechanisms respond to tissue injury with release of alarmins (eg IL-33, TSLP) which can initiate a type 2
response; helminths can block alarmin release or receptors for alarmins such as ST2 (the IL-33R). Pathogen associated molecular patterns may  also be recognised eg by Toll
Like  Receptors (TLRs) or C-type lectin receptors (CLRs), and these molecular patterns may  be directly presented by helminths, or indirectly through bacteria translocating
through injured epithelium. In the latter case, the Th1 response driven by IL-12 is blocked by helminth secreted immune modulators.
2. Host recognition of parasites
The first encounter between parasite and host generally entails
breaching of a barrier surface (such as skin or intestinal epithe-
lium) that provokes release of ‘alarmins’ [10] and recognition of the
invader by pattern recognition receptors (PRRs), such as the Toll-
like receptors (TLRs) that drive inflammatory cytokine production.
Alarmins, closely associated with helminth-mediated tissue dam-
age, include IL-33 and TSLP [11,12], which both promote a Type
2 pro-allergic and anti-helminth mode of the immune response.
However, helminths can partially or entirely circumvent this threat
(Fig. 1); for example, the response of dendritic cells (DCs) to TLR
ligation is effectively negated by products from Nippostrongylus
brasiliensis and other helminths, with IL-12 production being espe-
cially inhibited [13–17] while epithelial cell release of IL-33 is
directly blocked by products released by Heligmosmoides polygyrus
[18]. As discussed in the following section, some of the molecular
mediators responsible for blocking innate activation are now being
defined.
The archetypal PRRs react to microbial products such as LPS
and lipoteichoic acid by triggering production of pro-inflammatory
cytokines, such as IL-12, that drive the Th1 response. The consis-
tent ability of varied helminth products to suppress IL-12 release
following TLR stimulation may  be a mechanism aimed not so
much at blocking anti-parasite immunity, but at avoiding collat-
eral inflammation at barrier sites where, for example, bacterial
translocation could accompany helminth invasion. Whilst the cen-
tral role of TLRs in pathogen pattern recognition by the host is
now well understood, it is surprising that no parallel recogni-
tion system has yet been defined for Th2-inducing organisms such
as helminths. However, a few TLR ligands from helminths have
been described, including from Schistosoma mansoni both the lyso-
phosphatidylserine glycolipid [19] and RNA activating TLR3 [20],
and other receptor systems such as the C-type lectin receptors
(CLRs) may  fulfill the role of innate recognition in other settings
[21–23].
3. Protein-mediated interactions
The first level of parasite communication with the host can be
considered to be simple protein–protein interactions in the extra-
cellular milieu, either with fluid phase host components, or exposed
receptors on host cell surfaces. For example, H. polygyrus secretes a
functional mimic  of the immunomodulatory cytokine TGF-!, which
ligates mammalian surface receptor and transduces a suppressive
signal to T cells (Johnston et al., submitted for publication). Space
precludes further discussion of the many individual proteins now
found to be involved in host-helminth interactions, but perhaps the
most intriguing are members of the CAP superfamily (Pfam00188)
which are greatly expanded across all helminth parasite lineages
[24,25], and highly represented in the secreted protein compart-
ments [26,27]. One member of this family from Necator americanus
(a hookworm) was  one of the first to be characterised function-
ally as NIF, a secreted inhibitor of integrin binding that blocks
neutrophils [28].
While functional assignments for members of the CAP gene fam-
ily other than NIF are scarce, it is interesting to note that in a
plant parasitic nematode, a homologue binds to a tomato plant
innate defence protein, disabling resistance pathways and pro-
moting infection [29]. Thus, helminth secreted proteins are not
necessarily limited to interactions at the host cell surface, but can
perform functions within host cells, raising the question of how
they may  enter the cell.
3.1. Intracellular action of helminth proteins
Two well-studied helminth glycoproteins are known to enter
host cells and mediate profound biological effects. The Schistosoma
mansoni egg-derived glycoprotein "1 is a ribonuclease bearing
Lewis X glycan side chains, that bind to surface lectin of dendritic
cells, mediating uptake into the cell, resulting in the protein moi-
ety acting to block protein synthesis [30,31]. DCs pretreated with
"1 are also switched into the type 2 immune pathway, activating
naive T cells to become Th2 effector cells.
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A different mediator is the predominant secreted glycoprotein
of the filarial nematode Acanthocheilionema viteae. This product,
ES-62, is a 62-kDa component bearing N-linked phosphorylcholine
(PC) sidechains. Through interaction with surface TLR4, ES-62
enters the cell, and in the intracellular milieu the PC moiety inter-
rupts the downstream signalling of both the B cell receptor and
TLR4, effectively inhibiting cell activation [32]. A further exam-
ple is the FheCL1 cysteine protease from Fasciola hepatica, which
degrades TLR3 in host macrophages thereby inhibiting activation;
although TLR3 is an intracellular pathogen sensor, FheCL1 is able
to enter the endosome to degrade the receptor in situ [17].
A separate pathway is targetted by the filarial cystatin molecule
CPI-2. This protein has two inhibitory sites which target conven-
tional cysteine proteases, and asparaginyl endopeptidase (AEP)
respectively [33]. Human B cells exposed to CPI-2 from Brugia
malayi (a human filarial parasite) are no longer able to process pro-
tein antigen for presentation to T cells, a pathway dependent on AEP
activity in the endosome [33]. Further studies on a closely related
cystatin from A. viteae show that this protein is taken up by mouse
macrophages and activates ERK and p38 kinases, resulting in the
production of immunoregulatory IL-10, in a manner linked to the
phosphorylation of the CREB and STAT3 signalling factors [34].
Many other products have been shown to modulate intracel-
lular signalling in host cells, although the mode of entry is not
always understood. For example, the ALT-2 protein is derived from
an abundant larval transcript of the filarial parasite B. malayi.  The
effect of this protein is seen when added to macrophages, or intro-
duced into the macrophage via transfection of the intracellular
protozoan Leishmania mexicana, in the induction of the signalling
proteins GATA-3 and SOCS-1, which act to induce type 2 responses
and dampen IFN-# dependent inflammatory signals in the cell [35].
3.2. Discovery of exosomes
It is now becoming increasingly apparent that extracellular
vesicles, and exosomes in particular, play a key role in cellular
communication. Exosomes are nanovesicles around 50–100 nm in
size that are secreted by virtually all cells to facilitate the transfer
of selected cargo, mainly lipids, proteins and RNA species, whilst
retaining phenotypic markers from their cell of origin [36,37]. Exo-
somes develop within a cell by inward budding of multi-vesicular
endosomes, and thus contain components of the parental cell, such
as RNAs or proteins, that may  be trafficked into the same compart-
ment. The discovery of extracellular vesicles from kinetoplastids,
fungi and bacteria drove the theory that exosome-mediated com-
munication could operate on a cross-species platform, whereby
parasite-derived exosomes could interact with, and potentially
modulate, the host immune system [38]. Only recently have exo-
somes been recognised as integral products from extracellular
organisms like helminths [38,39].
It has recently been discovered that parasitic helminths produce
exosomes. This was initially reported in the excretory-secretory
components of the trematodes, Echinostoma caproni and Fasciola
hepatica, which infect the gastrointestinal tract and liver respec-
tively [40], and in the nematode H. polygyrus, which infects the
small intestine [41]. Data from the trematode studies further sug-
gests that ES-derived exosomes are capable of reaching the host
environment, as they appear to be found intact on the para-
sites’ tegument. Further support of this is demonstrated by the
internalisation of helminth exosomes by host intestinal epithelial
cells, suggesting their capacity for cross-phylum communication
between helminths and mammals.
The formation of exosomes by helminths had originally been
established in free-living nematodes, with the demonstration that
Caenorhabditis elegans use a novel secretion pathway from the
apical membrane, to co-secrete multivesicular bodies, contain-
Fig. 2. Proposed route of secretion of exosomes by the nematode H.polygyrus. (A)
Low-power micrograph of the intestinal tract of adult H. polygyrus showing brush
border epithelium, as well as ducted secretory gland (marked with asterisk). (B)
Higher power image of H.polygyrus intestinal ultrastructure, with (C) zoom of the
luminal contents containing a large number of vesicles and macromolecular struc-
tures consistent with the presence of exosomes.
ing exosome-like vesicles, with peptides that normally promote
cuticle development. [42]. Exosomes from helminths and proto-
zoa appear to share many specific markers, with those known to
be present in mammalian exosomes, such as Heat-shock protein
70 (HSP70), endosomal sorting components e.g. Alix, and sur-
face tetraspanins including CD9 and CD63 [37]. For example, it
was shown that whilst exosomes secreted by Leishmania-infected
macrophages undergo a series of phenotypic changes following
infection, they still retain some typical exosome markers, including
TsG101, Alix and CD63 [43]. Additionally, transcriptomic analy-
sis of the cestode, Echinococcus granulosus, revealed the existence
of other CD63-like tetraspanin family members [44]. Tetraspanins
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were independently selected as target candidates for vaccina-
tion against Echinococcus multilocularis, another tapeworm which
causes alveolar echinococcosis, a highly fatal disease dominating
parts of Siberia, Central Europe and China [45,46]. The focus on
a tetraspanin-targeting vaccine is also being explored against the
human pathogen S. mansoni [47,48].
Previously, we have shown the ability of H. polygyrus,  a murine
gastrointestinal nematode, to secrete exosomes that contain mul-
tiple miRNA species, as well as a significant number of proteins,
representing approximately 10% of the total protein secretion of
an adult worm [41]. Proteomic comparison of the secreted prod-
ucts represented in the soluble and vesicular fractions separate
by ultacentrifugation also demonstrated enrichment of a number
of key components within the exosomes. Interestingly, some of
these were proteins which have previously been located at the api-
cal membrane of intestinal epithelial cells of C. elegans; electron
microscopy also recorded multi-vesicular bodies in the intestinal
tissues of H. polygyrus adults and exosome-like structures released
into the lumen [41], strongly suggesting that the parasite releases
exosomes from its alimentary tract (Fig. 2).
Functionally, we were also able to show the immunomodula-
tory capacity of exosomes derived from extracellular helminths.
When given prophylactically, H. polygyrus exosomes suppress the
innate immune response to the fungus Alternaria alternata, com-
monly associated with respiratory allergies, primarily through the
modulation of type 2 innate lymphoid cells (ILC2s) [41]. Activa-
tion of ILC2s normally drives eosinophilia through the release of
IL-5, which is blocked by parasite exosomes (Fig. 3). Moreover,
H.polygyrus exosomes have been shown to reduce the expression of
IL1RL1/ST2 transcript, both in vitro and in vivo in murine cell popu-
lations. This gene encodes the IL–33 receptor, and is required for the
type 2 immune response to be initiated by ILC2s, consistent with
the observed protection from allergic inflammation conferred by
exosomes in vivo. The importance of the IL-33 ligand-receptor axis
in anti-parasite responses has also been well-documented [18,49].
Thus, our data demonstrated the ability of H. polygyrus-derived exo-
somes to avoid parasite clearance by modulating this key aspect of
the host immune response.
Parallel studies on the digenean trematode cattle parasite, Dicro-
coelium dendriticum, also found exosomes to be released into
culture medium, and to contain over 80 protein components as
well as at least 30 miRNA species with identity or near-identity to
known sequences [50]. Although no functional tests were reported,
the authors highlighted the commonality with the major Schisto-
some miRNAs Bantam, miR-10 and miR-3479 that are detectable
biomarkers in the plasma of infected hosts [51].
Most recently, Nowacki et al. described 30–100 nm exosome-
like vesicles secreted by S. mansoni schistosomulas that are
enriched in specific non-coding RNAs and proteins [52]; over 200
miRNAs were identified as well as 20 tRNA-derived small RNAs
and over 100 proteins. In addition, it was shown that the L3 infec-
tive stage of B. malayi secrete 50–120 nm vesicles rich in miRNA
species, and a protein complement that included not only clas-
sical exosome-associated products, but those with potential to
interfere with host cell responses, such as Cathepsin L [53]. Sig-
nificantly, the infective stage was found to be much more prolific
exosome producers than the adult worm stage, possibly reflect-
ing the demands of transition from vector to host at this point
in the life cycle. Sotillo et al. further reported that adult S. man-
soni worms release 50–130nm-sized exosome vesicles, containing
over 80 identifiable proteins 5 of which are tetraspanins and an
abundant saposin-like protein [54]. These authors also highlighted
that a number of known Schistosome vaccine candidate antigens,
including the tetraspanins discussed above, are prominent compo-
nents of the exosomes. In the related parasite, S. japonicum,  Wang
et al. reported that 30–100 nm vesicles released by adult worms
cultured in vitro for 5 h, detectable upon ultracentrifugation of
the culture medium [55]. These authors also found that S. japon-
icum exosomes stimulated the murine macrophage-like cell line
RAW264.7 to produce nitric oxide alongside other indicators of a
Type 1 pathway, although in this study the protein cargo of the
exosomes was  not identified. The presence of many key proteins,
as well as RNA species, in the secreted vesicles highlights both the
complexity and diversity of cargo within exosomes, with a corre-
spondingly wide range of potential interactions within recipient
cells [56].
A broader scope for helminth exosomes has also emerged
from analyses of the liver fluke Opisthorchis viverrini, a trematode
prevalent in parts of South-East Asia where it is causally linked
to cholangiocarcionoma (bile duct cancer). As with the species
described above, secretory material contained exosomes (measur-
ing in this case 40–180 nm), with a similar spectrum of associated
proteins including tetraspanins [57]. Some exosome-associated
proteins were also found in the bile fluid of infected hosts. Exosome
entry into host cells was  blocked with anti-tetraspanin antibody,
arguing that this protein is likely to be exposed on the vesicular
surface as found for mammalian exosomes. Most significantly, O.
viverrini exosomes were found to stimulate cell proliferation in a
human cholangiocyte cell line, and to also induce their production
of the pro-inflammatory cytokine IL-6 in a manner that was partly
inhibitable by anti-tetraspanin antibody. Taken together, these data
make a strong case that O. viverrini drives potentially tumorogenic
changes in the host bile duct that could account for the carcono-
genic effects of infection with this parasite.
3.3. Helminth miRNAs in exosomes
It has been well documented that non-coding RNAs, and microR-
NAs in particular, transfer between cells and organisms through
their encapsulation within exosomes and other extracellular vesi-
cles [58]. Indeed, this provides a mechanism for protecting RNAs
from degradation when outside of the cell, and presumably enables
an uptake pathway to deliver RNA to the appropriate cellular com-
partment in the recipient. Several of the studies discussed above
identified small RNAs within parasite-derived exosomes, including
those from the nematodes B. malayi [53] and H. polygyrus [41], and
the trematodes D. dendriticum [50] and S. mansoni [52].
In the case of H. polygyrus, we  were able to show a suite of
RNA species packaged within exosomes, including miRNAs such as
let-7, miR200 and bantam [41], which could suppress the mouse
phosphatase Dusp1 using a reporter assay. New data identify-
ing extensive miRNA repertoires in parasitic helminths are now
becoming available, although the distribution of these within secre-
tory exosomes has in most cases yet to be established.
Most importantly, definitive evidence for helminth-derived
miRNAs acting on host genes remains to be obtained; however,
the circumstantial evidence remains enticing; not only are exten-
sive seed sequences shared between helminth and host miRNAs,
but the miRNA-rich exosomes (of H. polygyrus at least) also carry
the worm Argonaut protein [41,59], suggesting that a functional
package for gene repression is being delivered to the target cells.
4. Small molecule interactions
Increasing attention is being paid to how small molecules,
metabolites, hormones and molecular cues, are intimately involved
in intercellular communication. For example, the short-chain fatty
acids (SCFAs, butyrate, acetate and proprionate) are not produced
by the mammalian organism, but are derived from commensals at
levels that promote regulatory T cells [60]; hence dysbiosis can be
pathogenic due to disruption of this pathway [61,62]. Interestingly,
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Fig. 3. Helminths release diverse molecular species to communicate with host cells, including proteins, glycans and exosome components, including miRNAs (A). They also
produce short chain fatty acids (SCFAs) and promote commensal microbes which release SCFAs, expanding the Foxp3+ Treg population (B).
helminths can also synthesise these compounds, [63] as well as pro-
mote the commensal bacteria able to produce significant quantities
of SCFAs [64].
Other small molecules include prostaglandins D2 and E2 pro-
duced by filarial parasites B. malayi [65] and Onchocerca volvulus
[66], and by the skin-invasive cercariae of S. mansoni [67]. In addi-
tion to small molecules and metabolites, helminths also directly
modify host-derived small ligands such as acetylcholine (through
acetylcholinesterase [68]), platelet-activating factor (PAF hydrolase
[69]) and ATP (apyrase [70]), among many others, a discussion of
which are beyond the scope of the current review.
5. Interactions through the microbiome
Helminth parasites, particularly in the intestinal tract, share
their niche with a myriad of micro-organisms, principally hundreds
of bacterial species known as the microbiota [71–73]. Notably,
helminth infections depend to a great extent on the presence of
these commensals: for example, in the absence of caecal bacte-
ria, Trichuris eggs do not hatch in the intestine [74]. Most studies
of the microbiota in mice infected with intestinal helminths have
found significant and occasionally sweeping changes in the species
composition, particularly among Bacteriodes and Lactobacillus pop-
ulations [71–73]. Recently, it was  found that BALB/c mice infected
with H. polygyrus showed expansion of the L. taiwanensis species,
and that the degree of colonisation with this bacterium positively
correlated with both adult worm numbers and the level of Treg acti-
vation [75]. Interestingly, if mice were given L. taiwanensis prior to
receiving H. polygyrus larvae, they were rendered more susceptible
to infection, establishing a mutual promotion between the bacteria
and helminth organisms.
It has also been suggested that the immune modulatory effects
of helminth infection may  be mediated in part indirectly, through
altering the intestinal microbiome. To date, intriguing experiments
have been reported in which the intestinal contents of infected mice
(containing bacteria but also a range of host and parasite products)
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are able to dampen the allergic response when transferred to recip-
ient mice [64]. It will be fascinating to analyse this effect in more
detail, particularly if as with L. taiwanensis, an individual bacteria
is found responsible.
Significantly, a recent report has shown that faecal miRNAs
derived from intestinal epithelial cells can influence the micro-
biome, potentially through direct interactions with bacterial genes
[76]. These miRNAs were suggested to be present in extracellu-
lar vesicles, raising the possibility that both host and helminths
could modulate the microbiome through this novel mechanism,
and indeed as mentioned below, that host exosomes could impact
on the helminth organisms parasitising the intestinal tract.
6. Two  way  street − helminths listening to their host
While the focus of this review has been on how helminths
deliver messages to the host immune system, there are some
intriguing examples of how helminths also detect and respond to
host immune status. Classic studies on N. brasiliensis found that
the adult worms adapt to an immunised host by switching expres-
sion levels and isoforms of secreted acetylcholinesterase [77]. More
recently, detection of host cytokines has been found in Schisto-
somes, which require the presence of host TNF to mature to egg
laying [78] and filarial parasites responding to high IL-5 levels
in vivo by accelerating their maturation and production of off-
spring [79]. An example of a helminth receptor able to ligate a host
cytokine was established in the case of the TGF-! family receptor
of S. mansoni [80].
An intriguing possibility that extracellular vesicles from the host
provide a channel of communications that influence the helminth
parasites, although as yet there are no reports of parasites being
directly receptive to vesicle-mediated signals. However there is a
growing literature demonstrating the use of host-derived extra-
cellular vesicle impact on defence against pathogens. For example,
exosomes derived from IFN-$ stimulated cells were able to induce
antiviral activity and limit viral replication in recipient infected
cells [81,82]. Furthermore, human semen exosomes have also been
implicated in resistance to HIV-1 following their uptake into naïve
cells by reducing viral fitness [83]. Another example of exosome-
mediated host defence is demonstrated during the innate response
to protozoan parasite Cryptosporidium parvum. TLR4-mediated
activation of the host epithelium induces the release of antimi-
crobial peptide-containing exosomes that limit infectivity of the
pathogen in the intestinal environment [84]. The development of
a directed anti-pathogen response by host exosomes has also been
explored for use in a more clinical setting, in which host exosomes
collected from parasite antigen-primed dendritic cells induce pro-
tection from different protozoan infections, including Toxoplasma
gondii [85] and Leishmania major [86].
7. Conclusions and outlook
Helminths have accompanied a vast range of host species
throughout evolution, developing sophisticated pathways of com-
munication with, and even control of, the immune system of their
hosts. The rapid discovery that many helminth species have the
ability to release exosomes to mediate cross-phylum interactions
speaks to the importance of this pathway in host-parasite biology.
In this new light, we now see how the large extracellular parasites,
classified as helminths, may  be able to “reach in’ to the intracellu-
lar machinery of host cells, modifying their behaviour in ever more
remarkable ways. As exosome uptake is not necessarily receptor-
dependent, it is difficult for the host to evolve counter-measures
to block parasite exosome effects, while it would be relatively easy
for the parasite to exploit exosome traffic for effective interference
molecules, from proteins and enzymes to small RNAs and other
modifiers of gene expression. Furthermore, these vesicles offer a
robust vehicle for parasites that may  have to deliver their ‘message’
through extracellular spaces of very different nature, and quite pos-
sibly through cells and tissues too.
Greater understanding of helminth exosomes, however, should
direct us to ways of neutralising their effects, building on our exist-
ing knowledge of immunomodulatory proteins and glycans. For
example, exosomes may  constitute good vaccine targets, if we  can
generate antibody responses to key surface membrane components
that are required for cell entry. In addition, new drug targets may
emerge from defining the pathways required for exosome biogen-
esis in helminths, and/or the events within the host cell that follow
helminth exosome uptake. Hence, a new window has opened not
only on how helminths defeat the immune system, but on how we
can turn the tables and defeat the strategy of the helminth.
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